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Abstract 
Study 1: Brachial artery flow-mediated dilation (FMD) using ultrasonography is used as a 
surrogate measure of coronary artery function.  The purpose of this study was to i) 
assess the reliability of the PhD student in the use of ultrasonography to measure 
endothelial vasomotor function, and ii) develop and validate a custom-designed 
software to measure arterial diameter.  The sonographer demonstrated excellent 
reliability in FMD assessment.  Compared to in-built ultrasound calipers, the custom-
designed software was shown to be a valid measure of arterial diameter.  
Study 2:  This study evaluated the physiological and vascular responses to self-regulated 
exercise (SRE) and high-intensity interval training (HIIT) in individuals with cardiovascular 
disease.  Physiological and perceptual responses were significantly higher in response to 
HIIT than SRE.  There was no change in FMD in either group following exercise. 
Study 3:  This study compared the effects of 4 weeks of traditional cardiac rehabilitation 
and 4 weeks of HIIT on the physiological and perceptual responses, endothelial function, 
and blood lipids in individuals with CVD.  Treadmill time to exhaustion and percentage 
change in FMD were significantly higher in the HIIT group at week 4 than week 1.   
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Chapter 1  
INTRODUCTION 
 Cardiovascular disease (CVD) is the leading cause of morbidity and premature 
mortality in men and women in Ireland 1.  Atherosclerosis, the most common form of 
CVD, involves a complex interplay between oxidative stress, inflammatory stimuli and 
the infiltration of oxidized low-density lipoproteins (LDL).  The endothelium is a 
biologically active barrier between the blood and the various physiological systems, and 
plays a crucial role in maintaining vascular integrity.  Atherosclerosis is initiated when 
the vascular endothelial phenotype is modulated by cardiovascular disease risk factors.  
Damage to the endothelium reduces nitric oxide (NO) bioavailability, leading to the 
development of pathological inflammatory processes and vascular disease 2.   
 Assessment of coronary and peripheral artery endothelial vasodilatory function 
provides useful diagnostic and prognostic information that helps to assess disease 
burden, and guide therapy in patients with CVD, and individuals with normal coronary 
arteries and risk factors for atherosclerosis.  Brachial artery flow-mediated dilation 
(FMD) using high-resolution ultrasonography to provide an indirect measure of NO 
bioavailabilty, is commonly used, and is a surrogate for coronary artery vasomotor 
function.   
 Ultrasound image acquisition during FMD assessment is technically challenging 
and requires specialized training.  The practitioner should be deemed proficient in the 
use of ultrasonography and the FMD technique.  Computerised analysis technology has 
emerged in recent years, and has been shown to significantly improve the accuracy of 
 2 
arterial diameter measurements compared to manual measurements 3.  Existing 
general-purpose segmentation algorithms are unable to reliably delineate the artery 
boundary, and are too computationally intensive to allow for real-time updates and 
feedback.   
 Moderate to vigorous intensity physical activity and improved cardiorespiratory 
fitness, specifically regular exercise training can delay the decrease in endothelial 
function with ageing 4 and can reverse impairment of endothelial function in individuals 
with documented CVD 5.  A single bout of exercise can also transiently alter 
atherosclerotic CVD risk factors and endothelial function.  
 The culture of exercise prescription can be perceived as highly controlling and 
aversive.  Physiologically based exercise prescriptions often exceed an individual’s 
preferred level of intensity.  Using effort perception to self-regulate preferred intensity 
may allow individuals to complete an activity within their perceptual preference range 
and without undue physiological strain.  Although effort perception is used to self-
regulate the pace of many daily activities, no studies have examined the effect of an 
acute bout of self-regulated exercise on endothelial function in men and women with 
CVD.  
 High-intensity interval training (HIIT) involves repeated bouts of high intensity 
exercise (10 to 300 sec) interspersed with active or passive recovery periods of equal, 
shorter, or longer duration 6.  Historically, HIIT has been used by athletes, but a number 
of studies have shown its efficacy and safety in improving exercise capacity and 
endothelial function in individuals with CAD and heart failure 7,8.  To date, only 4 studies 
have examined the effect of HIIT on endothelial function in men and women with CVD 8–
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11.  These studies were 8 - 24 weeks in duration and predominantly used exercise 
intervals of 4 min.  Recent studies indicate that 4 - 8 sessions of HIIT involving 30 sec 
exercise intervals illicit significant physiological and metabolic improvements in healthy 
individuals 6,12.   
Study Aims 
 The following series of studies will i) assess user reliability in the use of 
ultrasonography to measure endothelial vasomotor function, ii) develop and validate a 
custom-designed software to measure arterial diameter, iii) compare the exercise 
responses to an acute bout of self-regulated and high-intensity interval exercise, iv) 
compare the physiological and perceptual responses to 4 weeks of high-intensity 
interval training or community-based cardiac rehabilitation in individuals with CVD.  
Objectives 
1. To assess the reliability of a practitioner in the use of ultrasonography to 
measure endothelial vasomotor function 
2. To develop and validate a reliable custom-designed analysis tool to measure 
arterial diameter 
3. To evaluate the acute physiological and vascular responses to self-regulated (SR) 
and high-intensity interval exercise (HIIE) in individuals with CVD 
4. To compare the effects of 4 weeks of traditional cardiac rehabilitation and 4 
weeks of HIIT on the physiological and perceptual responses, endothelial 
function, and blood lipids in individuals with CVD 
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Hypotheses  
1. The sonographer will demonstrate reliability in the use of ultrasonography to 
assess FMD 
2. The custom-designed software will be a valid and reliable measure of arterial 
diameter 
3. Acute physiological and vascular responses will be significantly greater following 
a single bout of HIIE compared to SRE 
4. Physiological and vascular responses will be significantly greater following 4 
weeks of HIIE compared to 4 weeks of traditional phase IV cardiac rehabilitation 
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Chapter 2  
REVIEW OF LITERATURE 
Introduction 
 Cardiovascular disease (CVD) collectively refers to diseases of the heart and 
circulatory system, and typically includes coronary artery disease (CAD), cerebrovascular 
disease, and peripheral vascular disease, rheumatic heart disease, congenital heart 
disease, aortic aneurysm, deep venous thrombosis and pulmonary embolism.  It is the 
leading cause of mortality worldwide.  According to the World Health Organisation 
(WHO) roughly 17.3 million people died from CVD in 2004, accounting for 29% of all 
global deaths.  Ireland has the highest mortality rate from CVD in the EU (40%) 13.  In 
Europe, CVD is the number one cause of mortality accounting for nearly half of all 
deaths, while in the European Union it accounts for more than 2 million deaths each 
year 14.  In Ireland, approximately 10,000 people die each year from CVD accounting for 
36% of the deaths, making it the number one cause of death.  The socio-economic 
impact of CVD to the EU was €192 billion in 2006.  A total of 6  of the Irish healthcare 
budget in 2009 was spent on cardiovascular disease treatments 1. 
 Atherosclerosis is the most common cause of CVD, and is considered to be a 
chronic inflammatory disease resulting from the progressive interaction between 
modified lipoproteins, monocyte-derived macrophages, and endothelial and smooth 
muscle cells 15 in the sub-endothelial space of primarily large and medium-sized elastic 
and muscular arteries 16.  The inflammatory process results in the formation of 
atherosclerotic plaques, through a slow, insidious process over many years 15.  A 
 6 
substantial lag period exists between the initial development of atherosclerosis and 
clinical manifestations such as angina, and myocardial infarction.   
 The endothelium is a permeable biological barrier between the blood stream 
and the various physiological systems 17.  It plays a crucial role in maintaining vascular 
integrity, by releasing a wide variety of substances that regulate leukocyte adhesion, 
migration and activation, thrombus formation and vessel tone.  Atherosclerosis is 
initiated when the vascular endothelial phenotype is modulated by cardiovascular 
disease risk factors.  Endothelial function can be determined non-invasively by assessing 
flow-mediated vasodilation (FMD) of the brachial artery using ultrasonography.  Brachial 
artery FMD correlates with endothelial coronary function.  Brachial artery ultrasound 
has emerged as a useful tool for assessing the efficacy of preventive and/or 
interventional approaches to reducing the burden of CVD.  Exercise has been shown to 
improve endothelial function and decrease cardiovascular risk.  The purpose of this 
chapter is to review i) the biology of the endothelium, ii) the role of the vascular 
endothelium in the development of atherosclerosis, iii) the assessment of endothelial 
function and iv) the effect of acute and chronic exercise on endothelial function 
Vascular Endothelial - Structure 
 The endothelium is a 0.2 to 4 µm-thick monolayer of squamous endothelial cells 
that line the lumen of the entire surface of the vascular tree.  It represents a surface 
area of approximately 4000 to 7000 m2.  Malpighi's discovery in the 17th century of the 
endothelium as a physical separation between blood and tissue with no substantial 
functionality persisted through the nineteenth and twentieth centuries.  Landmark 
studies in the 1980’s demonstrated the obligatory role of endothelial cells in 
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acetycholine (ACh)-mediated vasodilation 18 and in the paradoxical ACh-mediated 
vasoconstriction of atherosclerotic vessels 19.  The endothelium is now viewed as a large 
endocrine organ system that operates as a dynamic barrier that maintains vascular 
integrity.  The healthy endothelium is anti-atherogenic, through favourable paracrine 
effects on vasodilation, inhibition of leukocyte adhesion, platelet aggregation and 
coagulation, and promotion of healing via progenitor cells.  However, because of its 
position in the vascular wall, it is also the target of hemodynamic and biochemical 
perturbations. 
Vascular Endothelial - Functions 
 The endothelium acts as a selectively permeable barrier, permitting the 
exchange of solutes between the blood and the subendothelial space to meet the 
metabolic demands of the surrounding tissue.  The movement of glucose and amino 
acids across the intima-lumen barrier relies on the endothelial derived transporters.  For 
example, glucose transporters, GLUT-1 and GLUT-4, are expressed in endothelial cells.  
Multiple transport systems also exist for the transport of amino acids across the intima-
luminal barrier.  One of these transport systems, the y+ cationic amino acid transporter, 
is responsible for the transport of L-arginine.  Caveolae are invaginations in the cell 
membrane and are important vesicle carriers, responsible for transcellular transport in 
endothelial cells.  Tight junctions are located between endothelial cells and can 
selectively regulate the passage of ions, water, and various macromolecules through 
paracellular spaces, and maintain cell polarity by preventing the movement of charged 
molecules.   
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 The endothelium provides a non-thrombogenic blood-tissue interface due to 
the expression of antiplatelet and anticoagulant molecules, and the synthesis of 
prostacyclin (PGI2), heparan sulphate and thrombomodulin-thrombin complex.  The 
diatomic gas, nitric oxide (NO), produced by endothelial cells is a fundamental 
determinant of cardiovascular homeostasis.  It is a potent vasodilator, counteracts 
leukocyte adhesion to the endothelium, attenuates vascular smooth muscle 
proliferation and migration, suppresses platelet aggregation, and can influence the 
production of superoxide anion 20.  The antiplatelet activity of endothelial-derived NO is 
considerably augmented in the presence of prostacyclin (PGI2).  NO also reduces the 
production by the endothelial cells of endothelin 21, a potent vasoconstrictor and 
adhesion molecules 22.  These biological actions make NO an important component in 
the endogenous defence against vascular injury, inflammation, and thrombosis, all key 
events in the development and progression of atherosclerosis. 
Vascular Smooth Muscle - Contraction 
 Healthy intact endothelial cells respond to humoral, neural and mechanical 
stimuli by synthesizing and releasing vasoactive substances that regulate vascular tone 
by relaxing or contracting the underlying smooth muscle 23.  Myosin light chains (MLC) 
are 20-kD regulatory subunits found on the myosin heads that regulate cross-bridge 
cycling in vascular smooth muscle (VSM).  Myosin light chain kinase (MLCK) is an enzyme 
that phosphorylates myosin light chain in the presence of ATP.  For contraction to occur, 
MLC-K must phosphorylate the myosin light chain, enabling the molecular interaction of 
myosin with actin.  Energy released from ATP by the action of myosin ATPase activity 
results in the cycling of the myosin cross-bridges with actin.  In some smooth muscle 
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cells, the phosphorylation of the light chain of myosin is maintained at a low level in the 
absence of external stimuli (i.e., no receptor or mechanical activation). This activity 
results in what is known as smooth muscle tone, and its intensity can be varied. 
 Vascular smooth muscle (VSM) contraction can be initiated by mechanical, 
electrical, and chemical activation of the actin and myosin contractile proteins and 
involves a number of signal transduction pathways that converge to increase 
cytoplasmic calcium [Ca2+].  Cytoplasmic calcium reflects the balance between the 
calcium that i) enters the cell from the extracellular space ii) is released by intracellular 
storage sites and iii) is re-sequestered by the intracellular storage sites, or removed from 
the cell. 
 Electrical depolarization of the VSM cell membrane elicits contraction, most 
likely by opening of voltage and ligand gated L-type calcium channels, which increases 
the intracellular [Ca2+].  Binding of agonists such as norepinephrine, angiotensin II, and 
endothelin to a Gq protein coupled receptor results in the activation of phospholipase C, 
and subsequent hydrolysis of phosphatidylinositol 4, 5-bisphosphate (PIP2) to inositol 
1,4,5-triphosphate (IP3) and diacylglycerol, (DAG).  The binding of IP3 to receptors on the 
sarcoplasmic reticulum results in the controlled release of [Ca2+] into the cytosol, where 
it rapidly increases above the 0.1 mM threshold for contraction.  Re-sequestering of 
calcium in the sarcoplasmic reticulum by an ATP-dependent calcium pump or removal 
from the cell to the external environment by either an ATP-dependent calcium pump or 
by the sodium-calcium exchanger (antiport) decreases intracellular [Ca2+].  The antiport 
uses the energy of the Na+ gradient for influx.   
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 Cytoplasmic [Ca2+] binds with the acidic protein calmodulin, and the calcium-
calmodulin complex activates myosin light chain kinase, and in conjunction with actin, 
cross-bridge cycling occurs, causing the vascular smooth muscle to contract and the 
lumen of blood vessels to narrow (Figure 2.1).  The calcium concentration within the cell 
is transient, and the contractile response is augmented at a given intracellular [Ca2+] by a 
calcium-sensitizing mechanism brought about by the inhibition of myosin light chain 
phosphatase (MLCPh) 24.  This promotes the contractile state, since the light chain of 
myosin cannot be dephosphorylated.   
 
Figure 2.1: Vascular smooth muscle contraction:  
R, receptor; Gq, Gq protein ; PL-C, phospholipase C; PIP2, phosphatidylinositol 4, 5-
bisphosphate; IP3, inositol 1,4,5-triphosphate; DAG, diacylglycerol; Ca
2+, calcium; MLC, 
myosin light chain; MLCK, myosin light chain kinase; P, phosphate; SR, sarcoplasmic 
reticulum.  An increase in free intracellular [Ca
2+
] can result from increased flux of [Ca
2+
] 
into the cell through calcium channels or by release of [Ca2+] from internal stores (e.g. SR).  
The free [Ca2+] binds to a calcium-binding protein called calmodulin.  Calcium-calmodulin 
activates MLCK, an enzyme that is capable of phosphorylating MLC in the presence of ATP.  
MLC phosphorylation leads to cross-bridge formation between the myosin heads and the 
actin filaments resulting in smooth muscle contraction. 
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Vascular Smooth Muscle - Relaxation 
 Smooth muscle relaxation requires a decreased intracellular [Ca2+] and 
increased MLCPh activity.  During relaxation, receptor and voltage-operated calcium 
channels in the vascular smooth muscle plasma membrane close resulting in a reduced 
[Ca2+] entry into the cell.  The sarcoplasmic reticulum and the plasma membrane contain 
Ca-ATPases that, along with Na+/Ca2+ exchangers, remove [Ca2+] from the cell.   
 The endothelium acts as a complex mechanical signal-transduction interface 
between the vessel wall and the circulating blood and assist in the regulation of vascular 
smooth muscle cell relaxation.  Furchgott and Zawadzki 18 were the first to demonstrate 
the obligatory role of the endothelium in the relaxation of isolated rabbit aorta in 
response to acetylcholine.  Subsequent studies revealed that the endothelium-
dependent response to exogenously administered acetylcholine (ACh) was attributable 
to the production and diffusion of NO, a hydrophobic, diatomic gas that is produced by 
endothelial derived nitric oxide (eNOS) in response to changes in shear forces or via a 
variety of agonists (histamine, bradykinin) acting on specific endothelial cell membrane 
receptors.   
Shear Forces 
 Blood flow exerts a frictional force on the endothelial surface of the vessel 
lumen termed, shear stress.  Mechanosensors located on the endothelial cells detect 
shear stress and alter endothelial cell function in a process called mechanotransduction 
25.  The increase in hemodynamic shear results in [Ca2+] efflux from the endoplasmic 
reticulum into the cytoplasm.  Calcium binds to calmodulin and activates endothelial 
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nitric oxide synthase (eNOS) resulting in the synthesis of nitric oxide (NO) from the 
terminal guanidino nitrogen of its amino acid precursor, L-arginine.  The NO molecule 
diffuses abluminally into the adjacent vascular smooth muscle, where it binds to the 1 
subunit of the heterodemic enzyme guanylyl cyclase, leading to activation of the 
enzyme, and the production of cyclic guanosine monophosphate (cGMP).  This 
intercellular signaling molecule leads to the inhibition of calcium influx into the SMC, 
and decreases calcium-calmodulin stimulation of myosin light chain kinase 26.  This in 
turn decreases the phosphorylation of myosin light chains, decreasing smooth muscle 
tension development and causing vasodilation.  
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Figure 2.2:  Shear stress-induced vascular smooth muscle relaxation:  
Ca2+, calcium; eNOS, endothelial nitric oxide; L-arg, L-arginine; NO, nitric oxide; GC, 
guanylyl cyclase; GTP, guanosine triphosphate; cGMP, cyclic guanosine monophosphate.  
Increases in hemodynamic shear result in [Ca2+] efflux from the endoplasmic reticulum 
into the cytoplasm.  [Ca2+] binds to calmodulin and activates eNOS resulting in the 
synthesis of NO from the terminal guanidino nitrogen of its amino acid precursor, L-arg.  
The NO molecule diffuses abluminally into the adjacent vascular smooth muscle, where it 
binds to the β1 subunit of the heterodemic enzyme GC, leading to activation of the 
enzyme, and the production of cGMP.  This intercellular signaling molecule leads to the 
inhibition of [Ca2+] influx into the smooth muscle cell, and decreases calcium-calmodulin 
stimulation of myosin light chain kinase.  This in turn decreases the phosphorylation of 
myosin light chains, decreasing smooth muscle tension development and causing 
vasodilation. 
 The significance of NO as a regulator of coronary vasomotor tone can be 
demonstrated experimentally by inhibiting its synthesis.  NG-monomethyl-L-arginine (L-
NMMA) is a relatively non-selective inhibitor of all NOS isoforms that competes with L-
arginine as the substrate for NO synthesis by the eNOS, but cannot be oxidized to form 
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NO 27.  It increases basal coronary vascular resistance and reduces the vasodilator 
response to the endothelium-dependent vasodilator agonists acetylcholine (ACh) and 
bradykinin in isolated perfused hearts 28.  
 There is no clear consensus as to how the frictional forces in response 
haemodynamic shear are sensed by endothelial cells.  Adams et al., 29 proposed that 
changes in membrane potential, associated with the activation of K+, Na+, and Cl- ion 
channels, alter the electrochemical gradient for Ca2+ transport across the endothelial cell 
membrane.  The serine/threonine protein kinase B (Akt) can directly phosphorylate and 
activate eNOS in response to shear stress, and the effect is independent of intracellular 
[Ca2+].  The stimulation of Akt phosphorylation by shear stress appears to be mediated 
by triphosphoinositide 3-OH kinase.  Repetitive episodes of increased hemodynamic 
shear causes an up-regulation of eNOS, mRNA and protein, permitting the endothelial 
cell to increase NO production 30.   
 The NO output elicited by shear stress is approximately a third of agonist-
induced NO production, but it is maintained for longer duration.  In addition to NO, 
other endothelial-derived vasodilators, prostacylin (PGI2) and endothelium-derived 
hyperpolarizing factors (EDHF), act locally to modulate vascular smooth muscle tone.  
The endothelium also produces vasoconstrictors such as endothelin and angiotensin II 31.  
The balance between vasodilators, vasoconstrictors and the sympathetic nervous 
system maintains blood vessel tone.  
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Endothelial Function – Assessment 
Invasive Assessment 
 The realization that endothelial dysfunction precedes the early morphological 
atherosclerotic changes in the arterial walls, and is significantly correlated with future 
cardiovascular events has resulted in the development of assessment techniques to 
monitor coronary and peripheral vascular health.  Clinically, coronary endothelial 
function is commonly assessed by measuring the endothelial receptor–mediated 
vasomotor response to intracoronary infusion of ACh or other agonists, and 
measurement of the subsequent change in vessel diameter using quantitative coronary 
angiography 32.   
 Angiographically normal coronary arteries dilate in response to ACh, and the 
vasodilator response is predominantly caused by the release of NO from the intact 
endothelial cells.  In the presence of endothelial dysfunction, intracoronary infusion of 
ACh causes paradoxical vasoconstriction as a result of a direct muscarinic smooth muscle 
constrictor effect 19.  Other endothelial-dependent agonists such as bradykinin and 
substance P are also used as a measure of endothelial function 33.  Exogenous 
nitrovasodilators such as glyceryl-trinitrate (GTN) and sodium nitroprusside (SNP) can 
act directly on the smooth muscle to activate guanylyl cyclase 34. 
 The nitric oxide synthase inhibitor, N-monomethyl-L-arginine (L-NMMA) is a 
commonly used pharmacological tool for investigating the contribution of NO to 
endothelial vasomotor responses 27.  Infusion of L-NMMA ameliorates ACh-induced 
paradoxical vasoconstriction, indicating that ACh-induced endothelial vasodilation is 
mediated, at least in a large part, by NO 35.   
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Cold Pressor Test 
 The cold pressor test (CPT) is another commonly used experimental technique 
to assess endothelial-dependent coronary vasomotor function.  Immersion of an 
extremity (foot, hand, forearm) in ice water activates the sympathetic adrenergic system 
resulting in increased heart rate, arterial blood pressure, and myocardial oxygen (M  O2) 
demand.  Angiographically normal coronary arteries dilate to accommodate the 
increased blood required to satisfy increased M  O2 demand.  In contrast, CPT can also 
induce paradoxical vasoconstriction in coronary arteries with different degrees of 
stenosis.  The vasodilatory response is thought to be mediated through -
adrenoreceptors with direct stimulation of nitric oxide synthesis and through a flow-
dependent release of endothelial-derived nitric oxide 36.  The response to CPT is studied 
using quantitative angiography.  
Venous Occlusion Plethysmography  
 Venous occlusion plethysmography is a relatively inexpensive, versatile, well-
tolerated and reproducible technique used to measure changes in forearm resistance 
and blood flow in response to arterial infusions of varying concentrations of endothelial-
independent and dependent agonists.  This procedure is however, invasive due to the 
arterial cannulation that is required for infusion. 
Non-Invasive Assessment 
 Although the assessment of endothelial function in the coronary artery is 
clinically important, the invasive nature of these assessments renders them impractical 
for use in asymptomatic individuals, and also limits repeated testing during serial follow 
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up.  Less invasive methods have been developed that are safe, reliable, and easy to 
perform. 
Pulse Wave Velocity 
 Compliance refers to the ability of a blood vessel to distend and increase 
volume with increasing transmural pressure.  Stiffness is the inverse of compliance and 
non-compliant blood vessels have a large transmural pressure for a given volume.  Pulse 
wave velocity (PWV) is a non-invasive, highly reproducible estimate of arterial stiffness.  
The technique involves measuring the time it takes for a pressure pulse to travel 
between two points in the arterial system, usually the carotid artery and femoral artery 
37. 
Brachial Artery Flow-Mediated Dilation 
 The principle of brachial artery FMD is based on the ability of healthy, intact 
endothelial cells to detect, and respond appropriately, to changes in shear stress with 
acute adjustments in vascular tone.  This method uses high-resolution ultrasonography 
to measure the diameter of the brachial artery before and after a brief period of arterial 
occlusion.  As a result of arterial occlusion, downstream resistance vessels dilate via 
autoregulatory mechanisms.  Release of the cuff causes a transient increase in blood 
flow through the brachial artery (reactive hyperemia) to accommodate the dilated 
resistance vessels.  This subsequent increase in blood flow causes the brachial artery to 
dilate 38.  The change in artery diameter is expressed as a percentage change from 
baseline diameter. 
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 It is believed that brachial artery FMD occurs predominantly as a result of NO 
release from the endothelial cells.  As in the coronary circulation, the FMD response of 
the brachial artery can be compared to the endothelium-independent dilator response 
to sublingual glyceryl-trinitrate (GTN) 39.  The non-invasive nature of the technique 
allows for serial assessment of endothelial function in young and old, healthy and 
diseased, and permits accurate evaluation of lifestyle and pharmacological interventions 
at an early, preclinical stage when the disease is likely to be reversible 40.   
 Using both hemodynamic shear and pharmacological agents as a stimulus in the 
peripheral circulation, and coronary arteries respectively, Anderson et al., 41 were the 
first to report a modest but significant relation between endothelium-dependent 
vasodilation in the brachial and coronary arteries.  Later, Takase et al., 42 used shear 
stress as the stimulus in both the brachial and coronary arteries to investigate the 
vasodilatory response in both vascular beds, and found a strong correlation between 
FMD in the coronary and the brachial arteries.  These findings indicate that FMD in the 
brachial artery can be used as a surrogate measure for coronary artery endothelial 
function. 
Brachial Artery FMD - Methodology 
 FMD assessment of endothelial function is technically challenging and a strict, 
standardized protocol is essential to provide accurate and reproducible data 38,43.  In 
addition to the brachial artery, FMD can also be assessed in the radial, axillary and 
superficial femoral arteries.  A limitation to using these vessels is their small diameter.  
Vessel diameters < 2.5 mm are difficult to accurately measure 44. 
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 Ultrasound images should be attained by the same, experienced and highly-
trained sonographer.  A number of factors that have been shown to affect the 
measurement of FMD should be controlled.  These include room temperature 45, time of 
day 46, diet 47, tobacco 48, exercise 49, caffeine 50, vitamin C 51, menstrual cycle phase 52, 
medications 47, sympathetic stimuli 53, and current viral illness 54.  Where possible all 
vasoactive medications should be withheld for at least four half-lives 55.   
Occlusion Time 
 Corretti et al., 38 compared different methodological aspects of the FMD 
technique in order to determine the most accurate means to assess endothelial 
function.  Similar flow increases have been found in response to 1, 3 and 5 min of cuff 
occlusion.  A statistically significant vasodilation occurred only after the 5 min duration.  
Since the resultant change in diameter are similar following 5 and 10 min occlusion 
periods, the more tolerable duration of 5 min is recommended.  
Cuff Placement 
 The sphygmomanometric cuff is inflated to at least 50 mmHg above systolic 
blood pressure to occlude arterial inflow, resulting in ischemia, and arterial occlusion is 
sustained for a standardized period of time.  Placement of the cuff has varied, with both 
the upper arm (proximal to the area of insonation) or the lower arm (distal to the area of 
insonation) being used.  Upper arm occlusion is technically more challenging due to the 
distorted image following the collapse of the brachial artery and the shift in soft tissue 
37,56.  
 20 
 A significantly greater peak hyperemic flow and FMD has been found when the 
cuff is placed on the upper arm, proximal to the area of isonation, than on the lower arm 
distal to the imaging site 57,58.  This may be due to the greater flow stimulus resulting 
from recruitment of resistance vessels, or perhaps to the direct effects of ischemia on 
the brachial artery 37.  The vasodilatory response to upper arm ischemia has also been 
shown to persist for up to 20 min 57.  In contrast, when the cuff is placed distal to the 
imaging site, on the lower arm, the vasodilatory response following vasoconstriction, 
reverses rapidly.  Doshi et al., 58 investigated how the placement of the cuff, relative to 
the area of insonation, can influence the degree to which endothelium-derived NO 
mediates the vasodilator response.  Doshi compared FMD with and without prior L-
NMMA infusion when the cuff was placed proximal and distal to the area of insonation.  
Occlusion on the lower arm distal to the ultrasound probe was associated with a 7% 
FMD response, which was abolished by L-NMMA.  When the cuff was inflated proximal 
to the ultrasound probe, there was a 12% FMD response that was only partially 
decreased by NO blockade.  These results indicate that dilation following lower arm 
occlusion is exclusively NO-mediated, whereas dilation following upper arm occlusion is 
only partly mediated by NO 15.  It is possible that the measured vasodilatory response 
obtained with upper arm occlusion may have been confounded by ischemic mediators 
other than NO.  
Timing Post Occlusion 
 The standard procedure for assessing endothelial function using FMD is to 
measure the peak artery diameter approximately 60 s after cuff release, or 45 – 60 s 
after peak reactive hyperemic blood flow 45,59.  The time to reach post occlusion peak 
 21 
diameter following 5 min of occlusion may be longer in individuals with CVD, or CVD risk 
factors compared to healthy individuals 60.  Irace et al., 60 measured FMD in the brachial 
artery at 50, 120, 180, and 300 sec following 5 min of forearm occlusion in apparently 
healthy men and men with Type II diabetes mellitus (T2DM).  Maximum FMD occurred 
after 50 sec and 120 sec in the healthy and diabetic men, respectively.  FMD response in 
the diabetic cohort was significantly lower than the healthy controls 50 sec following the 
cuff release.    
 Using a similar study design Thijssen et al., 61 used continuous diameter 
assessment to examine the time-course of brachial artery FMD after 5 min of forearm 
ischemia in 12 young, 12 fitness-matched older and 12 older untrained individuals.  
Arterial diameter was recorded 30 sec before and continued for 3 min after cuff release.  
Using the 50 - 70 sec or 70 – 90 sec post-cuff deflation time period, the FMD response 
calculated was significantly lower in all groups compared with the true peak FMD values 
observed.  There was a significant difference in brachial artery FMD between sedentary 
older subjects and healthy subjects when using the continuous assessment method.  
However, there was no difference in brachial artery FMD between groups when 
comparing diameter changes at 60 s post cuff release.  A limitation of this study is the 
fact that the diameter assessments were recorded at 30 sec interval.  With the absence 
of continuous diameter measurement, there is a possibility that the true peak diameter 
may have fallen between the predetermined time points. 
Gating 
 Brachial arterial diameters vary significantly throughout the cardiac cycle 56.  
ECG gating, a technique in which FMD measurements are performed at a pre-
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determined time-point during the cardiac cycle (e.g., R-wave or peak of the T-wave) is 
used to standardize FMD measurements.  Failure to use ECG gating may increase the 
magnitude of error in arterial diameter and FMD measurements 56.  Chuang et al., 56 
found that ignoring the temporal phase in the cardiac cycle artificially increased FMD 
values into the normal range despite impaired ‘true F D’  The range of apparent F D 
values calculated by ignoring the cardiac cycle was on average nearly threefold the 
magnitude of ‘true F D’.  Investigations into the necessity of QRS gating have yielded 
conflicting results.  Corretti’s guidelines in 2002 38 recommend ECG-triggered 
measurements for accurate FMD assessment 38.  However, recent data showed FMD 
measurements calculated with an average of the vessel diameter over the entire cardiac 
cycle produces equivalent results over a wide range of compliance 62,63. 
 
 
Figure 2.3: ECG Gating: Brachial artery diameter is recorded as an average of diameter measurements 
coinciding with 2-3 consecutive ECG R waves. 
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Normalization 
 The magnitude of the FMD response is related not only to the health of the 
vascular endothelium, but also to the magnitude of the imposed stimulus between 
subjects 64,65.  A limitation of the FMD technique is the uncontrolled nature of the 
evoked shear stress stimulus.  Recent evidence suggests that the mechanisms of FMD 
may vary depending on the rate of onset and duration of the shear stress stimuli.   
 Normalisation of the dilatory response to shear stress has been recommended as 
an appropriate way to express FMD 43, although there is no clear consensus as to what is 
the most accurate method 66.  Equating FMD responses to the underlying stimulus is 
believed to i) reduce day-to-day variability, ii) account for the magnitude of the stimulus 
evoking FMD, and iii) allow endothelial vasomotor measurements to be compared 
between studies and laboratories 67. 
 Shear stress is a function of vessel diameter, blood flow velocity at the vessel 
lumen, and blood viscosity, such that shear stress = V/D, where V is mean blood flow 
velocity, D is vessel diameter and  is blood viscosity 68.  Although it does not account 
for blood viscosity, shear rate (SR) (velocity/diameter) is an accepted surrogate measure 
of shear stress, as it considers both blood flow velocity and vessel diameter 43.  When 
mean blood flow velocity is not available, peak blood flow velocity (vmax) can be used to 
calculate shear rate, such that shear rate = 4 vmax/diameter 
69. 
 The technique of normalizing to the shear stimulus has evolved significantly.  
Initially, normalizing FMD to the shear stimulus used the peak shear response to 
occlusion 70.  Measuring the AUC shear response from post-occlusion to the time at 
which peak diameter occurs is now a commonly used means of normalisation 71.   
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Cardiovascular Disease Risk Factors and Vascular Health 
 Non-modifiable cardiovascular disease risk factors such as aging and a family 
history of CVD, and modifiable risk factors, including active and passive smoking, lipid 
disorders, hypertension, diabetes mellitus, obesity, and physical inactivity, among 
others, have been shown to promote the development of atherosclerosis through their 
deleterious effects on endothelial structure and function 72,73.  The underlying 
mechanisms through which risk factors initiate vascular injury are multifactorial.  The 
predominant mechanism is believed to be oxidative stress and redox injury resulting in 
decreased synthesis or increased degradation of NO 74.  The progressive inability of 
endothelial cells, exposed to risk factors, to generate sufficient NO promotes a vascular 
phenotype prone to atherogenesis 20.   
 Reactive oxygen species (ROS) interact with NO to reduce its bioavailability 20 
and directly damage cellular structures via the production of peroxynitrate.  O’hara et 
al., 75 examined the presence of superoxide anion (O-2) in normal vessels and vessels 
from cholesterol-fed animals and found there was an excess production of O-2 in 
hypercholesteremic vessels.  This O-2 was found to be endothelial-derived and 
responsible for accelerated degradation of NO.  In contrast, normal vessels were shown 
to have a protective effect, with reduced production of O-2.  The excessive production of 
O-2 in diseased vessels is thought to be related to excessive quantities of the enzyme 
xanthine oxidase.  
 The underlying pathogenesis of atherosclerosis involves an imbalance of lipid 
metabolism and a maladaptive immune response entailing a chronic inflammation of the 
arterial wall 76.  Elevated levels of total cholesterol, LDL-C, triglycerides, low levels of 
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HDL-C and an elevated ratio of total to HDL-C are inversely related to endothelial 
function 77, even in the absence of CVD 78. 
 A large number of clinical studies have demonstrated improved coronary and 
brachial artery endothelial function in response to both pharmacological 79 and non-
pharmacological therapies 80 in men and women, with and without CVD, with markedly 
elevated or borderline total cholesterol, LDL-C, triglycerides, low levels of HDL-C or an 
elevated ratio of total to HDL-C.  Putative mechanisms for the associated link between 
improved lipid profile and endothelial function are increased synthesis of NO 81 and  
improved antioxidant capacity 82. 
 Hypertension is the most common cardiovascular risk factor in the world 83.  
Patients with hypertension are characterized by functional and structural vascular 
abnormalities.  Brachial artery FMD is significantly reduced and the severity is related to 
the duration of blood pressure elevation.  There is conflicting opinion as to whether 
hypertension precipitates endothelial dysfunction or a defect in endothelial NO activity 
acts directly or indirectly to increase the risk of developing hypertension.  
 Type 2 diabetes mellitus (T2DM) is associated with impaired endothelial 
responses to pharmacological and physiological stimuli 83.  In addition, disturbances in 
the endothelium are a fundamental component in the development of diabetic 
microvascular and macrovascular complications 84.  Hyperglycemia is the major causal 
factor in the development of endothelial dysfunction in individuals with T2DM.  
Individuals with T2DM tend to have a constellation of other risk factors, including 
obesity, hypertension, elevated triglycerides and LDL-C and reductions in HDL-C, that 
also impair endothelial function 85.  
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 Endothelial function declines with age 74 and this can occur independent of 
other cardiovascular risk factors 86.  Although, the underlying mechanism of age-related 
development of vascular dysfunction is difficult to assess in humans, numerous 
contributing factors have been identified.  These include reduced bioavailability of NO 
due to oxidative stress, increased endothelin-1 (ET-1) bioactivity, reduced endothelial 
production of prostaglandins, vascular inflammation, production of advanced glycation 
end-products, increased endothelial apoptosis and reduced expression of estrogen 
receptors 86.  Other contributing factors to the modulation of vascular endothelial 
function with age include physical activity, diet, body composition, menopause, and 
vitamin D status.  
 Studies in children and adults have consistently found a significant relation 
between obesity and endothelial dysfunction, and weight loss in overweight or obese 
individuals improves endothelial function 77.  Short-term (8 weeks) weight cycling 
involving the repeated loss and regain of body weight also impairs endothelial function  
78.  Adipose tissue is a proinflammatory organ.  There is evidence that visceral fat may 
contribute to endothelial dysfunction through the direct effect of the adipokines, 
adiponectin and TNF-α, which are secreted by adipose tissue following the recruitment 
of monocytes  79. 
Endothelial Function - Prognostic Value 
 The functional and structural integrity of the endothelium is critical in 
maintaining vascular homoeostasis.  The presence of atherosclerosis has been shown to 
affect the vasomotor responses of the diseased vessel to shear stress, and vasoactive 
compounds such as ACh, serotonin, thrombin, and ADP 87. 
 27 
 Assessment of coronary and peripheral artery endothelial vasodilatory function 
may provide substantial diagnostic and prognostic information that may be useful to 
assess disease burden and guide therapy in patients with CAD and those with normal 
coronary arteries and risk factors for atherosclerosis.  The prognostic significance of 
endothelial function as a predictor of cardiovascular events in healthy individuals and 
those with vascular disease has been addressed in a number of studies.   
 In a retrospective study, Halcox et al., 88 evaluated the relation between 
coronary endothelial function and the occurrence of cardiovascular death, in patients 
with and without coronary atherosclerosis.  Study participants underwent cardiac 
catheterisation at baseline and follow-up for a mean of 46 ± 3 months.  Patients in the 
tertile with the best microvascular responses to ACh, and those with epicardial dilation 
in response to ACh had improved survival among all patients, as well as those in the 
subset without CAD.  Endothelium-independent responses were not predictive of 
outcome. 
 Endothelial-dependent coronary vasoreactivity was associated with a 
significantly higher incidence of cardiovascular events over a 7.7-year period in 147 
patients undergoing either routine catheterisation, evaluation of chest pain or 
percutaneous transluminal coronary angioplasty (PTCA) for single vessel disease 89.  
Tests of coronary vasoreactivity were significant, independent predictors of a poor 
prognosis, even after adjustment for traditional cardiovascular risk factors, or the 
presence of atherosclerosis.  Coronary artery endothelial dysfunction was also found to 
be associated with a higher rate of cardiac events over a 28-month period in patients 
with non-obstructive CAD 90.  In patients with a normal coronary angiogram, abnormal 
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vasoreactivity of epicardial coronary arteries (0 to 30% vasoconstriction) in response to 
sympathetic stimulation (cold pressor test) was associated with the risk of developing 
cardiovascular events 91. 
 Abrogated brachial artery FMD predicts complications in high-risk patients 30 d 
and 1.2 yr following vascular surgery 92,93, and cardiac events in patients with chest pain 
and no angiographic evidence of CAD, heart failure (HF) or valvular defects 94.  During 5 
years of follow-up, patients with impaired brachial artery reactivity and chest pain were 
more likely to undergo PTCA, and coronary artery bypass graft (CABG) surgery than 
patients with normal flow-mediated dilation 94.  Furthermore, normal flow-mediated 
dilation in the brachial artery of patients with chest pain was associated with a low risk 
of cardiac events.  Brachial artery FMD also predicts future cardiovascular events in 
older adults aged 72 – 98 years (41.4% men), even after adjustment for conventional risk 
factors 95.   
 Forearm endothelial function assessed by intra-arterial infusion of ACh and 
sodium nitroprusside has been shown to predict cardiovascular events in men and 
women (35 – 54 yr) with essential hypertension 96.  In a subsequent study, Modena et 
al., 97 found that improvements in brachial artery flow-mediated dilation in response to 
antihypertensive treatment decreased the risk of cardiovascular events over a mean 
period of 6 – 7 years in postmenopausal women with mild to moderate hypertension 
and impaired flow-mediated dilation.  Interestingly, there was an increased risk of 
cardiovascular disease events in the women who showed no improvement in 
endothelial function in response to hypertension medication 97. 
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 Combining carotid plaque echolucency and endothelial function of the brachial 
artery has an additive value on the prediction of cardiovascular events during a mean 
follow-up period of 52 ± 10 months in men and women with stable CAD 98.  Using a 
similar cohort, Chan et al., 99 showed that both brachial artery FMD and carotid 
atheroma burden were independent predictors of coronary events in 152 men and 
women.  However, endothelial function was significantly more related to outcome in 
that it provided better discriminatory information with respect to event-free survival 
and it modulated the outcome for any degree of atheroma burden in patients with CAD.   
 During a median follow-up period of 21 months, Brevetti et al., 100 found that 
reduced brachial artery FMD was an independent predictor for increased cardiovascular 
risk, in 131 patients with intermittent claudication who did not require vascular surgery.  
The predictive value of FMD was independent of classic risk factors and of previous 
incidence of cardiovascular events.  Brachial artery FMD improved the prognostic value 
of ankle-brachial pressure index, the most powerful marker of cardiovascular risk in PAD.   
 Fichtlscherer et al., studied forearm blood flow (FBF), using venous 
plethysmography, in 191 patients within 5 days of surviving an acute coronary 
syndrome, documented by coronary angiography.  The incidence of recurring 
cardiovascular events increased significantly with decreasing vasodilator responses to 
the intra-arterial infusion of ACh.  Improvement of systemic endothelial vasodilator 
function within 8 weeks of the index assessment during the acute coronary syndrome 
was associated with significantly fewer cardiovascular events 101.   
 The majority of prognostic studies have been conducted in individuals who are 
already at increased risk for cardiovascular events.  In contrast, a prospective study by 
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Shimbo et al., 102 evaluated baseline brachial artery FMD in 842 asymptomatic, low risk 
individuals from a multi-ethnic sample.  The individuals were tracked annually for the 
occurrence of cardiovascular events or deaths, for up to 36 months.  Significant 
association was found between impaired FMD and the risk of experiencing a 
cardiovascular event.  The predictive value of FMD however, was not independent of 
traditional risk factors (e.g. older age, diabetes mellitus, and history of smoking) in this 
population-based sample. 
 Suessenbacher et al., 103 examined the efficacy of serial brachial artery FMD 
measurements to predict cardiovascular events in 68 individuals with CAD (53 years ± 
9.1) one day after coronary angiography and 14 ± 12 months later. Individuals were 
divided into two groups, determined by the FMD-median at baseline.  They were further 
characterized by their FMD results, at baseline and after follow up, as FMD-improvers 
(absolute improvement  3%) or FMD-non-improvers (absolute improvement  3%). Ten 
cardiovascular events were recorded 44 ± 12 months after baseline assessment.  When 
using a single FMD measurement (baseline) there was no difference in cardiovascular 
events between the two groups.  The FMD-improvers group had significantly fewer 
events compared to the FMD-nonimprovers group (1 vs 9) when serial assessments 
were considered.  These findings highlight the benefit of multiple FMD assessments.  
While a single measurement of FMD may not determine clinical outcome, improvements 
in FMD over time may be associated with a lower risk of long-term cardiovascular 
events, and may provide more detailed, prognostic information than a single 
measurement.  
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 In contrast Frick et al., 104 found no relation between FMD and future 
cardiovascular events after a mean follow-up of 39 ± 12 months in 398 men who 
underwent coronary angiography due to chest pain (315 had documented CAD).  
Median FMD value was used to divide the men into two groups.  Group 1 had FMD 
values below the group median, and group 2 had FMD values above the group median. 
No significant difference in cardiovascular events was observed when the men were 
divided according to the median FMD value.  Moreover, FMD was not significantly 
different between individuals with and without CAD.  
 In a prospective study assessing the prognostic value of brachial artery 
reactivity in 444 (179 women; 58 ± 14 years) individuals at risk of CVD, individuals with 
the greatest FMD impairment had significantly greater risk of cardiovascular events than 
those who had normal or mildly impaired FMD response 105.  
Endothelial Function - Exercise 
 There is accumulating evidence that cardiorespiratory fitness delays the 
decrease in endothelial function associated with ageing 4 and reverses impaired 
endothelial function in individuals with atherosclerotic CVD 5 and HF 106.  Exercise 
induced improvements in vascular function appear to occur more readily and with 
remarkable consistency in vessels with antecedent functional impairment 107.  
Improvements in endothelial function induced by exercise training are attributable to a 
combination of enhanced vasodilatory capacity and arterial remodeling.  
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Endothelial function and Cardiorespiratory Fitness – Cross Sectional Studies 
 A large number of cross-sectional studies involving young and old, healthy and 
diseased have assessed the effect of fitness on endothelial vasomotor function.   
 Despite a significant difference in   O2max, Moe et al. 
108 found no difference in 
brachial artery FMD between endurance-trained and sedentary female university 
students.   
 Aging is associated with endothelial dysfunction and exercise training can have 
a protective effect in preserving endothelial function and reducing the risk of CVD 
development. 
 Rinder et al. 4 found a superior brachial artery FMD in response to hyperemia in 
10 endurance-trained older men (68.5 ± 2.3 years) compared to 10 age-matched 
sedentary controls (64.7 ± 1.4 years).  Endothelium-dependent dilation at 1 min post 
occlusion was significantly related to   O2max.  Considering that only 2 of the trained 
individuals performed upper extremity exercise, these results indicate that lower-limb 
exercise can induce systemic improvements in endothelium-dependent dilation and are 
not mediated exclusively by local adaptations. 
 Others 109 have found that brachial artery FMD is reduced in sedentary older 
men compared to exercising older men and young controls.  However, older fit men had 
similar FMD to the young controls.  Exercising older men and young controls had lower 
expression of the p47phox subunit of the oxidant-producing enzyme nicotinamide 
adenine dinucleotide phosphate (NADP) oxidase and the redox-sensitive pro-oxidant 
transcription factor nuclear factor kappa B (NFB), and greater expression of antioxidant 
enzyme manganese superoxide dismutase (SOD) than older sedentary men.    
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 An underlying gender-related difference in endothelial function may exist.  In a 
recent study Black et al, 110 found no difference in brachial artery FMD between healthy 
young men and fit and sedentary older men.  In contrast, the vasomotor response 
following 5 min of brachial artery occlusion was significantly impaired in older sedentary 
women compared to both healthy young and older fit women.  These finding suggest 
that women can reduce the age-related decline in vascular function through 
maintenance of cardiopulmonary fitness. 
 Tew et al., 111 used laser Doppler flowmetry to measure changes in forearm skin 
blood flow in response to post-occlusive reactive hyperemia, local heating, ACh and SNP 
administration in young active, older sedentary and older fit individuals.  Peak blood 
flow was greater in the young and older fit group compared to the older sedentary 
group in response to hyperemia, and 30 min of local heating at 42C. Reactive 
hyperemia and local heating responses were moderately correlated with   O2max in the 
older groups.  Skin vasodilator responses to ACh were higher in the young than the older 
sedentary group, and SNP responses were higher in the young group compared to both 
older groups.  There was no relation found between   O2max and ACh and SNP 
responses.  Using strain-gauge plethysmography, Taddei et al., 112 compared forearm 
blood flow in young and older trained and untrained men and women in response to 
infusion of ACh, SNP, L-NMMA, vitamin C, and combined L-NMMA and vitamin C.  The 
vasodilator response to ACh was significantly impaired in the older group compared to 
the young individuals.  While there was a reduced response compared to young group, 
the ACh response was significantly greater in the elderly trained individuals than the 
elderly sedentary individuals.  Infusion of L-NMMA induced a significant decrease in 
vasodilation in the young and elderly trained individuals, but was ineffective in the 
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elderly sedentary controls.  In contrast to the young group and the older trained 
individuals, vitamin C infusion significantly increased vasodilation induced by ACh 
infusion and also restored the inhibiting effect of L-NMMA on the endothelial agonist.  
Response to SNP was similar in all groups.  These findings indicate that oxidative stress-
induced reductions in NO availability may be responsible for the age-related decline in 
endothelial function in older sedentary individuals, and habitual physical training can 
preserve NO availability in older men and women. 
 To assess the putative role of oxidative stress in the age-related decline in 
endothelial function, Eskurza et al. 113 assessed brachial artery FMD before and after 
acute infusion, and 30 days supplementation of vitamin C, in young sedentary, older 
sedentary and older endurance-trained, healthy men.  Baseline FMD was significantly 
lower in the older sedentary men than the young and older exercise-trained men.  
Vitamin C infusion significantly improved FMD in the older sedentary men, but had no 
effect on the young or older trained men.  In contrast, 30 days of vitamin C 
supplementation had no effect on FMD in any of the 3 groups.  Endothelial-independent 
dilation in response to NTG did not differ between groups and was unchanged after 
vitamin C infusion and supplementation. 
Endothelial Function - Acute Exercise 
 Observations that a single bout of exercise can transiently alter atherosclerotic 
CVD risk factors 114 have led to the notion that perhaps some of the effects of exercise 
on endothelial function may be attributable to the acute effect of exercise.  A number of 
studies have investigated the effect of an acute bout of exercise on endothelial function 
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in healthy and disease populations.  Table 2.1 provides a summary overview of studies 
that have examined the effect of acute exercise on endothelial function 
 Cosio-Lima et al., 115 compared the effect of 30 min of treadmill walking at 70-
85% HRmax on brachial artery FMD in kidney transplant (KT) recipients and healthy 
controls (HCs).  Brachial artery FMD was significantly higher in HCs than KT recipients 
after exercise (22% vs 3%).  This is perhaps not surprising considering that incidence of 
hypertension, hyperlipidemia, and T2DM is high among renal transplant recipients and 
CVD is the principal cause of death in renal transplant patients. 
 Compared to healthy controls, brachial artery FMD was significantly reduced 
following treadmill exercise to maximal claudication pain at 30 min and 2 hr post 
exercise in patients with PAD 116.  An acute bout of treadmill exercise to the onset of 
claudication pain has no effect on brachial artery FMD measured 5 min post exercise in 
men and women (62 ± 2 yr) with PAD 117.  In contrast, FMD is significantly impaired 
following treadmill exercise to maximal claudication pain, demonstrating that exercise-
induced ischemia further deteriorates FMD.  Intravenous administration of vitamin C 
ameliorates the impaired FMD response following treadmill exercise to maximal 
claudication pain only.  Others have shown that antioxidant treatment can prevent acute 
impairment in endothelial function.  The benefits of vitamin C on endothelial function 
are believed to be due to superoxide scavenging, and/or inhibition of LDL-C that takes 
place during high-intensity exercise.  Vitamin C is also an important regulator of the 
intracellular redox 117.   
  Brachial artery FMD is significantly reduced in healthy male smokers compared 
to non-smokers (7.7 v 4.1%) immediately following 40 min of submaximal steady-state 
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exercise on a cycle ergometer 48.  Endothelium-independent dilation was similar in both 
study groups.  In contrast, 30 min of acute cycling at 50%   O2peak increases brachial 
artery FMD in female smokers (20.6 ± 2.1 years) and non-smokers (20.5 ± 2.3 years) 118.  
The different findings may be due to the fact that the men were older (30-51 year) than 
the women (20.5 yr), and may therefore have a longer history of smoking.  Flow-
mediated vasodilation at rest is significantly lower in postmenopausal, than 
premenopausal women (5.3% vs 12.1%).  Treadmill exercise for 34 min at 60%   O2max 
almost doubled brachial artery FMD in postmenopausal women and had no effect on 
FMD in premenopausal women 119. 
 A study examining diurnal variation on vascular characteristics and function in 
healthy young men found significantly greater brachial artery blood flow velocity and 
shear rate following 30 min of semi-supine cycling at 70%   O2peak in the morning 
(0800) compared to evening (1600).  Despite higher shear rates in the morning, there 
was no difference in post exercise brachial artery diameter between the two times of 
day 120. 
Rognmo et al., 121 compared the effect of a single bout of high-intensity interval 
running on brachial artery diameter, peak blood flow and FMD in men with normal and 
high levels of aerobic capacity.  The interval protocol involved 5 x 5 min of high-intensity 
running, interspersed with 2 min of active recovery.  Brachial artery FMD and 
endothelial-independent dilation (EID) were assessed immediately before, 1 h, 24 h and 
48 h post exercise.  High fit individuals had significantly larger resting arterial diameters 
and maximal arterial diameters following cuff release at each time point than the 
sedentary individuals.  High fit individuals experienced a 38% reduction in FMD 1 h after 
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exercise, compared with baseline and returned to pre-exercise values within 24 h after 
the exercise bout.  There was no difference in EID between the two groups following the 
acute bout of exercise.  There was a significant inverse relation between the pre-
exercise resting diameter and FMD.  
 Llewellyn et al., 49 also found a decrease in brachial artery FMD in healthy young 
men and women (19-30 years) after 30 min of continuous treadmill exercise at 60% 
  O2max.  The percentage change in diameter was not significantly different from rest 
when normalized for shear rate (SRAUC).  Baseline diameter was not altered after 
exercise, but shear rate was significantly augmented.  There was a significant positive 
relation between FMD and SRAUC at rest, but not after the acute bout of exercise.  The 
absence of a relation between FMD and SRAUC after exercise may be attributable to the 
fact that the change in SRAUC from rest to post-exercise varied greatly among individuals, 
e.g., SRAUC decreased in 7 participants and increased in 6 participants.  A high degree of 
variability in the physiological shear rate response to reactive hyperemia post-exercise 
was observed.    
 Brachial artery FMD is enhanced 1 h following 45 min acute bouts of low, 
moderate and high-intensity treadmill exercise in active overweight men, but is 
attenuated in inactive overweight men 122  
 Dawson et al., 123 found that resting femoral artery diameter is unchanged 
while FMD is significantly reduced in non-elite runners 1 h after completing a marathon.  
Resting and maximal brachial artery diameters were both significantly increased post 
marathon, but brachial artery FMD was unchanged.  Reduced bioavailability of NO 
resulting from an increased oxidative stress and/or inflammation in the exercising limbs, 
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may help to explain the impaired femoral artery FMD.  Furthermore, the femoral and 
brachial artery are exposed to different blood flow velocities and shear rate patterns 
during prolonged, strenuous exercise.  The profound changes in blood flow and shear 
rate in the femoral artery during the marathon may exhaust eNOS. Interestingly, the 
increased resting brachial artery diameter following the race may account for the 
unchanged brachial artery FMD. 
 Both low volume high-intensity interval exercise (HIIT) and moderate-intensity 
endurance exercise (END) significantly increased absolute and normalized brachial artery 
FMD 1 h post exercise in CAD patients.  Despite differences in exercise intensities and 
durations, this study demonstrated similar acute increases in brachial artery FMD 1 h 
after a single bout of END and HIT exercise in men and women with CAD.  Although 
there was only a 10 min difference in exercise duration between the END and the HIT 
protocols, total work performed was significantly lower for the HIT group, and was equal 
to 60% of the work performed by the END group 124.  
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Table 2.1: Studies that examined the effect of acute exercise on endothelial function 
Author Patient Cohort Mode of Exercise Duration Intensity FMD 
Cosio-Lima et al., (2006) Renal Transplant/healthy  TM Walking 30 min 70 - 85% HRmax  
Gaenzer et al., (2001) Smokers/non-smokers Cycling 40 min 50%   O2peak  vs. non-smokers 
Silvestro et al., (2002) PAD TM Walking Max claudication 3 km.h-1 @ 3%  
Harvey et al., (2005) Pre & post menopausal TM Walking    vs. pre menopausal 
Rooks et al., (2011) Smokers vs. non-smokers Cycling 59%   O2peak 30 min  in both groups 
Jones et al., (2009) Healthy men (28 y) Intermittent Cycling 3 x 10 min 70%   O2peak Morning  vs. evening 
Jones et al., (2010) Healthy men (28 y) Intermittent Cycling 3 x 10 min 70%   O2peak  post ex morn vs. eve 
Rognmo et al., (2005) Normal/high aerobic capacity 
HII Running 5 x 5 min 90% HRmax  high fit,  low fit 
Harris et al., (2008) 
Active/inactive overweight  Intermittent Cycling 45 min 
25%   O2peak 
50%   O2peak 
75%   O2peak 
 active  
 inactive 
Llewellyn et al., (2012) Healthy (M/F; 19-30 y) TM Running 30 min 60% v   O2max  
Currie et al., (2012) CAD Intermittent vs. Continuous 10 x 1min vs 30 min 80% vs. 55% POpeak  in both ex groups 
Dawson et al., (2008) Non-elite Runners Marathon 42.2 km n/a  
Joras et al., (2008) PAD/healthy controls TM Walking Max claudication 3.2 km.h-1 @ 12%  
CAD, coronary artery disease; FMD, flow-mediated vasodilation; TM, treadmill; HII, high-intensity interval 
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Endothelial Function – Moderate-intensity Exercise Training 
 Appropriately planned, systematic increases in the training load coupled with 
optimal recovery will induce adaptive changes in the structure and function of cells, 
tissues and organs systems that are disturbed during the workout.  The physiological 
adaptations called training effects increase fitness levels, and help to diminish the 
magnitude of the disruptions to the internal environment from future exercise at the 
same absolute intensity.  This in turn permits an individual to exercise subsequently for a 
longer duration at the same absolute workrate before the onset of fatigue.   
 Exercise training involving 30 min of daily home-based cycle ergometry at 75% 
HRmax, coupled with a 90 min outdoor group session, twice per week, for 6 months was 
found to significantly improve brachial artery endothelial-dependent dilation in 
individuals with CAD and pre-diabetes.  In contrast, 6 months of rosiglitazone therapy (8 
mg/day) had no effect on endothelial function in the same patient cohort.  Shorter 
duration training programs consisting of 4-12 weeks of aerobic training, resistance 
training or a combination of both reversed endothelial dysfunction in men and women 
with a recent first MI 125,126.  The training effects are lost after 4 weeks of detraining. 
 Hospital-based exercise training for 10 min, 6 times per day for 4 weeks 
significantly attenuates the vasoconstrictive response to 7.2 g/min of ACh, and 
increases coronary blood flow above baseline with no change in EID in men with CAD 
and abnormal baseline ACh-induced vasoconstriction 127.  Glyceryl trinitrate-induced, 
endothelium-independent coronary vasodilation did not change in response to training, 
indicating that the response of the vascular smooth muscle to NO was not impaired.   
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 Using a similar study design Hambrecht et al., 128 examined the effects of 
exercise training on endothelial vasodilator function and eNOS expression in the left 
internal mammary artery (LIMA) in response to ACh infusions and to increases in blood 
flow after adenosine administration in men with CAD.  Patients were randomized to 4 
weeks of supervised, hospital-based, aerobic exercise training or an inactive control 
group.  Exercise training involved 10 min of rowing ergometry, followed by 10 min of 
cycle ergometry, 3 times per day for 4 weeks.  Vasodilation and peak blood flow velocity 
of the LIMA were significantly enhanced in response to ACh after exercise training.  
Similarly, adenosine-induced flow-dependent vasodilation of the LIMA was markedly 
improved after exercise training.  There was no change in EID in response to training.  
Expression of eNOS mRNA expression and eNOS protein content doubled.  The rise in 
eNOS expression is thought to be mediated by shear stress-responsive elements in the 
promotor region of the eNOS gene, or by stabilization of eNOS mRNA. 
 The precise mechanism by which endothelial cells sense changes in flow or 
blood pressure amplitude are not clearly understood.  In addition to eNOS protein 
expression, NO production is also dependent on eNOS phosphorylation.  The Ser1177 
residue seems to function as a sensor of shear stress, because exposure of endothelial 
cells to laminar shear stress specifically, increases phosphorylation at this site leading to 
a rise in the enzymatic activity of eNOS and enhanced NO production.  The shear stress-
induced phosphorylation of eNOS is maintained, whereas the agonist-mediated Ser1177 
phosphorylation, e.g., bradykinin, is only transient indicating that a sustained eNOS 
phosphorylation, resulting in an increased NO production or availability mediates the 
improvement in endothelial function in response to exercise training. 
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 Heart failure is now regarded as a systemic rather than a cardiac disorder 
involving hemodynamic, neurohormonal and peripheral derangements.  Reduced 
peripheral blood flow at rest, during exercise, and in response to endothelium-
dependent vasodilators have been identified as factors contributing to key symptoms of 
CHF like exercise intolerance.  Findings from studies examining the systemic vascular 
effects of lower limb exercise in HF have been equivocal.   
 Cycling 14 min per day, 2 to 3 days per week for 3 months significantly increases 
posterior tibial artery FMD and has no effect on brachial artery FMD in patients with HF 
129.  In contrast, 6 daily hospital-based, supervised 10 min bouts of cycle ergometry at 
70%   O2peak for 4 weeks significantly improved ACh and flow-mediated dilation in the 
brachial artery 130.  Peak aerobic capacity increased significantly and the improvements 
in ACh- and flow-mediated dilation were correlated with the increase in aerobic 
capacity.  Radial artery FMD and   O2max increased significantly following 12 weeks of 
daily exercise for 30 min on a cycle ergometer in individuals with HF 131.   
 In HF patients, femoral artery blood flow increased by 203% in response to 6 
months of exercise training, 6 times daily for 10 min on a cycle ergometer at 70% 
HRpeak.  In contrast, peripheral perfusion decreased 174% after L-NMMA infusion, 
indicating that the improvements in peripheral perfusion may be attributed to an 
enhanced formation and/or release of NO 106. 
 Although L-arginine is stored in significant amounts in intracellular depots, oral 
supplementation of L-arginine has been shown to increase exercise-induced blood-flow 
in patients with  chronic HF.  There is evidence that 4 weeks of combined L-arginine 
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supplementation and daily handgrip training have superior effects to either intervention 
alone on radial artery endothelium-dependent vasodilation in patients with HF 132.  
Endothelial Function – High-intensity Interval Training 
 High intensity interval training (HIIT) involves repeated bouts of high intensity 
exercise (10 to 300 seconds) interspersed with active or passive recovery periods of 
equal, shorter, or longer duration 6.  The rapid repletion of phosphagen stores during 
recovery coupled with a reduction in blood lactate accumulation allows individuals to 
undertake a greater volume of high-intensity exercise during a single training session 133.  
Historically, HIIT has been used by athletes, but a number of studies have shown its 
efficacy and safety in improving exercise capacity and endothelial function in individuals 
with CAD and heart failure 7,8.  
 Studies have found a significant increase in   O2max and indices of cardiac 
function in men and women with CAD following HIIT on a treadmill, cycle ergometer, 
stairclimber and combined arm and leg cycle ergometer.  In one of the first HIIT studies 
involving CAD patients,   O2max, heart rate, blood pressure and ST-segment changes 
during maximal exercise testing on a treadmill and cycle ergometer were assessed 
before and after 12 months of intense exercise training 134.  The double-product 
threshold for an ischemic ST-segment response was also assessed.  The first 3 months of 
exercise training involved alternate walking and jogging, continuous jogging or cycling at 
50 – 70%   O2max 3 times per week.  After 3 months, exercise sessions were increased to 
4 - 5 times per week and the intensity was increased to 70 – 80   of   O2max, 
interspersed with 2 – 3 intervals at 80 - 90% lasting 2 - 5 min.   
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 Absolute and relative   O2max and the double-product threshold for ischemic 
ST-segment depression were increased significantly, and resting HR and HR at the same 
submaximal workload decreased significantly at 12 months.  Systolic blood pressure was 
significantly lower at the same submaximal workloads during exercise on the treadmill 
and cycle ergometer.  Left ventricular end-diastolic dimension and posterior wall 
thickness were significantly increased after training.  Training also reduced the extent of 
ST-segment depression at the same double product and reduced or unchanged 
maximum ST-segment depression despite a large increase in maximum double product.  
With the slower heart rate and lower systolic blood pressure, the double-product was 
significantly lower at the same submaximal work rates.  However, after 12 months 
training, the double product in both treadmill and cycle ergometer exercise increased 
20% and 19%, respectively, at maximal exercise.  
 Using a combination of continuous training and interval training for 12 months 
Ehsani et al., 135 found a significant increase in    O2max and left ventricular end-diastolic 
diameter in individuals with CAD.  Resting heart rate, submaximal heart rate and systolic 
blood pressure at given work rate were lower after training.  
 Both moderate-intensity continuous training for 41 min at 50 – 60  %  O2max 
and treadmill walking involving four intervals of 4 min at 80 – 90    O2max interspersed 
with 3 min of walking at 50 – 60 %   O2max,    mes per wee  for 10 wee s have been 
shown to increase   O2max in CAD patients.  The improvement was significantly greater 
in the high-intensity aerobic training group than the moderate-intensity group (17.9% vs 
7.9%) 7.  In contrast, improvements in   O2max were similar in response to 16 weeks of 
continuous bouts of exercise at 65% HR reserve and HIIT involving 90% HR reserve, and 
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interval durations of 2 min interspersed with 2 min active recovery bouts.  Both groups 
exercised for a total of 30 min per day, 2 days per week 136.  A 16-week programme of 
HIIT involving 5 to 10 min intervals (15-18 on the Borg scale) was also found to increase 
quality of life and performance in a 6-min walk test in HF patients 137. 
 The metabolic syndrome (MetSyn) is characterized by a group of metabolic risk 
factors that increase the risk for premature heart disease, stroke, peripheral vascular 
disease and type 2 diabetes.  Risk factors include central obesity, atherogenic 
dyslipidemia, elevated resting blood pressure and insulin resistance or high fasting 
glucose levels.  A 16-week aerobic interval training (AIT) programme comprised of four 4 
min intervals at 90% HRmax, with 3 min active recovery at 70% HRmax, 3 times per 
week, was superior to 47 min of continuous moderate-intensity exercise (CME) at 70% 
HRmax in reversing risk factors for metabolic syndrome 138.  After 16 weeks, FMD and 
  O2max were significantly improved in both training groups, but the increases in the AIT 
group were significantly greater than the CME group.  Insulin sensitivity, –cell function 
and PGC-1 levels were also significantly greater in the AIT group, than the CME group 
at week 16.   
 Interval training  (4 x 4 min at  90% HRmax) 3 times per week for 12 weeks 
partly reversed the impaired age-related diastolic function in healthy men and women  
(72 ± 1 yr) at rest, and significantly improved LV diastolic and systolic function during 
exercise 139.   
 To date, only 4 published studies have examined the effect of HIIT on 
endothelial function in men and women with CVD (Table 2.2).  Wisløff et al., 8 found a 
significantly greater increase in   O2max and brachial artery FMD in elderly men and 
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women (75.5 ± 11.1 years) with post-infarction HF, following 12 weeks of AIT compared 
to moderate continuous training (MCT), 3 times per week.  The AIT involved four 4-min 
intervals at 90 – 95% HRpeak.  The MCT group walked continuously at 70 – 75% HRpeak 
for 47 min in order to expend an equivalent number of calories to the AIT group.  
Changes in FMD were significantly related to changes in aerobic capacity in the 
combined training groups  
 Munk et al., 10 compared the effect of 6 months supervised HIIT, 3 times per 
week for 1 hour, to a non-exercising control group, on aerobic capacity, degree of 
restenosis, FMD, and CRP levels in 40 men and women, following percutaneous 
intervention (PCI).  The HIIT involved 4 min intervals at 80 - 90% HRmax on a cycle 
ergometer or running, followed by 3 min active recovery at 60 – 70%.  Changes in 
  O2peak, ventilatory threshold, CRP, heart rate variability and FMD were significantly 
greater in the HIIT than the control group at 6 months.  Endothelium-independent 
dilation did not change in either group.  Restenosis was measured as in-segment late 
luminal loss of the stented coronary area and was smaller in the HIIT group than the 
control at 6 months.   
 Hermann et al., 9 found that 8 weeks of HIIT, involving cycle ergometry and 
running, with interval blocks of 4 min/2 min/30 s at 80%, 85% and 90%   O2peak, and 1-2 
min recovery periods, significantly improved endothelial function and   O2max in stable 
heart transplant recipients compared to inactive controls.  There was a significant 
relation between the change in FMD and the change in   O2peak.    
 In a recent randomized controlled trial, Moholdt et al., 140 found similar 
improvements in   O2peak and brachial artery FMD in post MI patients following 12 
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weeks of treadmill interval training (n=29) involving 4 min intervals at 85 - 95% HRmax, 
followed by 3 min active recovery at 70% HRmax, and 12 weeks of cardiac rehabilitation 
(n=44).  All participants met for exercise training in the hospital twice weekly, and 
exercised once weekly at home.  The increase in   O2peak was greater in the interval 
training group than the cardiac rehabilitation group (15% v 8%).  
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Table 2.2: Summary of studies that evaluated the effect of HIIT on endothelial function in individuals with CVD 
Author Patient Cohort Exercise Mode Intervals Intensity 
Frequency  
(per wk) 
Duration FMD   O2peak 
Hermann et al., 
(2011) 
HT (active vs. con)  
(N = 30) 
Treadmill 4 min/2 min/30 s 
80%/85%/90% 
  O2peak 
2 8 weeks 
 vs. 
con 
 vs. con 
Munk et al., (2009) 
PCI (bare metal/drug  
eluting stent) vs con 
(N = 30) 
Cycling/Running 4 x 4 min 
85 - 95% 
HRpeak 
3 8 weeks  vs. 
con 
 vs. con 
Wisloff et al., (2007) 
HF (MCT vs. AIT) 
(N = 20) 
Cycling/Running  (4 x 4 min) 80 - 90  
HRmax 
3 24 
weeks 
 vs. 
MCT 
 vs. MCT 
Molholdt et al., 
(2012) 
HF (AIT vs. UCR) 
(N = 9) 
Treadmill  4 x 4 min 
85-95%  
HRpeak 
2 12 
weeks 
 vs. 
UCR 
 both groups 
HT, heart transplant; Con, non-exercising controls; HF, heart failure; PCI, percutaneous coronary intervention; MCT, moderate continuous training; 
AIT, aerobic interval training; UCR, usual care rehabilitation 
 49 
Mechanisms for Exercise-induced Adaptations in BAR 
 Repetitive increases in blood flow and shear stress that accompany regular 
exercise elicit an adaptive response that alters the intrinsic responsiveness of the 
endothelium by increasing mRNA expression of NOS 141.  This in turn increases the 
synthesis and release of NO, and improves endothelial function.  Chronic increases in 
shear stress can also enhance vascular structure and function due to functional and 
histological alterations of vascular endothelium 142.  
 The benefits of exercise training in terms of endothelial function may also be 
related to secondary effects, mediated through risk factor modification.  Lower 
cholesterol levels were related to an enhanced forearm dilation response to ACh in 
highly-trained athletes compared with sedentary controls 143.  However, improvements 
in endothelial function following 10 weeks of combined aerobic–anaerobic training were 
not related to changes in total cholesterol, high-density lipoprotein (HDL)-C, 
lipoprotein(a), fibrinogen level or resting blood pressure 144. 
 Different patterns of shear rate are believed to induce different vascular 
adaptations 145.  Shear rate can differ significantly in response to different types of 
exercise.  For example, handgrip exercise results in elevated antegrade (forward) shear 
rate, while cycling can induce large increases in both antegrade and retrograde blood 
flow and shear rate 144.  Both in vitro and animal studies have found that different shear 
patterns induce different cellular events, varying between proatherogenic and 
antiatherogenic changes.   
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Self-Regulated Exercise 
 Exercise prescription is as much an art as a science, and there is a need to 
balance physiological effectiveness with enjoyment and pleasure, and positively effect 
desired biological changes.  According to the hedonic theory of motivation 146 people are 
likely to repeat an activity if they derive pleasure, sense of energy, or enjoyment from 
their participation in the activity.  In contrast, if people derive displeasure, sense of 
exhaustion, pain, or discomfort from their physical activity, the chances of them 
repeating the activity would be reduced.  
 Studies that have evaluated the acute effect of exercise on endothelial function 
have for the most part prescribed exercise based on objectively measured thresholds of 
caloric expenditure or percentage of HRmax or   O2max.  This form of exercise 
prescription may exceed an individual’s preferred level of intensity and may establish a 
negative attitude toward physical activity 146.   
 Longitudinal studies report that participants tend to deviate from prescribed 
levels of intensity in favour of their apparently preferred levels 147.  In contrast, allowing 
individuals to use effort perception to self-regulate 148 their preferred intensity may 
encourage the development of intrinsic motivation, a central element in promoting 
adherence to exercise, and increase enjoyment and participation levels.  In a recent 
study, Johnson et al., 148 found that 86% of women involved in aerobic exercise used 
effort perception exclusively to determine exercise intensity.  This is not surprising 
considering that exertional feedback is often used unconsciously to regulate the pace of 
many daily activities.  The intensity of home, recreational, and even some occupational 
activities is often self-regulated, using exertional perceptions that reflect local and 
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general fatigue and shortness of breath.  In most cases, the pace with which these 
activities are undertaken allows their successful completion without undue physiological 
strain.  
 Walking (4.8-6.4 km.h-1) is promoted as a moderate-intensity (~3-6 METS) 
activity that is highly accessible, requires no special skills or facilities, can be easily 
accommodated into an existing lifestyle and can be undertaken at almost any age with 
little risk of injury and has been shown to positively impact on physical, psychological 
and cognitive function.  Most individuals prefer to walk alone and unsupervised, self-
regulating their own intensity 146. 
 Although effort perception is used to select exercise intensity during walking, 
few studies have examined the effect of walking at preferred intensity on endothelial 
function in men and women with CVD.  
 In one of the first published studies to examine the physiological, metabolic and 
perceptual responses to self-regulated exercise, Spelman et al., 149 covertly measured 
the walking velocity during a typical walking session in 29 adult habitual walkers (22 
women and 7 men) with a mean age of 35 yr.  Participants subsequently performed an 
8-min level treadmill walk at the velocity determined in the typical walking session to 
determine physiological, metabolic, perceptual and treadmill speed responses.  The 
mean walking speed was 1.78 m.s-I and the effort was perceived to be “fairly light” (10.9) 
on Borg scale.  The average metabolic cost of walking at a self-selected pace was 5.2 
METS and corresponded to 52%   O2max and 70% HRmax.  Spelman estimated that the 
subjects expended approximately 257 kcal, or 3.8 kcal/kg of body weight, during a 
typical walking session, reaching a level associated with improvements in health and 
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longevity.  Using a similar design Murtagh et al., 150 covertly observed the walking 
velocity in 11 women with a mean age of 40 years.  They found a mean walking velocity 
of 1.56 m.s-1 which corresponded to 59 %  O2max and 67% HRmax.  The RPE was 11.5 
(fairly light).  When as ed to demonstrate their interpretation of “bris ” wal ing over 
the same course the velocity increased significantly to 1.79 m.s-1, which corresponded to 
69%   O2max and 79% HRmax and an RPE of 13.6.  These findings indicate that when 
walking for exercise, adults self-select speeds and intensities that meet definitions of 
moderate intensity activity, and instructing them to walk briskly encourages vigorous 
exercise.  
 A number of studies have shown that when allowed to self-regulate their 
exercise intensity healthy young men and women and middle-aged men and women 146 
select an intensity that equates to 55-65%   O2max, 65-75% HRmax, and RPE 11-13 
(fairly light to somewhat hard on the Borg RPE scale).   
 Lind et al., 151 examined the intensity of physical activity that sedentary middle-
aged women self-select during 20 min of treadmill exercise.  They found that the 
%HRmax, %  O2max, and RPE during the 20 min walk was 81%, 66% and 13.4 
respectively and was similar to the intensity corresponding to the ventilatory threshold.  
The RPE values ranged from 12-14 on the 12-point Borg RPE Scale.  The ratings of 
affective valence (decreases in pleasure or increases in displeasure) remained 
unchanged, and were within the positive (or nonnegative) range.  Rose and Parfitt et al., 
152 found that exercise at a self-regulated intensity resulted in more positive affective 
responses compared with exercise above and at lactate threshold in sedentary women 
(39.4 ± 10.3 years).  When allowed to self-select their exercise intensity, sedentary 
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middle-aged women  (age 43. 7 ± 4.8 years   O2max 23.0 ± 5.7 mL.kg
-1.min-1) choose a 
level that approximates their ventilatory (or lactate) threshold in order to allow them to 
maintain a stable and positive affective state 151. 
 54 
Chapter 3  
 STUDY 1 
USER RELIABILITY AND DEVELOPMENT AND VALIDATION OF A CUSTOM-DESIGNED 
ARTERIAL DIAMETER MEASUREMENT SOFTWARE 
Brachial artery flow-mediated dilation (FMD) using high frequency 
ultrasonography is commonly used to non-invasively assess endothelial function.  Image 
acquisition and analysis are technically challenging and are reliant on the skill level of the 
practitioner.  Vigilant attention to image acquisition and analysis is required in order to 
ensure reproducible FMD measurements.  Typically, 6 months of training, and > 100 
supervised scans is required before a practitioner is deemed proficient 153.   
Brachial artery diameter is calculated by measuring the distance between the 
arterial walls at one or more cross-sections.  Manual measurement of arterial diameter, 
using B-mode or M-mode ultrasound images, is typically performed in real-time using 
electronic or virtual calipers built into the ultrasound hardware.  The major disadvantage 
of this technique is the time-consuming nature of the manual measurements, which are 
prone to error and variance among practitioners.  In addition, manual, real-time 
measurements require the presence of the patient, and limits the number of time-points 
at which the diameter can be assessed.  
Computerised analysis systems utilizing edge-detection and wall tracking 
software allow for multiple, objective measurements along the vessel wall and can 
markedly improve the precision and accuracy of the FMD technique 3.  Studies 
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comparing the validity and reproducibility of computerised edge-detection and wall 
tracking software have found significantly lower intraobserver variation for the 
automated systems than for the manual technique 66.  It has been recommended that 
validated, accurate, and reproducible edge-detection and wall-tracking systems should 
be used to assess FMD measurements 66. 
Existing general-purpose segmentation algorithms, such as seeded region 
growing, are inadequate for segmenting an ultrasound image of an artery into arterial 
lumen and arterial tissue for two reasons 154.  First, many general purpose segmentation 
algorithms are unable to reliably delineate the artery boundary.  This is often caused by 
the inherent noise in ultrasound images.  In particular, unconstrained region growing 
algorithms often generate incorrect segmentations, since they do not incorporate prior 
knowledge about the shape of the region of interest 154.  Algorithms that incorporate 
prior shape knowledge, like active contour models 155 and active shape models 156, 
require careful initialization and significant user interaction.  Second, most existing 
segmentation algorithms are too computationally intensive to allow for real-time 
updates and feedback.   
Off-the-shelf ultrasound analysis software tends to be considerably expensive.  
There is a need for an ultrasound image processing tool that is low cost, can be 
implemented with minimal investment and development time, will allow sonographers 
to quickly and robustly assess the diameter and wall thickness of arteries from 
ultrasound images whilst requiring minimal input or interaction from a sonographer.  
Moreover, there remains a need for segmentation methods that facilitate rapid and 
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reliable segmentation of tubular structures such as vascular tissues so as to aid the 
processing steps discussed above. 
Study Purpose 
The purpose of this study was to assess the reliability of the present investigator 
in the use of ultrasonography in the measurement of endothelial vasomotor function 
and to develop and validate a reliable, custom-designed arterial diameter measurement 
(ADM) software.   
Specific Aims 
1. To assess the reliability of the investigator in the use of ultrasonography to 
assess brachial artery diameter (Study 1A) 
2. To assess the reliability of the investigator in the use of ultrasonography to 
assess Doppler blood flow (Study 1A) 
3. To develop and validate a custom-designed analysis software (ADM 
software) that will semi-automatically calculate brachial arterial diameter 
(Study 1B) 
4. To assess the reliability of the ADM software to assess brachial artery 
diameter by comparing off-line brachial artery diameter measurements 
using the ADM software and manual measurements using in-built 
ultrasound calipers (Study 1B) 
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Hypothesis 
1. There will be no significant difference in brachial artery diameter 
measurement recorded on two separate occasions by the same 
sonographer 
2. There will be no significant difference in Doppler blood flow 
measurements recorded on two separate occasions by the same 
sonographer 
3.  The custom-designed ADM software, utilizing segmentation methods, will 
allow sonographers to obtain similar brachial artery diameters as when 
using in-built ultrasound calipers   
4. The custom-designed ADM software developed will provide valid and 
reliable measurements of the brachial artery diameter 
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STUDY 1A  
USER RELIABILITY OF ULTRASOUND IMAGE ACQUISITION AND ANALYSIS 
METHODOLOGY 
Participants 
Twenty-five healthy men (n=12) and women (n=13) (mean age 32.2 yr) 
volunteered to participate.  Exclusion criteria included smoking and currently taking 
prescribed medication for cardiovascular disease.   
Study Overview 
 The study involved assessing brachial artery flow-mediated dilation (FMD) on 2 
separate occasions, no more than 5 d apart.  FMD was assessed using high-resolution 
ultrasonography, by the same investigator, in a quiet, temperature-controlled room 
(VRU).  Ultrasound measurements were performed on a SonoSite MicroMaxx® (SonoSite 
Inc., Bothell, Washington, US) ultrasound system with a linear array transducer (Figure 
3.1), operating at a frequency of 12.0 MHz.   
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Figure 3.1: SonoSite MicroMaxx® Ultrasound system and 12.0 MHz linear array transducer 
Overview of Endothelial Function Assessment 
All brachial artery images were acquired with the participants in a supine 
position.  A baseline brachial artery image was acquired following a 10 min rest period 
and was immediately followed by assessment of FMD.  Ultrasound images were 
analysed in real time, using in-built ultrasound calipers (SonoSite MicroMaxx®). 
The right arm of the participant rested on an examination table perpendicular to 
the bed, and was extended and externally rotated to permit imaging of the right brachial 
artery.  An automated blood pressure cuff was placed on the right forearm, distal to the 
brachial artery (Figure 3.2) and electrodes for a 3-lead ECG were placed on their chest.  
The ECG tracing was activated and settings adjusted to ensure clear identification of the 
R wave which corresponds to the end of diastole in the cardiac cycle.   
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Participant Preparation 
 Participants were tested between 7 and 10 am, by the same experienced 
investigator, in the same, quiet, temperature-controlled room (Vascular Research Unit).  
Participants arrived to the Vascular Research Unit, DCU after an overnight fast (from 
10pm the previous night).  Only water consumption was permitted.  Participants were 
not permitted to exercise, or ingest substances that might affect FMD such as caffeine 
and vitamin C or use tobacco for at least 6 h before the study.     
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Figure 3.2:  Arm position and cuff placement. 
Ultrasound Technique and Image Acquisition 
Anatomic landmarks such as veins and fascial planes were noted and used to 
ensure that all M-mode images and Doppler measurements were recorded at the same 
site.  A longitudinal image of the brachial artery was obtained using B mode ultrasound.  
The brachial artery was insonated 3-7 cm above the antecubital crease.  Great care was 
taken to ensure that the anterior and posterior intimal interfaces between the lumen 
and the arterial wall were clearly visible.  Depth and gain settings were optimized to 
delineate the lumen-arterial interface optimally on both the near (anterior) and far 
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(posterior) wall.  The boundaries were clearly visualized with the angle of insonation 
perpendicular to the vessel.  It is recommended that the imaging plane should bisect the 
vessel in the longitudinal direction to ensure that diameter measurements obtained 
from the images reflect the true diameter of the vessel 38.  Images were magnified using 
a “zoom” function.  
M mode Imaging 
The brachial artery was imaged using M mode function to facilitate arterial 
diameter measurements at appropriate time points (Figure 3.3).  Brachial artery 
diameter was assessed in real time using the in-built ultrasound calipers (SonoSite 
MicroMaxx®).  Each image acquired incorporated a minimum of 2 and a maximum of 3 
consecutive ECG R waves.  The brachial artery diameter measurements were obtained at 
cross sections corresponding to the R waves, which represent the end of diastole in the 
cardiac cycle. 
 
Figure 3.3:   M mode ultrasound image of the brachial artery 
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Doppler Imaging 
Doppler imaging was used to measure blood flow velocity (cm/s) in the brachial 
artery.  The Doppler scale was adjusted to accommodate the spectral signal and the 
expected increase in blood flow following cuff release.  The scale was maintained at the 
minimum range to decrease measurement error.  The Doppler gate was set to minimum 
(1.5 mm) and was positioned in the centre of the artery lumen.  The Doppler gate was 
aligned with the direction of flow and the transducer was adjusted to achieve an angle 
of insonation of 60 157.   The insonation angle between the pulsed-wave Doppler beam 
and the vessel walls was adjusted by manipulation of the transducer, to allow the beam 
to be steered and the angle corrected in alignment with the vessel orientation/parallel, 
and blood flow axis at a discrete segment of vessel 60 157.  The Doppler function traced 
the spectral wave-form (Figure 3.4).  The image was frozen and peak systolic velocity 
was manually measured using the in-built ultrasound calipers (SonoSite MicroMaxx®). 
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Figure 3.4:   Frozen screen shot of a Doppler image 
Baseline Assessment 
 Once a satisfactory image was obtained the investigator and the participant 
remained in the same position throughout the study (anatomic landmarks such as veins 
and fascial planes were noted).  The baseline brachial artery image was named and 
saved for subsequent off-line analysis of arterial diameter using a custom-designed, 
semi-automated ultrasound arterial measurement software.  The saved M-mode images 
incorporated at least 2 and a maximum of 3 R waves on an ECG.  The “Doppler” function 
traced the spectral wave form.  The investigator froze the image and manually measured 
the peak systolic velocity using in-built calipers on the ultrasound system.  
Endothelial-Dependent Dilation (EDD) 
 Figure 3.5 illustrates the endothelial-dependent dilation assessment protocol.  
Following a 10 min rest period a pneumatic cuff was inflated to 250 mmHg for 5 min 38.  
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Following 5 min of occlusion, the cuff was rapidly released resulting in reactive 
hyperemia and a subsequent increase in brachial artery blood flow.  Post-deflation peak 
systolic velocity was measured using Doppler within 15 sec of cuff release 107.  M-mode 
images of the brachial artery were recorded every 60 sec post-deflation for 5 min.   
 
 
 
 
 
Figure 3.5:   Overview of the protocol used to assess endothelial-dependent 
dilation  
Real-time analysis of the ultrasound images was performed using in-built 
ultrasound calipers.  The virtual calipers were placed at the anterior and posterior 
intimal interfaces between the lumen and the arterial walls to provide an estimate of 
the arterial diameter.  The diameter of the brachial artery was measured at a minimum 
of two and maximum of three consecutive R waves on the ECG, a process referred to as 
“gating”.  The R wave represents the end of diastole in the cardiac cycle.  Gating allows 
diameter estimates to be taken at specified vertical cross-sections of the artery.  The 
mean of the 2-3 measurements was taken as the brachial artery diameter.   
Statistical Analysis 
Pearson product-moment correlation was used to assess the reliability in brachial 
artery measurement between day 1 and day 2 (p<0.001).  Data was analysed using SPSS 
(V19.0, SPSS Inc, IL).  
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Results 
 Scattergrams for FMD and Doppler blood flow are illustrated in Figure 3.6 and 
Figure 3.7.  There was a significant correlation between the two brachial artery diameter 
measurements (r=0.78, p<0.001) and the two Doppler blood flow measurements 
(r=0.83, p<0.001) 
 
Figure 3.6. Scattergram of brachial artery diameter measurements (cm) on two 
separate occasions.  
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Figure 3.7. Scattergram of Doppler blood flow measurements (cm/sec) on two 
separate occasions.  
Summary 
 The reproducibility of the FMD measurement was confirmed as there was a 
significant correlation between the repeated measures.    
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STUDY 1B 
IMAGE DETECTION SOFTWARE DEVELOPMENT - VALIDITY AND RELIABLITY 
METHODOLOGY 
Image Detection Software Development 
The new segmentation algorithm was developed by Dr. Kevin McGuinness, a 
postdoctoral researcher in CLARITY: The Centre for Sensor Web Technologies.  The 
algorithm operates in two stages: horizontal expansion, and vertical expansion.  In the 
horizontal expansion stage the seed point is expanded to a single pixel thick horizontal 
connected path.  This is achieved by growing the seed point in both the left and right 
directions using a simple greedy strategy.  This strategy begins by setting the current 
pixel to the seed pixel.  Assuming that the line is growing in the correct direction, at each 
step, the three neighboring pixels to the right of the current pixel are examined.  The 
current pixel is updated to be the darkest of these and is added to the line.  This process 
continues until the expansion has reached a predefined boundary.   
In the vertical expansion stage the region is grown upwards and downwards 
using a dynamic programming approach.  The region is expanded upwards by examining 
each pixel above the topmost part of the previous region in turn. If the pixel brightness 
is below a certain threshold, and the three neighboring pixels behind it are already part 
of the front, the pixel is added to the new front.  This process is repeated recursively 
until the front is fully expanded.  A similar strategy is followed to expand the front 
downwards. 
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Image processing 
Image processing is divided into the following stages, i) image acquisition, ii) 
calibration, iii) pre-processing, iv) segmentation, v) post-processing, vi) robust statistics, 
vii) refinement and viii) additional tools 
Image acquisition 
 The practitioner selects one or more images of a large artery for analysis using a 
standard dialog box.  For each image, the practitioner locates the artery and clicks the 
area between the arterial walls.  The software can handle images stored in various file 
formats including BMP, PNG, JPEG, and GIF. 
Calibration 
 A device specific calibration step establishes the number of pixels per centimetre 
in each ultrasound image.  The implementation is based on a Sonosite MicroMaxx® 
ultrasound system.  Calibrating this device requires first detecting the mode, zoom level, 
and depth, followed by counting the number of pixels between the measurement bars 
on the right-hand-side of the image.  The mode and zoom-level are recognized by 
template matching at pre-defined areas of the image.  The depth is recognized by 
template matching using prototypes of the digits zero through nine in the bottom right 
hand corner of the image.   The distance between the measurement bars in cm is a 
function of the mode, zoom-level, and depth.  As such, counting the number of pixels 
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between each measurement bar may be used to determine the number of pixels per cm 
in the image. 
Preprocessing  
 The image is cropped to remove irrelevant information according to the device 
setup.  Excessive noise can diminish the effectiveness of medical image processing 
algorithms.  As such, a pre-smoothing step is optionally performed to reduce the noise in 
the image.  In this step, the image is filtered with a Gaussian bilateral filter.  This helps 
ameliorate noise without disturbing significant edge information in the image.  
Preprocessing can be disabled in the user interface if desired. 
Segmentation 
 The practitioner identifies the artery of interest, and notifies the application of its 
position by clicking inside it.  A constrained seeded region-growing algorithm is used to 
delineate the arterial boundary based on the position indicated by the practitioner and a 
live adjustable threshold (algorithm protected by invention disclosure).  The result is 
depicted visually in that the segmented arterial lumen is highlighted using grey shading.   
Post-processing 
 The region boundary is smoothed by convolving it with a 1-dimensional Gaussian 
kernel.   
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Robust statistics 
 An estimate of the arterial diameter is computed from the segmentation using a 
subset of the vertical diameters that correspond to the inter-quartile range.  The cross-
sections that correspond to these diameters are shown in a lighter color so that the 
practitioner may easily distinguish them. 
Refinement 
 The practitioner observes the feedback and diameter estimate from the previous 
step and decides if the estimate is satisfactory.  At this stage, the practitioner may 
choose to adjust the threshold used in the segmentation step with a slider or pick a new 
seed point and start again.  As the slider is moved the feedback and diameter estimate 
are updated in real time. 
Additional tools 
 The application includes built-in software calipers that allow manual 
measurements to be taken at fixed points in conjunction with the diameter estimates. A 
gating tool is included to allow measurements to be taken at specific cross-sections of 
the estimated arterial region. 
Validation of ADM Software 
 Concurrent validity quantifies the relation of one measure to another.  To assess 
the concurrent, criterion related validity of the ADM software, 143 brachial artery 
ultrasound images were randomly selected and arterial diameter was assessed by the 
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same investigator using the ADM software and the SonoSite ® virtual calipers.  The 
diameter was assessed at a minimum of 2 and a maximal of 3 ECG R waves.  All 
measurements were performed in a blinded fashion. 
Arterial Diameter Assessment Using ADM Software 
All images were selected for analysis using a standard dialog box (Figure 3.8).  For 
each image, the artery was located and the area between the anterior and posterior 
arterial walls was manually selected.  The software used this point to segment the 
arterial boundary using a constrained region-growing algorithm, and the result was 
depicted visually in that the segmented arterial lumen was highlighted using grey 
shading.  The segmentation of the artery was updated in real-time.  The automated 
values can be overridden by selecting a new seed point or using a slider to change the 
threshold intensity values of the segmentation.   
 
Figure 3.8:  Standard dialog box 
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Gated measurements of the brachial artery diameter were recorded using a 
minimum of 2 and maximum of 3 consecutive R waves on an ECG.  The mean of the 2-3 
measurements was taken as the brachial artery diameter.   
 
Statistical Analysis  
Bivariate and intraclass correlation coefficients were used to assess the validity of 
the ADM software.  Due to limitations of these statistical procedures, agreement 
between the methodologies was further assessed using the Bland and Altman 
procedure.  Pearson product-moment correlation was used to assess the reliability of 
the ADM software Data, using SPSS (V19.0, SPSS Inc, IL).    
Results 
ADM Software – Validity 
The bivariate correlation between techniques was 0.99 (p<0.001) (Figure 3.9) and 
average measurement intraclass correlation coefficient was 0.99 (99% CI = 0.992 – 
0.996).   
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Figure 3.9. Scattergram of brachial artery diameter using ultrasound calipers and ADM 
software 
Using the Bland and Altman analysis 158 there was generally good agreement (i.e. 
± 2 SD) between the two measurement procedures thus confirming the results for the 
bivariate and intraclass correlations (Figure 3.10). 
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Figure 3.10.  Bland and Altman limits of agreement between the arterial diameter 
measurements using the ADM software and ultrasound calipers 
ADM Software - Reliability 
A total of 112 brachial artery ultrasound images were randomly selected and 
arterial diameter was assessed in a blinded fashion by the same investigator using the 
ADM software on 2 separate occasions.  The correlation coefficient was r = 0.98 
(p<0.001) (Figure 3.11).  
 
 
 
 
Figure 3.11. Scattergram of brachial artery diameter measurements on two separate 
days  
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Summary 
 Compared to in-built ultrasound calipers, the user-friendly, custom-designed 
ADM software was shown to be valid and reliable.  Its unique feature is the fact that it 
utilizes a novel algorithm that allows for updating the seed points and parameters while 
providing real-time feedback to the operator during offline, retrospective analysis.  The 
semi-automated nature of the software reduces operator subjectivity and as a 
consequence human error.  This makes the method more resilient to noise than manual 
arterial diameter estimation tools, such as virtual calipers.  It is low-cost and can be 
implemented with minimal investment and development time.  
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Chapter 4  
STUDY 2 
Effect of an Acute Bout of Self-Regulated and High-Intensity Interval Exercise on 
Physiological Responses and Endothelial Function in Individuals with Cardiovascular 
Disease 
Rationale 
 Cardiovascular disease (CVD) refers to coronary heart disease, cerebrovascular 
disease and peripheral arterial disease, and is the leading cause of death in Ireland.  The 
treatment of individuals with CVD has evolved considerably in the last 50 years 159.  
Individuals with CVD are now encouraged to undertake a rehabilitation programme that 
offers a multi-faceted and multidisciplinary approach to optimize cardiovascular risk 
reduction, promote adoption and adherence to healthy behaviours, enhance emotional 
well-being, reduce disability, and encourage an active lifestyle 160.  Lifestyle modification 
involving diet and exercise has been found to result in a significant reduction in cardiac 
and total mortality 161.   
 Traditionally, physiologically based exercise prescriptions for individuals with 
CVD involve identifying an intensity range that elicits a predetermined   O2 or heart rate.  
In many instances prescribed exercise may exceed an individual’s preferred level of 
intensity and may establish a negative attitude toward physical activity.  Longitudinal 
studies report that participants tend to deviate from physiologically based, prescribed 
levels of intensity in favour of their apparently preferred levels.  
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 Participation in regular physical activity is influenced by a number of factors.  
These include demographic, psychological, behavioural, socio-cultural, environmental 
and activity characteristics 162.  For example, a number of surveys involving women from 
various racial-ethnic groups have found that they prefer to exercise on their own 
(autonomously performed physical activity).  The reasons are not well understood but 
may be related to the fact that activity is experienced as pleasant due to the greater 
sense of perceived autonomy in determining the mode, duration, frequency and 
intensity of exercise 163. 
 Allowing individuals to use effort perception to self-select their preferred 
intensity may encourage the development of intrinsic motivation, a central element in 
promoting adherence to exercise and increase enjoyment.  In a recent study Johnson et 
al., 148 found that 86% of women involved in aerobic exercise used effort perception 
exclusively to determine exercise intensity.  This is not surprising considering that 
exertional feedback is commonly used to regulate the pace of many daily activities.  This 
is often done without conscious awareness.   
 Self-regulated exercise intensity may increase enjoyment by allowing 
individuals complete an activity within their perceptual preference range and without 
undue physiological strain.  Exercise activities of lower-intensities and shorter duration 
are associated with significant and often substantial shifts toward more pleasant affect 
164 and are more likely to be continued  165.  Although effort perception is used to self-
regulate the pace of many daily activities, few studies have examined the effect of an 
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acute bout of short duration (20 min), self-regulated exercise on physiological and 
perceptual responses in men with CVD. 
  High-intensity interval exercise (HIIE) involves a series of repeated bouts of 
short duration ( 5 min) high intensity exercise (70 – 100% of maximal effort), 
alternated with periods of active or passive recovery.  A growing body of evidence has 
found that HIIE can be an effective alternative to traditional continuous exercise 
interventions.  When compared to continuous endurance exercise, interval training has 
been shown to elicit similar or even superior physiological adaptations, in healthy men 
and women 6 and those with CVD 8.  The majority of studies that have evaluated HIIE in 
C D patients have used cycling and involved exercise interval durations of ≥ 2 min 
interspersed with ≥ 2 min active or passive recovery (Cornish et al, 2010).  Relatively few 
HIIE studies have involved exercise interval durations of  1 min and recovery periods  
30 sec.   
 The vascular endothelium is a single layer of cells which line the inside of blood 
vessels and forms a biological interface between circulating blood elements and the 
various organ systems 166.  It is a dynamic tissue that is involved in the modulation of 
vascular smooth muscle tone, platelet aggregation, monocyte and leucocyte adhesion 
and thrombosis by synthesizing and metabolizing vasoactive substances 23.  Given its 
strategic location, the endothelium is a primary target for injury from mechanical forces 
and processes related to cardiovascular risk factors.  Impairment of the normal function 
of the endothelium, a process known as endothelial dysfunction (ED), represents one of 
the earliest events in the pathogenesis of atherosclerosis.  The ability of large conduit 
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vessels to dilate in response to a brief period of occlusion and sublingual administration 
of GTN is termed endothelial-dependent dilation (EDD) and endothelial-independent 
dilation (EID), respectively, and are commonly used to non-invasively assess endothelial 
function.   
 The purpose of this study was to compare the effect of an acute bout of self-
regulated exercise (SRE) and short (<1 min) high-intensity interval exercise (HIIE), 
interspersed with short recovery periods (<30 sec), on physiological and perceptual 
responses and endothelial vasomotor function in individuals with documented 
cardiovascular disease (CVD).   
Specific Aims 
1. To compare the physiological responses during an acute bout of SRE and HIIE in 
individuals with CVD  
2. To compare the effects of an acute bout of SRE and HIIE on endothelial-
dependent and endothelial-independent dilation in individuals with CVD 
3. To compare the perceptual responses during an acute bout of SRE and HIIE in 
individuals with CVD  
Hypothesis 
1. Physiological responses will be significantly greater during an acute bout of HIIE 
than SRE in individuals with CVD 
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2. There will be a significantly greater increase in endothelial-dependent dilation 
(EDD) immediately following an acute bout of HIIE than SRE in individuals with 
CVD 
3. Perceptual responses will be significantly greater during an acute bout of HIIE 
than SRE in individuals with CVD  
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METHODOLOGY 
Participants 
 The present investigator volunteered to help with the supervision of two 
community-based phase IV cardiac rehabilitation classes per week for 18 months prior 
to the beginning of the study.  Men (n = 20) and women (n = 2) with documented 
cardiovascular disease, who had been participating in the exercise programme 
(HeartSmart), twice a week for a minimum of 6 months, were informed of the research 
study and a brief summary and contact details were provided.  Following an expression 
of interest, potential subjects were asked to visit the Vascular Research Unit (VRU) in the 
School of Health and Human Performance for a screening visit.  The natures, benefits, 
risks and discomforts of the study were explained.  Inclusion criteria were stable angina; 
prior myocardial infarction; prior revascularisation; ability to achieve 30 min of 
continuous walking without symptoms (cardiac chest pain/discomfort, severe 
breathlessness, dizziness or palpitations) or be able to undertake activities of at least 5 
METS (manually washing a car, digging/turning soil, walking/jogging a mile in less than 
15 min) without symptoms; clinically stable and in good health for a minimum of 2 
weeks prior to beginning the study.  Participants were excluded if they were current 
smokers, had unstable angina, uncontrolled hypertension (systolic blood pressure (BP) 
>180 mmHg, diastolic BP >100 mmHg), resting tachycardia or unstable/acute heart 
failure.  Individuals who met the entry criteria and who received medical clearance from 
a physician to participate were randomly assigned to the SRE (n = 12) or HIIE (n = 12, 2 
female) group.  Two of the participants in the SRE group withdrew due to illness, 
 83 
another withdrew due to orthopedic limitations and a fourth withdrew for personal 
reasons.  One participant withdrew from the HIIE group due to illness.  Participants’ 
medications are summarized in Table 4.4.  Individuals who took part in study 3, did not 
partake in study 4. 
Overview of Study Design 
Research Design 
Participants in both experimental groups visited the Cardiovascular Research 
Unit in DCU on two separate occasions.  The first visit was used to screen potential 
participants and measure peak aerobic capacity (  O2peak).  During the second visit 
endothelial vasomotor function was assessed before and immediately following an 
acute bout of SRE or HIIE.   
Visit 1 
Participants fasted for 4 h, and refrained from strenuous physical activity for 24 h 
prior to the visit.  The nature and risks of the study were explained.  A plain language 
statement was read and informed consent was obtained in accordance with the 
Research Ethics Committee at Dublin City University (DCUREC 148).  Participants then 
completed a physical activity readiness questionnaire (PAR-Q), a general health 
questionnaire (Appendix B), had their blood pressure, height and weight measured and 
performed an exercise test on a treadmill to determine   O2peak.      
 84 
Visit 2 
 Participants arrived to the Cardiovascular Research Unit, DCU at 7.00 am after 
an 8 h overnight fast.  Water consumption was permitted during the fasting period and 
where possible, all vasoactive medications were withheld for at least 4 half-lives.  
Participants were not permitted to exercise for at least 24 h before the visit or ingest 
substances that might affect FMD such as caffeine and vitamin C or use tobacco for at 
least 6 h before the study.  Women recruited for this study were post-menopausal, 
therefore menstrual cycle phase was not relevant.  Following a 10 min rest period in a 
quiet, temperature-controlled room, a blood sample was drawn from the antecubital 
vein, and endothelial function was assessed.  Participants then undertook an acute bout 
of SRE or HIIE on a treadmill.  Within 5 min of exercise cessation a blood sample was 
taken and endothelial function was again assessed (Figure 4.2).  
 
Figure 4.1:   Overview of visit 2 
 85 
Self-Regulated Exercise 
 The SRE group exercised for 20 min on a treadmill at a self-selected intensity.  
Participants were allowed to alter the treadmill speed and grade during the first min of 
exercise and subsequently during the first 30 sec of every 6th min.  The velocity control 
arrows were kept visible to allow participants alter the treadmill grade and velocity 
when signalled by the research assistant.  Metabolic measurements were recorded 
throughout the exercise bout using open circuit spirometry (Sensormedics Vmax 229 
metabolic system, SensorMedics Corp., Yorba Linda CA).  Heart rate and RPE were 
recorded during the last 30 sec of every 5th min using telemetery (Polar  antage N ™ 
Polar, Port Washington, NY) and the Borg RPE scale, respectively.  Participants were 
as ed to “select an intensity that you prefer…that you feel happy to do regularly”. 
High-Intensity Interval Exercise 
 Figure 4.2 illustrates the HIIE protocol.  The session began with a 10 min warm-
up at 50% HRmax followed by 2 min of seated rest.  Participants then performed three 
blocks of 8 x 45 sec of treadmill exercise at  85% HRpeak.  Grade and/or speed was 
adjusted to reach target intensity.  Each 45 sec interval was interspersed with a 15 sec 
period of passive recovery.  The session concluded with a 5 min cool-down period.  
Participants were continuously monitored with a 12-lead ECG. Arterial blood oxygen 
saturation (SpO2) and heart rate were continuously monitored.  Participants were asked 
to provide subjective estimates of perceived exertion and degree of chest pain at 
regular intervals during both exercise sessions. 
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Figure 4.2:  High intensity interval exercise session 
Anthropometrics 
 Height and mass were measured using a wall stadiometer and electronic 
balance (Seca 797, USA) respectively.  Footwear was removed prior to the 
measurement.  Height was measured to the nearest cm, and weight was measured to 
the nearest 0.1 kg. 
Blood Sampling and Storage 
 Blood sample were obtained with participants in a seated position for 5 min 
with legs uncrossed in order to minimise plasma volume shifts.  Serum vacutainers were 
allowed to stand for 30 min before centrifugation at 3000 rpm (1600 g) for 15 min at 
4°C.  Sodium citrate vacutainers were pre-chilled in an ice bucket and samples returned 
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to the ice bucket prior to centrifugation.  Blood for microparticles analysis was collected, 
prepared and stored according to the double centrifugation method of Bernal-Mizrachi 
et al., (2004).  Blood was collected in pre-chilled sodium citrate vacutainers and spun 
first at 160 g for 9 min to produce platelet rich plasma (PRP).  This was harvested from 
the top leaving a 0.5 cm layer of plasma undisturbed close to cell debris.  The PRP was 
centrifuged for a further 9 min at 1000 g to yield platelet poor plasma (PPP).  PPP was 
aliquoted and stored at – 80°C until analysis.  
Biochemical Analysis 
 Serum triglycerides, total cholesterol, HDL-cholesterol (HDL-C), free fatty acids 
(FFA) and glucose were determined using spectrophotometric assays, performed on an 
automated bench-top clinical chemistry system (ACE®, Alfa Wassermann B.V., 
Netherlands) using appropriate reagents, calibrators and controls (Randox Laboratories, 
UK).  Serum insulin was determined by a dissociation enhanced lanthanide fluorescent 
immunoassay (DELFIA) using a commercially available kit (Perkinelmer, Wellesley MA, 
USA).  Serum concentration of sVCAM-1, sICAM-1 and interleukin-6 (IL-6) were 
determined in duplicate using a quantitative sandwich enzyme immunoassay technique 
and commercially available kits (R & D Systems, Minneapolis, USA).  Haematocrit values, 
haemoglobin concentrations and counts of leukocytes were determined from an EDTA 
whole blood sample using an automated haematology analyser (AcTdiff2, Beckman 
Coulter, USA).   
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Peak Aerobic Capacity  
 Peak aerobic capacity test (  O2peak) was assessed on a treadmill (Marquette 
2000, General Electric, USA) using 1 of 5 incremental protocols (Appendix E), depending 
on individual exercise capacity.  The Balke protocol was selected and modified to allow 
participants to reach volitional fatigue in 8 – 12 min.  A 2 min warm up preceded each 
test and the gradient was increased 2.5% every 2 min until the subject reached volitional 
exhaustion or presented with contraindications to exercise. If necessary, treadmill speed 
was increased by 1 km.h-1 every 2 minutes while the treadmill gradient was maintained 
at 22.5%.  Participants were verbally encouraged to give their best effort. 
 Respiratory metabolic measures, heart rate and an ECG were monitored 
continuously throughout the test. RPE was recorded every 2 min.  Peak oxygen uptake 
was determined by averaging the three highest consecutive 20 second values.   
Cardiorespiratory and Metabolic Measures  
 Respiratory metabolic responses were determined using standard open-circuit 
spirometry techniques (Sensormedics Vmax 229, SensorMedics Corp., CA).  Prior to 
testing, the gas analysers were calibrated with standard gases of known concentration.  
A mass flow sensor (Sensormedics, Loma Linda, CA, USA) was used to collect breath-by-
breath measurement of ventilation.  A 3 L volume syringe (Sensormedics, Loma Linda, 
CA, USA) was used to calibrate the mass flow sensor prior to each test.   
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Mass Flow Sensor Heated Wire Anemometer-Mode of Operation  
 The mass flow sensor is a low resistance tube with a tapered internal diameter 
extending from both ends of a laminar flow throat.  A cold and hot stainless steel wire 
electrically heated to -180°C and -240°C respectively, are centered in the flow stream.  
These wires are elements in a servo-controller bridge circuit that maintain the resistance 
ratio of the two wires at a constant value.  If only the temperature of the inspired gases 
changes then both wires lose heat at the same rate and no current change is required to 
keep the bridge balanced.  As air flows across the wires, the hot air loses heat more 
rapidly than the cold air and current must be added to keep the bridges balanced at a 
3:4 ratio. The amount of current required is proportional to the mass flow of the gas.  
This method ensures that the sensor measures only the heat loss from the molecular 
convection of the moving gas stream, and not the artifact due to cooling of the gas as it 
passes through a breathing assembly.   The mass flow meter responds to instantaneous 
flow rates between 0-16 L.sec-1 and integrated flow between 0-350 L.min-1 with flow 
resistance <1.5 cmH2O.L-1.sec
-1.  The mass flow sensor was outputted to the analyser 
module of the Vmax 229 and was sampled at a rate of 125 Hz.  
Mass Flow Sensor Calibration  
 A 3 L volume syringe (Sensormedics, Loma Linda, CA, USA) was connected to 
the mass flow sensor, and stroked four times in order to measure inspired and expired 
volumes.  The volumes were calculated by expressing 3 L as a fraction of each measured 
inspired and expired volume achieved during calibration.  An average correction factor 
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was calculated for inspired and expired volumes, and used to fine-tune the volume 
measurement.   
 A verification procedure was performed. This involved stroking the 3 L volume 
syringe four times.  Inspired and expired volumes were measured using the newly 
calculated correction factors.  In order to pass the calibration procedure, one of the four 
strokes had to have an average flow rate < 0.5 L.sec-1, and at least one of the four 
strokes had to have an average flow > 3.0 L.sec-1.  
Gas Analysers  
 The Vmax 229 utilizes a rapid response infrared measurement technique.  An 
O2 and CO2 analyser is integrated with the Vmax 229.  A small sample of inspired air is 
drawn through a sample cell, and exposed to an infrared light through an optical that is 
passed through a band pass filter and the sample cell.  An infrared detector responds to 
the amount of infrared light that passes through the sample cell.  The amount of light 
that passes through the sample cell varies according to the concentration of CO2 in the 
sample cell.  Based on measured levels of infrared light intensity, the analyser computes 
the PCO2 in the gas sample.  The CO2 analyser is linearly scaled across the 0-100% range 
with a resolution of 0.01% CO2, and a response time of < 130 ms (10-90%) at 500 ml.min
-
1 flow.  The O2 analyser is based on the high paramagnetic susceptibility of O2.  A 
diamagnetic glass dumbbell suspended in a magnetic field rotates in proportion to the 
PO2.  The analyser is linearly scaled across the 0-100% range with a resolution of 0.01% 
O2 and a response time of < 130 ms (10-90%) at 500ml.min
-1 flow.  
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Calibration of CO2 and O2 Analysers  
 The gas analysers were calibrated with standard gases of known concentration 
(BOC gases, Dublin, Ireland).  The first calibration gas contained 26.00 ± 0.02% oxygen 
and the balance nitrogen (N2).  The second calibration gas contained 4.00 ± 0.02% 
carbon dioxide, 16.00 ± 0.02% O2, and the balance N2.  A small bore drying tube 
connected to the CO2 and O2 analysers sampled the calibration gases.  The absorption 
and evaporative properties of the drying tube ensured that the relative humidity of the 
calibration gas was equilibrated to ambient conditions prior to sampling by the O2 and 
CO2 analysers.  The calibration gas was sampled at a rate of 125 Hz. The response time 
was similar between O2 and CO2 analyser.  
Ratings of Perceived Exertion  
 RPE was obtained using the 16-point Borg category RPE scale.  Prior to the 
maximal exercise test participants read a standard set of perceptual scaling instructions.  
These instructions followed an established format used in previous investigations.  Low 
and high “perceptual anchors” were established during the maximal exercise test.  This 
involved asking participants to assign a rating of 6 (low anchor) to the lowest exercise 
intensity, and 20 (high anchor) to the highest exercise intensity.  Participants were 
instructed to make their subjective assessments of perceived exertion relative to these 
minimum and maximum standards (perceptual anchors). 
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Electrocardiographic Monitoring (ECG) 
 Heart rate (HR) and electrical activity of the heart were monitored continuously 
using a 12-lead ECG monitor (GE Case 8000 12 lead ECG).  The signal to noise ratio at the 
skin electrode interface was reduced by cleansing the area with an alcohol saturated 
gauze pad.  The superficial layer of skin was then removed using light abrasion with fine 
grain emery paper.  The electrodes were placed on 10 standard anatomical landmarks. 
Ventilatory Threshold 
 The V-slope method described by Beaver et al., 167 was used for the 
determination of ventilatory threshold (VT).  This method involves the analysis of the 
CO2 elimination (  CO2) in relation to O2 upta e (  O2).  By plotting   O2 against   CO2 the 
initial slope of 1.0 is followed by a steeper slope when lactic acid is buffered by 
bicarbonate and CO2 is formed.  When VT could not be determined using V-slope 
method, the ventilatory breakpoint method was employed 168.  This involved plotting 
  O2 and minute ventilation (  e).  The   O2 at which the   e increased nonlinearly was 
used to determine the point of the VT.   
Endothelial Function Assessment  
 Endothelial function was assessed, pre and post exercise, using FMD 39.  
Endothelial function was assessed with the participants in a supine position in a quiet, 
temperature-controlled room.  The right arm rested on an examination table, 
perpendicular to the bed, and was extended and externally rotated to permit imaging of 
the right brachial artery.  An automated pneumatic cuff was placed on the forearm, 
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distal to the brachial artery and electrodes for a 3-lead ECG were placed on their chest.  
The ECG tracing was activated and settings adjusted to ensure clear identification of the 
R wave, which corresponds to the end of diastole in the cardiac cycle.   
Endothelial-Dependent Dilation 
 Figure 4.3 illustrates the brachial artery FMD assessment procedure.  Following 
a 10 min rest period the pneumatic cuff was inflated to 250 mmHg for 5 min.  The cuff 
was rapidly deflated and peak systolic velocity was measured using Doppler within 15 
sec of cuff release.  M-mode images were named and recorded every 60 sec post-
deflation for 5 min.  Brachial artery diameter was analysed off-line, using the ADM 
software.  FMD was normalised for the shear stimulus.  Shear rate was calculated using 
the formula; 4 x peak velocity/peak diameter 69. 
 
 
Figure 4.3:   Overview of the protocol used to assess endothelial-dependent dilation  
Endothelial-independent Dilation 
 Figure 4.4 illustrates the endothelial-independent dilation assessment protocol.  
Following a 15 min rest period, a baseline brachial artery image was again recorded.  
Gylceryl trinitrate (GTN; 400 g) was then administered sublingually.  To assess brachial 
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artery diameter, M-mode images were named and recorded every 30 sec following 2.5 
min of GTN administration.  
 
 
Figure 4.4:  Overview of endothelial-independent dilation 
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Off-line Analysis 
 Ultrasound images were analyzed off-line, using the ADM software (see chapter 
3 for details).  The same experienced investigator performed the off-line analysis of the 
ultrasound images using a custom-designed arterial diameter measurement tool.  Image 
processing is divided into the following stages, i) image acquisition, ii) calibration, iii) pre-
processing, iv) segmentation, v) post-processing, vi) robust statistics and vii) refinement.  
This method of arterial diameter estimation using the ADM software is explained in 
detail in chapter 3. 
Statistical Analysis 
Prior to statistical analysis the data was checked for normality using the Shapiro-
Wilks test.  An independent t-test was used to compare the physiological and perceptual 
responses between the two experimental groups at maximal exercise.  A condition (HIIE 
and SRE) by time (pre exercise and post exercise) two-way repeated measure ANOVA 
was used to compare the percentage change in brachial artery diameter in response to 
hyperemia and GTN administration.  A one-way ANOVA was used to compare the 
physiological and perceptual responses for each block of HIIE and every 5 min during 
SRE.  Significant main effects were probed using a Bonferroni post hoc test.  SPSS for 
Windows statistical software (ver 19.0) was used to perform the statistical analysis. 
Statistical significance was accepted at the p < 0.05 level of confidence.   
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Results 
Participant characteristics 
Baseline physical characteristics, blood pressure and blood lipids are summarized 
in table 4.1.  With the exception of LDL-C, there were no differences in any of the 
measured parameters at baseline between the SRE and HIIE groups.  There was no 
significant difference in any of the measured parameters at maximal exercise between 
groups (Table 4.2).  
Acute Exercise Bout 
The mean physiological and perceptual responses during the SRE and HIIE are 
summarized in table 4.3.  Average treadmill velocity, treadmill gradient,   O2, %  O2peak, 
METs, %VT, RPE, HR, respiratory rate and ventilation were significantly higher during 
HIIE than SRE. 
The mean physiological and perceptual responses during each block of HIIE are 
summarized in table 4.4.  Heart rate, %HRmax and SpO2 were significantly higher during 
block 2 than block 1.  Respiratory rate, minute ventilation and %HRmax were 
significantly higher during block 3 than block 1 and block 2.  Relative   O2 and %VT, were 
also significantly higher during block 3 than block 1.   
The mean physiological and perceptual responses during each 5 min period of 
SRE are summarized in table 4.5.  Treadmill velocity, RPE, and respiratory rate were 
significantly higher between 10-15 and 15-20 min than 0-5 min.  Oxygen uptake, 
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%  O2peak, METs, and minute ventilation were significantly higher between 10-15 min 
than 0-5 min.  The %VT was significantly higher between 15-20 min than 0-5 min.  
Compared to 5-10 min, %  O2peak and RPE were significantly higher between 10-15 min 
and 15-20 min respectively.   
Endothelial Function 
There was no significant difference in endothelial-dependent dilation or 
endothelial-independent dilation before or after exercise in either experimental group 
(Figure 4.5).  Peak diameter, peak blood flow velocity and endothelial-independent 
dilation results are illustrated in Figures 4.6 – 4.8. 
ECG Changes and Clinical Symptoms 
 ST-segment changes ranged from 1 – 3 mm, and returned to normal during 
passive recovery.  None of the participants reported angina symptoms during or 
following the acute bout of HIIE.  
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Table 4.1: Medication 
Main Drug Class SRE HIIE 
Statins 6 7 
ACE Inhibitor 4 4 
Beta Blocker 2 3 
Anti-platelet 5 7 
Diuretic 2 1 
Proton Pump 1 2 
Values are means  
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Table 4.2: Physical characteristics and blood lipids of the participants 
 Mean 
 SRE (n = 8) HIIE (n = 11) 
Age (y) 65.8 ± 4.5 65.7 ± 7.2 
Height (cm) 169.9 ± 9.1 168.7 ± 5.7 
Weight (kg) 85.9 ± 13.6 80.8 ± 10.6 
BMI (kg.m-2) 29.7 ± 3.3 28.3 ± 2.7 
Systolic blood pressure (mmHg) 130.9 ± 5.5 138.3 ± 13.6 
Diastolic blood pressure (mmHg) 83.1 ± 7.4 80.6 ± 6.9 
Total cholesterol (mmol)  3.9 ± 0.8 2.9 ± 1.2 
HDL-cholesterol (mmol) 1.3 ± 0.2 1.1 ± 0.1 
LDL-cholesterol (mmol) 1.8 ± 0.5 1.3 ± 0.3* 
Triglycerides (mmol) 1.3 ± 0.2 0.7 ± 0.3 
ApoB 76.9 ± 17.9 74.1 ± 13.0 
ApoA 134.1 ± 16.7 137.8 ± 17.9 
Values are means  SD; *p < 0.05 vs. self-regulated 
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Table 4.3:  Descriptive characteristics of the participants in the SRE and HIIE group during graded exercise 
test  
 Mean 
 SRE (n = 8) HIIE (n = 11) 
  O2peak (ml
.kg1.min1) 28.1 ± 7.0 29.05 ± 6.9 
  O2peak (L
.min1) 2.4 ± 0.6 2.33 ± 0.7 
Heart rate max (beats.min-1) 122.3 ± 29.7 132.27 ± 13.6 
  O2VT (ml
.kg1.min1) 23.2 ± 5.9 24.21 ± 4.6 
%   O2VT  81.3 ± 8.9 73.29 ± 26.3 
Ventilation peak (L.min1) 64.1 ± 20.8 64.94 ± 19.2 
RER 1.1 ± 0.1 1.13 ± 0.1 
Values are means  SD; *p < 0.05 vs. self-selected 
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Table 4.4:  Average Responses during SS and HIIE 
 Exercise Condition 
 SRE (n = 8) HIIE (n = 11) 
Treadmill velocity (km.h-1) 5.1 ± 0.8 7.5 ± 2.0† 
Grade (%) 0.6 ± 1.0 3.6 ± 1.6‡ 
  O2 (ml
.kg-1.min-1) 17.6 ± 4.2 23.3 ± 5.1† 
  O2 (L
.min-1) 1.50 ± 0.5 1.9 ± 0.5* 
   O2peak 63.8 ± 12.8 77.9 ± 9.7† 
METs 5.0 ± 1.2 6.7 ± 1.5† 
%   O2VT 74.0 ± 12.8 98.5 ± 13.5† 
RPE 11.4 ± 1.9 14.1 ± 2.0† 
Heart rate (beats.min-1) 96.3 ± 15.7 117.4 ± 18.0† 
%HRmax 80.2 ± 12.4 89.2 ± 13.4 
Respiratory rate (breaths.min-1) 25.9 ± 2.2  32.7 ± 7.1† 
Ventilation (L.min-1) 33.0 ± 9.1 49.8 ± 16.1† 
Systolic blood pressure (mmHg)  160.6 ± 21.7 
Diastolic blood pressure (mmHg)  71.3 ± 3.3 
SPO2 (%)  95.4 ± 2.2 
 Values are means  SD, *p < 0.05 vs.SS †p < 0.01 vs. SS; ‡p < 0.001 vs. SS 
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Table 4.5:  HIIE  
 Exercise Blocks 
 1 2 3 
Treadmill velocity (km.h-1) 7.3 ± 1.8 7.5 ± 2.1 7.7 ± 2.2 
Grade (%) 3.7 ± 1.6 3.7 ± 1.6 3.5 ± 1.5 
  O2 (ml
.kg-1.min-1) 22.4 ± 4.3 22.6 ± 5.2 25.0 ± 6.5 
  O2 (L
.min-1) 1.8 ± 0.5 1.8 ± 0.5 2.0 ± 0.6 
   O2peak 74.8 ± 8.7 75.9 ± 12.4 83.1 ± 11.9* 
METs 6.4 ± 1.2 6.5 ± 1.5 7.2 ± 1.8 
RPE 13.4 ± 2.5 14.1 ± 2.1 14.8 ± 2.0 
%   O2VT 94.2 ± 13.0 95.8 ± 17.1 105.6 ± 15.4* 
Systolic Blood Pressure (mmHg) 159.3 ± 19.5 162.0 ± 20.9  160.4 ± 32.8 
Diastolic Blood Pressure (mmHg) 70.4 ± 6.5 74.7 ± 7.0 68.7 ± 5.8 
Heart rate (beats.min-1) 111.0 ± 15.7 117.5 ± 18.2* 115.9 ± 42.1 
%HRmax 84.4 ± 12.4 89.2 ± 13.7* 95.2 ± 15.4*¥ 
Respiratory rate (breaths.min-1) 30.3 ± 7.1 32.0 ± 6.2 35.8 ± 8.5‡¥ 
Ventilation (L.min-1) 44.9 ± 14.2 48.0 ± 16.1 56.5 ± 19.7†¥ 
SPO2 (%) 96.0 ± 1.8 95.0 ± 2.5* 95.1 ± 2.4 
Values are means  SD; *p < 0.05 vs. Bloc  1; †p < 0.01 vs. Block 1; ‡p < 0.001 vs. Block 1;  
¥p < 0.05 vs. Block 2 
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Table 4.6: Self-Regulated Exercise 
 Time (min) 
 0-5 5-10 10-15 15-20 
Treadmill velocity (km.h-1) 4.5 ± 0.9 5.0 ± 0.8 5.3 ± 0.9* 5.5 ± 1.0* 
Grade (%) 0.2 ± 0.6 0.7 ± 1.1 0.8 ± 1.2 0.7 ± 1.2 
  O2 (ml
.kg-1.min-1) 14.6 ± 2.7 16.7 ± 3.2† 18.7 ± 4.6* 20.3 ± 6.6 
  O2 (L
.min-1) 1.2 ± 0.3 1.4 ± 0.4† 1.6 ± 0.5* 1.7 ± 0.7 
Kcal/min 3.9 ± 0.4  4.0 ± 0.3  4.1 ± 0.3 4.3 ± 0.3* 
   O2peak 53.5 ± 11.5 61.1 ± 11.0‡ 67.7 ± 13.5†¥ 72.7 ± 18.3 
Energy Cost (MET) 4.2 ± 0.8 4.8 ± 0.9† 5.4 ± 1.3* 5.8 ± 1.9 
RPE 9.9 ± 2.1 10.6 ± 2.1 12.2 ± 1.8† 12.9 ± 2.4*¥ 
%   O2VT 55.5 ± 25.9 63.0 ± 27.8† 68.6 ± 29.8† 72.2 ± 32.2* 
Heart rate (beats.min-1 86.9 ± 10.9 93.9 ± 13.0 98.9 ± 17.2 105.4 ± 24.4 
%HRmax 73.2 ± 14.2 78.6 ± 13.3† 82.2 ± 13.1 86.6 ± 11.5 
Respiratory rate (breaths.min-1) 23.5 ± 2.5  25.3 ± 3.3 26.6 ± 2.8† 28.4 ± 4.0* 
Ventilation (L.min-1) 26.6 ± 7.3 30.8 ± 7.6† 35.2 ± 10.0† 39.4 ± 14.4 
Values are means  SD; *p < 0.05 vs. 0-5 min; †p < 0.01 vs. 0-5 min; ‡p < 0.001 vs. 0-5 min;  
¥p < 0.05 vs. 5-10 min 
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Figure 4.5:  Percent change in brachial artery diameter before and after an acute bout of self-
regulated exercise (SRE) and high intensity interval exercise (HIIE)  
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Figure 4.6: Peak brachial artery diameter (cm) before and after an acute bout of self-regulated 
exercise (SRE) and high intensity interval exercise (HIIE) 
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Figure 4.7: Peak blood flow velocity (cm/s) before and after an acute bout of self-regulated exercise 
(SRE) and high intensity interval exercise (HIIE)
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Figure 4.8: Percent change in brachial artery diameter (%) following GTN administration before and 
after an acute bout of self-regulated exercise (SRE) and high intensity interval exercise 
(HIIE) 
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Summary 
 The SRE group self-selected an average treadmill velocity of 5.1 km.h-1, while 
the HIIE group exercised at 7.5 km.h-1, which correspond to 64% and 78%   O2peak, and 
80% and 89% HRmax, respectively.  The RPE values for the SRE were within a narrow 
range and indicated that when allowed to self-regulate their exercise intensity 
individuals with CVD will exercise at an intensity that they perceive to be fairly light to 
somewhat hard.  Alternatively, when HIIE is prescribed, individuals with CVD perceive 
the intensity to be somewhat hard to hard. There was no significant difference in 
endothelial-dependent or endothelial-independent dilation before or after exercise in 
either experimental group  
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Chapter 5  
STUDY 3 
EFFECT OF 4 WEEKS OF HIIT OR COMMUNITY-BASED CARDIAC REHABILITATION ON 
AEROBIC CAPACITY, ENDOTHELIAL FUNCTION AND SELECTED CARDIOVASCULAR 
BIOMARKERS IN INDIVIDUALS WITH CARDIOVASCULAR DISEASE 
Rationale 
 Individuals with cardiovascular disease are now encouraged to undertake a 
rehabilitation programme that offers a multi-faceted and multidisciplinary approach to 
optimize cardiovascular risk reduction, promote adoption and adherence to healthy 
behaviours, enhance emotional well-being, reduce disability, and encourage an active 
lifestyle 160.  A 20% reduction in overall mortality has been found in patients who 
undertake an exercise-based cardiac rehabilitation programme 169.   
 There is still, however, no clear consensus on the precise type, volume, 
intensity and frequency of exercise to achieve optimum health benefits.  Traditionally, 
individuals with CVD are encouraged to undertake continuous, moderate-to-vigorous 
intensity exercise as part of their cardiac rehabilitation programme.  A growing body of 
evidence has shown that high-intensity interval training (HIIT) can be an effective 
alternative to traditional continuous, moderate-to-vigorous intensity exercise 
interventions.   
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 High-intensity interval training involves a series of repeated bouts of exercise 
performed between 70 – 100% of maximal effort, and alternated with periods of active 
or passive recovery.  The duration of the high-intensity intervals can range from 10 sec 
to 5 min.  Interval training has been shown to elicit similar or even superior physiological 
adaptations than continuous endurance exercise, in both healthy and diseased 
populations. 
Compared to usual care cardiac rehabilitation, 12 weeks of treadmill interval 
training was more effective in improving   O2peak in cardiac patients, but resulted in 
similar increases in endothelial function 140.  Similarly, when HF patients were 
randomised to either moderate continuous training (MCT; 70% HRpeak), aerobic interval 
training (AIT; 95% HRpeak) or a control group (recieved standard advice regarding 
physical activity) for 12 weeks, improvements in   O2peak and brachial artery FMD were 
significantly greater in the AIT group than baseline, and the MCT and control group.  
Postive left ventricular (LV) remodeling occurred in the AIT group only.  A marker of 
hypertrophy, proBNP declined by 40% in the AIT group 8. 
 The benefits of aerobic exercise training on blood lipid profiles are well 
established 170.  The effect of high-intensity interval training on blood lipids, however, 
have been investigated, but to a lesser extent.  A recent study by Lamina et al., 171 
observed significant decreases in total cholesterol and significant increases in HDL-
cholesterol following 8 weeks of moderate-intensity (60 - 79% HRR) interval training in 
245 men with mild–moderate hypertension.  Each session was 45 – 60 mins, with an 
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interval to rest ratio of 1:1, 6 min each.  An earlier study 172 involving 8 weeks of HIIT 
(90% HRmax), resulted in significant improvements in HDL-cholesterol, and total 
cholesterol/HDL-cholesterol but no changes in total cholesterol in young, untrained men 
with normal total cholesterol.  Tsekouras et al., 173 found that 2 months of HIIT, involving  
3 sessions/week, running at 60 – 90%   O2peak in 4 min intervals for 32 min, lowered the 
rate of very low-density lipoprotein-triglyceride secretion from t she liver in previously 
sedentary men.  The potential role of HIIT as an alternative mode for improving blood 
lipid profile in individuals with CVD has not been adequately explored. 
 Studies examining the effect of interval training on endothelial function in 
individuals with CVD have involved a training period of 8 - 24 weeks, and intervals  3 
min in duration.  Recent studies found that 4 - 8 sessions of HIIT involving 30 sec exercise 
intervals, illicit significant physiological and metabolic improvements in healthy 
individuals.  The purpose of this study was to compare the effect of 4 weeks of HIIT (8 
sessions; interval duration < 1 min) or community-based cardiac rehabilitation on 
aerobic capacity, endothelial function and selected CVD risk biomarkers in men and 
women with CVD.    
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Specific Aims 
1. To evaluate the effect of an individualized 4-week HIIT programme on 
endothelial-dependent dilation in men and women with CVD 
2. To evaluate the effect of an individualized 4-week HIIT programme on 
endothelial -independent dilation in men and women with CVD 
3. To evaluate the effect of an individualized 4-week HIIT programme on   O2peak in 
men and women with CVD 
4. To evaluate the effect of an individualized 4-week HIIT programme on circulating 
levels of total cholesterol, LDL-cholesterol, HDL-cholesterol and triglycerides in 
men and women with CVD 
Hypotheses 
1. There will be a significant increase in endothelial-dependent dilation after a 4-
week HIIT programme and no change after 4 weeks participation in a traditional 
community-based cardiac rehabilitation programme in men and women with 
CVD 
2. There will be no change in endothelial-independent dilation after a 4-week HIIT 
programme or 4 weeks participation in a traditional community-based cardiac 
rehabilitation programme in men and women with CVD 
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3. There will be a significant increase in   O2peak after a 4-week HIIT programme 
and no change after 4 weeks participation in a traditional community-based 
cardiac rehabilitation programme in men and women with CVD 
4. There will be no change in total cholesterol, LDL-cholesterol, HDL-cholesterol and 
triglycerides after a 4-week HIIT programme or 4 weeks participation in a 
traditional community-based cardiac rehabilitation programme in men and 
women with CVD 
 
 
114 
 
 
METHODOLOGY 
Participants 
 The present investigator volunteered to help with the supervision of two 
community-based phase IV cardiac rehabilitation classes per week for > 2 yr prior to the 
beginning of this study.  Twenty-five men and five women with documented CVD, who 
had been participating in a community-based phase IV cardiac rehabilitation 
programme, twice a week, for a minimum of 6 months, were informed of the research 
study and a brief summary and contact details were provided.  Following an expression 
of interest, potential subjects were asked to visit the Vascular Research Unit (VRU) in the 
School of Health and Human Performance for a screening visit.  The natures, benefits, 
risks and discomforts of the study were explained.  Inclusion criteria were stable angina; 
prior myocardial infarction; prior revascularisation; ability to achieve 30 min of 
continuous walking without symptoms (cardiac chest pain/discomfort, severe 
breathlessness, dizziness or palpitations) or be able to undertake activities of at least 5 
METS (manually washing a car, digging/turning soil, walking/jogging a mile in less than 
15 min) without symptoms; clinically stable and in good health for a minimum of 2 
weeks prior to beginning the study.  Participants were excluded if they were current 
smokers, had unstable angina, uncontrolled hypertension (systolic blood pressure (BP) 
>180 mmHg, diastolic BP >100 mmHg), resting tachycardia or unstable/acute heart 
failure.  Individuals who met the entry criteria and who received medical clearance from 
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a physician to participate were randomly assigned to HIIT (n = 15, 3 female) or to 
continued participation in cardiac rehabilitation (CPCR) (n = 15).  Participants’ 
medications are summarized in Table 5.5.  
Research Design 
 Participants visited the Health and Human Performance Laboratories for a 
screening visit, and for 2 visits before and after 4 weeks of HIIT or CPCR (Figure 5.1).   
 
 
 
 Figure 5.1:    Study design 
 Screening visit: The nature and risks of the study were explained and written 
informed consent was obtained from each participant (Appendix D).  The experimental 
procedures were approved by the Research Ethics Committee at Dublin City University, 
Ireland. Participants then completed a general health (Appendix A) and physical activity 
readiness questionnaire (PAR-Q) (Appendix B). 
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 Visit 1: Participants abstained from strenuous physical activity for 24 h, and 
abstained from food, alcohol and caffeine for at least 3 h before the visit.  During this 
visit, height, weight, and blood pressure were measured and peak aerobic capacity 
(  O2peak) were assessed using an exercise test on a treadmill.   
 Visit 2: Participants arrived to the laboratory after an overnight fast.  Resting 
blood pressure was obtained, blood was drawn, and endothelial function was assessed 
by measuring brachial artery FMD. 
HIIT 
 Participants assigned to HIIT, undertook two supervised high-intensity interval 
sessions per week for 4 weeks in the cardiovascular research unit (Sch. HHP, DCU), and 
did not attend the community-based phase IV cardiac rehabilitation for the duration of 
the study.  Following a 10 min warm-up, participants performed three blocks of 8 x 45 
sec intervals of high-intensity exercise at ≥85 %HRmax on a treadmill (Figure 5.2).  Each 
interval was interspersed with a 15 sec period of passive recovery and a 2 min interval 
separated each block.  The session concluded with a 5 min cool-down.  Participants were 
continuously monitored via a 12-lead ECG throughout each exercise session.  Heart rate, 
blood pressure, percentage of oxygen saturation (SpO2), RPE and angina score were 
obtained throughout each HIIT session.  The present investigator and principle 
investigator, Prof. Moyna, supervised the HIIT.   
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Figure 5.2:   Overview of a HIIT session 
CPCR  
 Participants assigned to CPCR attended HeartSmart two times per week.  
HeartSmart is an established community-based cardiac rehabilitation programme that 
takes place in DCU sports complex and is supervised by a physician and DCU Sport staff.  
Cardiac rehabilitation involves highly structured, medically supervised, and electronically 
monitored exercise regimes.  The programme is multi-faceted but predominantly 
focuses on exercise.  Exercise classes are normally 60 minutes in duration and primarily 
involve aerobic exercise and some form of resistance training.  Sessions begin with a 10 
min warm-up at a low-intensity.  The main exercise phase can range from 15 – 40 min at 
a moderate-intensity.  Participants exercise in small groups and rotate between local 
muscular endurance circuits, various cardio machines and aerobics, during a class.  The 
class concludes with a 10 min cool-down. 
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Anthropometrics 
Height and mass were measured using a wall stadiometer and electronic balance 
(Seca 797, USA) respectively.  Footwear was removed prior to the measurement.  Height 
was measured to the nearest cm, and weight was measured to the nearest 0.1 kg. 
Peak Aerobic Capacity  
 Peak aerobic capacity test (  O2max) was assessed on a treadmill (Marquette 
2000, General Electric, USA) using 1 of 5 incremental protocol (Appendix F), depending 
on individual exercise capacity.  The Balke protocol was selected and modified to allow 
participants to reach volitional fatigue in 8 – 12 min.  A 2-min warm up preceded each 
test and the gradient was increased 2.5% every 2-min until the subject reached 
volitional exhaustion or presented with contraindications to exercise.  If necessary, 
treadmill speed was increased by 1 mph every 2 minutes while the treadmill gradient 
was maintained at 22.5%.  Participants were verbally encouraged to give their best 
effort.  Respiratory metabolic measures, heart rate and an ECG were monitored 
continuously throughout the test. RPE was recorded every 2 min.  Peak oxygen uptake 
was determined by averaging the three highest consecutive 20 second values.   
Open Circuit Spirometry 
Respiratory metabolic responses were determined using standard open-circuit 
spirometry techniques (Sensormedics Vmax 229, SensorMedics Corp., CA).  Prior to 
testing, the gas analysers were calibrated with standard gases of known concentration. 
 
 
119 
 
 
The calibration gas was sampled at a rate of 125 Hz.  A mass flow sensor (Sensormedics, 
Loma Linda, CA, USA) was used to collect breath-by-breath measurement of ventilation.    
A 3 L volume syringe (Sensormedics, Loma Linda, CA, USA) was used to calibrate the 
mass flow sensor prior to each test.   
Ratings of Perceived Exertion  
RPE was obtained using the 16-point Borg category RPE scale.  Prior to the 
maximal exercise test participants read a standard set of perceptual scaling instructions.  
These instructions followed an established format used in previous investigations.  Low 
and high “perceptual anchors” were established during the maximal exercise test.  This 
involved asking participants to assign a rating of 6 (low anchor) to the lowest exercise 
intensity, and 20 (high anchor) to the highest exercise intensity.  Participants were 
instructed to make their subjective assessments of perceived exertion relative to these 
minimum and maximum standards (perceptual anchors). 
Electrocardiographic Monitoring (ECG) 
Heart rate (HR) and electrical activity of the heart were monitored continuously 
using a 12-lead ECG monitor (GE Case 8000 12 Lead ECG).  The signal to noise ratio at 
the skin electrode interface was reduced by cleansing the area with an alcohol saturated 
gauze pad.  The superficial layer of skin was then removed using light abrasion with fine 
grain emery paper.  The electrodes were placed on 10 standard anatomical landmarks. 
 
 
120 
 
 
Endothelial Function Assessment  
Endothelial-Dependent Dilation 
Figure 5.3 illustrates the FMD protocol.  M-mode images were named and 
recorded every 30 sec post-deflation for 5 min.  Shear rate was calculated using the 
formula; 4 x peak velocity/peak diameter 69. 
 
 
Figure 5.3:  Overview of endothelial-dependent dilation 
Endothelial-Independent Dilation 
To assess brachial artery diameter, M-mode images were named and recorded 
every 30 sec post-deflation for 5 min (Figure 5.4).   
 
 
Figure 5.4:  Overview of endothelial-independent dilation 
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Off-line Analysis 
The same experienced investigator performed the off-line analysis of the 
ultrasound images using a custom-designed arterial diameter measurement tool.  Image 
processing is divided into the following stages, i) image acquisition, ii) calibration, iii) 
pre-processing, iv) segmentation, v) post-processing, vi) robust statistics and vii) 
refinement.  This method of arterial diameter estimation using the ADM software is 
explained in detail in chapter 3. 
Statistical Analysis 
Prior to statistical analysis the data was checked for normality using the Shapiro-
Wilks test.  A group (HIIT and CPCR) x time (baseline and week 4) repeated measures 
ANOVA was used to compare the mean differences within and between group.  
Significant main effects were probed using a Bonferroni post hoc test.  SPSS for 
Windows statistical software (ver 19.0) was used to perform the statistical analysis.  The 
criterion for significance (alpha) was set at 0.05 and with a sample size of 12 the study 
had a power of 80% to show a 50% increase in FMD. 
 
 
122 
 
 
Results 
Training compliance was excellent.  Four participants dropped out of the CPCR 
group; 2 due to illness, 1 due to orthopedic problems and 1 due to lack of interest.  Two 
participants were unable to complete one of their HIIT sessions due to illness, but we 
stopped the exercise and completed the session on another day. 
Participant characteristics 
 Physical characteristics, blood pressure and blood lipids in both the HIIT and 
SCR groups at week 1 and week 4 are summarized in table 5.2.  There were no group 
differences in height, weight, blood pressure and blood lipids at week 1 and week 4.  
There were no changes in height, weight, blood pressure and blood lipids in either group 
between week 1 and week 4.   
Maximal Exercise 
 Participant responses at maximal exercise at week 1 and week 4 are 
summarized in table 5.3.  There was a significant increase in treadmill time to exhaustion 
in the HIIT group at week 4 compared to week 1.  There was no significant difference in 
any of the other measured parameters at maximal exercise between or within 
experimental groups at week 1 or week 4.  
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High-intensity Interval Training  
 The mean physiological and perceptual responses for each training block of HIIT 
are summarized in table 5.4.  There average treadmill velocity was significantly higher 
during block 2 than block 1.  Average heart rate, %HRmax, %HRR and RPE were 
significantly higher during block 2 than block 1 of HIIT and during block 3 than block 1 
and block 2.   
Endothelial Function 
 There was no significant difference in percentage change in brachial artery FMD 
between the two groups at week 1.  The percentage change in FMD was significantly 
greater at week 4 than week 1 in the HIIT group only.  Brachial artery FMD was 
significantly higher in the HIIT group than the CPCR group at week 4 (Figure 5.5). There 
was no significant difference in endothelial-independent dilation between or within 
experimental groups at week 1 or week 4.  Compared to week 1, there was no change in 
shear rate at week 4 in the HIIT group (951.2 ± 294.1 s-1 vs. 1020.5 ± 245.1 s-1) or the 
CPCR group (1009.5 ± 179.9 s-1 vs. 932.5 ± 146.2 s-1).  Peak diameter, peak blood flow 
velocity and endothelial-independent dilation results are illustrated in Figures 5.6 – 5.8. 
ECG Changes and Clinical Symptoms 
 ST-segment changes ranged from 1 – 3 mm, and returned to normal during 
passive recovery.  None of the participants reported angina symptoms during or 
following the 4 weeks of HIIT.  
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Table 5.1: Medication 
Main Drug Class HIIT CPCR 
Statins 9 5 
ACE Inhibitor 6 3 
Beta Blocker 2 2 
Anti-platelet 9 6 
Diuretic 1  
Proton Pump 3 2 
Values are means  
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Table 5.2:  Physical characteristics and blood lipids of the participants at week 1 and week 4 
  Group 
 HIIT (n=15)  CPCR (n=11) 
 Week 1 Week 4  Week 1 Week 4 
Age (y) 66.6 ± 6.7   68.6 ± 5.7  
Height (cm) 170.6 ± 6.9    167.6 ± 8.3 167.6 ± 8.3 
Weight (kg) 80.8 ± 10.3 80.6 ± 10.3  77.8 ± 12.0 79.3 ± 11.5 
BMI (kg.m-2) 27.7 ± 2.6 27.3 ± 2.6  27.8 ± 4.4 28.2 ± 4.8 
Systolic blood pressure (mmHg) 140.1 ± 14.5 137.0 ± 18.7  122.0 ± 11.3 130.0 ± 26.5 
Diastolic blood pressure (mmHg) 81.1 ± 9.6 80.3 ± 2.8  71.0 ± 1.4 78.3 ± 7.6 
Total cholesterol (mmol) 3.4 ± 0.7 4.5 ± 1.7  3.6 ± 0.6 3.4 ± 0.3 
HDL-cholesterol (mmol) 1.2 ±0.2 1.3 ± 0.2  1.3 ± 0.2 1.0 ± 0.2 
LDL-cholesterol (mmol) 1.4  ± 0.3 1.8 ± 0.6  1.8 ± 0.8 1.5 ± 0.3  
Triglycerides (mmol) 1.0 ± 30.3 1.3 ± 0.4  1.1 ± 0.4 1.1 ± 0.2 
ApoA (mg.dL-1) 142.8 ± 19.9 142.1 ± 19.1  140.0  ± 15.2 127.3 ± 19.2 
ApoB (mg.dL-1) 70.4 ± 12.3 84.5 ± 17.2  84.1 ± 33.0 62.3 ± 16.4 
Values are means   SD; *p < 0.05 vs. wee  1; †p < 0.01 vs. wee  1 
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Table 5.3:  Participant responses at maximal exercise 
  Group 
 HIIT (n=15)  CPCR (n=11) 
 Week 1 Week 4  Week 1 Week 4 
Treadmill velocity (km.h1) 5.50 ± 1.16  5.38 ± 1.31  5.30 ± 0.79 5.90 ± 2.04 
Treadmill grade (%) 12.00 ± 3.16 12.30 ± 2.59  9.50 ± 2.75 10.54 ± 3.22 
Time to exhaustion (s) 524.54 ± 110.96 591.77 ± 97.8 †  584.86 ± 180.51 550.00 ± 152.04 
  O2peak (ml
.kg1.min1) 30.48 ± 7.90 32.23 ± 7.77  28.52 ± 6.14 29.20 ± 6.47 
  O2peak (L
.min1) 2.37 ± 0.81 2.40 ± 0.60  2.03 ± 0.53 2.10 ± 0.65 
Heart rate (beat.min1) 138.20 ±13.75 135.87 ± 13.75  126.90 ± 14.44 129.38 ±22.51 
Ventilation (L.min1) 63.95 ± 20.32 66.20 ± 59.63  56.02 ± 16.14 59.63 ± 18.59 
RER 1.13 ± 0.07 1.14 ± 0.84  1.09 ± 0.10 1.15 ± 0.08 
Values are means   SD; †p < 0.01 vs. week 1 
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Table 5.4:  Average Responses during HIIT 
  Exercise Blocks 
 1 2 3  Mean 
Treadmill velocity (km.h1) 6.5 ± 1.9 6.8 ± 2.1* 6.9 ± 2.2  6.7 ± 2.1 
Grade (%) 4.0 ± 1.7 4.0 ± 1.7 4.0 ± 1.7  4.0 ± 1.7 
Heart rate (beat.min1) 103.6 ± 9.9  109.7 ± 9.6‡ 114.1 ± 10.9†‡  109.7 ± 9.6 
%HRpeak 72.7 ± 8.2 77.0 ± 8.1‡ 79.9 ± 8.2†‡  76.5 ± 7.9 
%HRR 53.4 ± 11.6 60.8 ± 11.6‡ 65.9 ± 12.2†‡  60.0 ± 11.3 
Systolic blood pressure (mmHg) 155.0 ± 40.2 152.5 ± 40.0 148.6 ± 39.8  152.0 ± 39.8 
Diastolic blood pressure (mmHg) 70.0 ± 17.4 69.4 ±17.3 67.5 ± 16.8  69.0 ± 17.1 
RPE 12.2 ± 3.3 13.1 ± 3.4‡ 1 .9 ±  .5†‡  13.1 ±3.3 
SPO2 (%) 90.0 ± 22.7 86.2 ±21.4 89.6 ± 22.6  89.6 ± 22.6 
 Values are means   SD, *p < 0.05 vs. bloc 1 †p < 0.01 vs. bloc  2; ‡p < 0.001 vs. block 1 
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Figure 5.5:   Percentage change in FMD in the HIIT and CPCR group at week 1 and week 4 
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Figure 5.6: Peak brachial artery diameter (cm) in the HIIT and CPCR group at week 1 and week 4 
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Figure 5.7: Peak blood flow velocity in the HIIT and CPCR group at week 1 and week 4 
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Figure 5.8: Percent change in brachial artery diameter (%) following GTN administration at week 1 
and week 4
 
 
132 
 
 
  
Chapter 6  
Discussion 
Overview  
The endothelium is a complex dynamic barrier that plays a crucial role in 
maintaining vascular integrity.  It is central to the initiation, development and 
progression of atherosclerosis 31.  Established CVD risk factors promote the 
development of atherosclerosis through their deleterious effects on endothelial 
structure and function, 174 and subsequent reduction in nitric oxide (NO) bioavailability.  
This is evident as a reduced vasomotor response of the diseased vessels to shear stress, 
and a variety of vasoactive compounds.  
Flow-mediated dilation (FMD) is a commonly used non-invasive procedure to 
assess endothelial function, and is based on the assumption that healthy, intact 
endothelial cells can detect changes in shear stress following 5 min of occlusion and 
dilate in response.  The percentage change in arterial diameter in response to shear 
stress can be measured using ultrasonography, and is believed to be endothelial-
dependent and mediated by NO 58.  Diameter changes are also measured after 
administration of GTN to assess the response of the vessel to endothelium-independent 
vasodilation.  Assessment of brachial artery FMD provides substantial diagnostic and 
prognostic information that is useful in assessing disease burden and guiding therapy in 
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patients with CAD and those with normal coronary arteries and risk factors for 
atherosclerosis.  
A series of studies were undertaken to assess user reliability in the use of 
ultrasongraphy to measure endothelial vasomotor function, develop and validate a 
custom-designed software to measure arterial diameter, and evaluate the effect of 
acute and chronic exercise on endothelial function in men and women with CVD.  
Study 1 
 Study 1 assessed the reliability of the practitioner (present investigator) in the 
use of ultrasonography to measure endothelial vasomotor function, and the 
development and validation of a reliable, custom-designed arterial diameter 
measurement tool.  
 Reproducible FMD measurements require careful attention to training, 
technique and analysis.  The practitioner underwent intensive training in the use of 
ultrasonography under the guidance of a chief vascular technician from a local hospital.  
After 6 months of training and > 100 supervised scans, the investigator was deemed 
proficient in the use of ultrasonography, and reproducibility of the FMD measurement 
was confirmed on repeated tests in 25 healthy men and women.   
 The manual method of using ultrasound calipers for blood vessel diameter 
assessment has several drawbacks.  Firstly, because measurements are only taken at a 
small, fixed number of vertical cross-sections, they are sensitive to small variations, 
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which may arise from noise in the ultrasound imaging system.  Secondly, manual 
methods are time-consuming.  They require the practitioner to carefully examine each 
image to differentiate the upper and lower arterial boundary.  The boundary positions 
chosen by a practitioner are subjective, and can vary across practitioners based on 
individual skill and experience.  Finally, calipers are often built into the ultrasound 
hardware, precluding off-line measurements.   
 Technical modifications and the development of edge-detection and wall-
tracking software have evolved to significantly improve the sensitivity of blood vessel 
diameter measurements during FMD 175  43.  Existing semi-automatic methods used in 
ultrasound analysis have two primary drawbacks.  Firstly, they can often be more time-
consuming than using calipers.  The practitioner must select around the boundary of the 
artery, multiple times, to obtain an accurate estimation.  Secondly, although software 
for delineating the boundary is general, and is usable in various different medical 
imaging tasks, it tends to be very expensive.  The ADM software, developed in the 
present study addressed many of the problems with in-built calipers.  It enables the 
imaging and recording of brachial artery ultrasound images and supports post-analysis 
at an increased number of time-points.  The measurements are fast, can be performed 
offline, and are semi-automatic.   
 The ADM software developed is innovative because it i) uses a novel 
constrained region-growing algorithm to provide fast and reliable segmentation of M-
mode ultrasound images, ii) provides real-time feedback to the practitioner, showing 
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clearly the cross-sections used to compute the diameter estimate, iii) uses robust 
statistics to ameliorate the effect of any inaccuracies in the segmentation, iv) allows 
measurements to be taken at specific cross sections of the estimated arterial boundary 
using a gating tool, thus accounting for cyclic changes in arterial dimensions at different 
phases of the cardiac cycle, v) provides for the comparison of boundary estimates with 
manual measurements using in-built software calipers, and vi) allows measurements to 
be taken offline, without requiring patient presence. 
 The algorithm used by the ADM system has a number of advantages over 
existing alternatives.  It is more specific and less expensive, and the computational 
complexity of the segmentation is low, so live feedback is provided, permitting 
adjustment of the segmentation in real time.  The system requires a single click inside 
the arterial region, and a possible slider adjustment, and the use of the inter-quartile 
mean provides a diameter estimation that is robust to inaccuracies in the segmentation 
of the artery.  Visual feedback giving the exact region used in the diameter estimation 
increases the practitioner’s confidence in the results, and prevents the practitioner 
spending time correcting errors that will have no impact on the final estimation.  
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 Using in-built calipers as the criterion reference, the custom-designed ADM 
software was found to be a valid and reliable measurement of brachial artery diameter.  
The use of a semi-automatic arterial diameter estimation algorithm reduces the 
subjectivity of the results and makes the method more resilient to noise than the 
manual calipers.  Enhanced data collection is provided, using the software, due to the 
fact that a greater number of ultrasound images can be recorded.  In addition, the ADM 
software permits an increased number of time points and cross-sections at which the 
vessel diameter can be assessed.  
Study 2 
Observations that a single bout of exercise can transiently alter atherosclerotic 
CVD risk factors 114 have led to the notion that perhaps some of the effects of exercise 
on endothelial function may be attributable to the acute effect of exercise.  Study 2 
compared physiological and perceptual responses and endothelial vasomotor function 
following a single bout of SRE and short duration HIIE in men and women with CVD.  
Current physical activity guidelines recommend that individuals with CVD should 
undertake moderate-intensity aerobic (endurance) physical activity for 30 min or more 
for 5 days per week.  This equates to approximately 40-60 %   O2max (ACSM Guidelines). 
Standard exercise prescription procedures normally involve the titration of exercise 
intensity, to elicit a pre-determined heart rate, or   O2.  The culture of exercise 
prescription can however, be perceived as highly controlling and aversive.  Allowing 
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individuals to self-regulate their exercise intensity may provide a sense of control over 
their behavior, resulting in perceptions of autonomy 146 and greater levels of enjoyment.  
In addition to potentially improving vascular function, it is also important to ensure that 
an acute bout of SRE is within the prescribed range for improving health, and reducing 
the risk for CVD.   
HIIE was, until quite recently, used primarily by athletes in preparation for 
athletic competitions.  A number of recent studies have found supervised HIIT to be safe 
and effective for improving health in men and women with CVD 7,8.  When compared to 
continuous endurance exercise, HIIE has been shown to elicit similar or even superior 
physiological adaptations, in healthy men and women 6 and those with CVD 8.  Most of 
the previous studies that examined the effect of acute HIIE on endothelial function used 
intervals ≥ 4min in duration.  It was hypothesized that an acute bout of high intensity 
treadmill exercise involving intervals of 45 sec and 15 sec passive recovery would 
provide a greater hemodynamic shear than SRE, and transiently, improve endothelial 
function.   
On average, participants in the SRE and HIIE group exercised at 64% and 78% 
  O2peak, respectively, and all participants in both groups exercised at an intensity ≥ 50 
%  O2peak (moderate-intensity).  Four participants in the SRE group and all of the 
participants in the HIIE group exercised an intensity considered to be vigorous (60–85 % 
  O2max) (Figure 6.1).  The average metabolic cost was 5.0 and 6.7 METS for the SRE and 
HIIE group, respectively. 
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Figure 6.1:  Mean individual %  O2peak values during the acute bout of HIIE and SRE 
An individual’s perception of physical exertion can be viewed as a 
psychophysiological construct that represents the integration of multiple sensory inputs 
between external stimuli arising from physical work and internal responses reflecting 
physiological functions and situational and dispositional factors 146.  When allowed to 
self-regulate their exercise intensity men and women with CVD, on average, exercised at 
an intensity that they perceive to be fairly light (Figure 6.2).  In contrast, the HIIE group 
perceived the exercise to be hard, and two of the participants perceived the effort to be 
very hard or very, very hard (Figure 6.2). 
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Figure 6.2:  Mean individual RPE-O values during the acute bout of HIIE and SRE  
Although affect was not measured in the present study, it is worth noting that 
when given a choice, individuals will generally adjust their effort intensity during 
exercise to maximize affect.  This is important considering that a positive affective 
response may lead to greater enjoyment of the exercise session, promote a positive 
memory of that activity, and, consequently, contribute to increased motivation for 
future physical activity behaviour 146.  In contrast, activities that are perceived to be 
difficult are more likely to lead to withdrawal from the activity.  Although the acute bout 
of HIIE may have resulted in a significantly higher physiological and metabolic response 
compared to the SRE exercise, the high RPE would indicate that the exercise experience 
may be perceived as negative, and may have a deleterious effect on subsequent 
exercise participation. 
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Despite exercising within the desired intensity range for cardiovascular benefits, 
a single SRE session does not appear to provide an appropriate shear stimulus to elicit 
acute improvements in endothelial function.  Similarly, endothelial-dependent dilation 
did not change significantly after the acute bout of HIIE, compared to pre-exercise 
values, despite the fact that participants exercised at an intensity, generally deemed 
‘vigorous’ 176, and one that was significantly higher than SRE.   
Cycling for 30 min at 50%   O2peak increases brachial artery FMD in young 
female smokers .  Treadmill exercise for 30-45 min at low-, moderate- and high-intensity 
almost doubled brachial artery FMD in postmenopausal women 119 and active 
overweight men 122.  A recent study 124, found that both low volume high-intensity 
interval exercise and moderate-intensity endurance exercise significantly increased 
absolute and normalized brachial artery FMD 1 h post exercise in men and women with 
CAD.  In contrast, Joras et al., 116 showed that brachial artery FMD was significantly 
decreased in men with PAD, 30 min and 2 h following 10 min of treadmill exercise to 
intolerable ischaemic pain in the affected lower extremity.  Similarly, an acute bout of 
treadmill exercise to the onset of claudication has no effect on brachial artery FMD in 
men and women with PAD 117.  Indeed, FMD was significantly impaired following 
treadmill exercise to maximal claudication pain, demonstrating that exercise-induced 
ischemia further deteriorates FMD.   
A  number of other studies have found a transitory functional deterioration in 
FMD in i) healthy young men and women (19-30 years) after 30 min of continuous 
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treadmill exercise at 60% v  O2max 
49, ii) fit individuals 1 h after a single bout of high-
intensity interval running 121, iii) non-elite runners 1 h after completing a marathon 123, 
and iv) healthy male smokers compared to non-smokers (7.7 v 4.1%) immediately 
following 40 min of submaximal steady-state exercise on a cycle ergometer 48 . 
Previous acute exercise studies have found a significant positive relation 
between FMD values and shear rate (area under the curve) at rest, but not after an 
acute bout of exercise.  This may be attributable to the fact that the change in shear 
rate (area under the curve) from rest to post-exercise can vary greatly among 
individuals.  In a study investigating the effect of 30 min of continuous treadmill exercise 
on brachial artery FMD in healthy young men and women, shear rate (area under the 
curve) decreased in 7 and increased in 6 participants 49.  FMD was significantly 
attenuated after exercise compared with rest.  When the percent change in diameter 
was normalized to shear rate (area under the curve) the difference in FMD from pre to 
post exercise was abolished.  As a result of the high degree of variability in physiological 
shear rate in response to hyperemia post-exercise observed in previous literature, FMD 
values were not normalized to shear rate in this acute exercise study.  
 There was no difference in endothelial function within or between groups 
following the acute bouts of SRE or HIIE.  Results from previous studies examining the 
effect of acute exercise on endothelial function in individuals with CVD have been 
equivocal.  Many of these studies, observing acute improvements in endothelial function 
following exercise, assessed brachial artery FMD 1 hour after the exercise bout.  Currie 
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et al., 124 observed an increase in FMD following bouts of endurance and interval 
exercise in men and women with CAD.  In this study, FMD was assessed 1 hour after 
each exercise bout.  Similarly, Harris et al., 122 observed enhanced FMD following acute 
exercise in active overweight men when FMD was assessed 1 hour after the exercise 
bout.  In contrast, the present study examined FMD within 5 min of exercise cessation.  
Exercise-induced alterations in arterial diameter as a result of augmented blood flow in 
the brachial artery, may result in vasodilation that can exist for up to 1 hour post 
exercise cessation 177.  This post exercise arterial dilation may be responsible for the 
relatively low FMD results.    
Study 3 
Study 3 compared the effect of 4 weeks of HIIT to 4 weeks of CPCR on aerobic 
capacity, endothelial function and selected cardiovascular biomarkers in CVD patients. 
Traditionally, exercise guidelines to promote health, and reduce cardiovascular risk 
factors and all-cause mortality have encouraged continuous, moderate-to-vigorous 
intensity exercise training (ACSM).  The most recent position statement on exercise 
prescription for individuals with CVD 178 recommends continuous exercise involving 
large-muscle groups (e.g. walking, jogging, cycling etc.) performed at a moderate-
intensity level corresponding to 40-85% heart rate reserve.   
Exercise performed at a vigorous intensity (6 METs) has been shown to induce a 
greater reduction in CVD risk, and greater improvements in diastolic blood pressure, 
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glucose control, and aerobic capacity compared to exercise performed at a moderate 
intensity 179.  It is thought that exercise guidelines for phase IV cardiac rehabilitation 
may fall below the threshold to induce physiological and metabolic changes that will 
improve cardiovascular health. 
 Historically, HIIT has been used to improve athletic performances.  In recent 
years a number of studies have shown its efficacy and safety in improving exercise 
capacity and endothelial function in individuals with CAD and heart failure 7,8.  Recent 
training studies, utilizing a short exercise interval duration and fewer exercise sessions 
have found similar or superior physiological and metabolic improvements compared to 
traditional, continuous, high-volume exercise.  Gibala et al., 6,12 observed similar 
responses to 2 weeks of HIIT and continuous endurance exercise, despite the fact that 
the total training volume for the HIIT group was approximately 10% of the endurance 
exercise group, with the HIIT group exercising for a total of 2.5 h over 2 weeks compared 
to 10.5 h in the endurance group.  The HIIT consisted of 6 sessions of six  0 sec “all out” 
cycling, whereas the endurance training involved six 90 – 120 min of continuous cycling 
at 65%   O2peak.  These findings indicate that HIIT is a time-efficient method of exercise 
training in healthy population. 
To date, 4 studies have evaluated the effect of HIIT on endothelial-dependent 
dilation in CVD patients (Table 2.2).  Study duration ranged from 8 – 24 weeks, and 
exercise intervals of 4 min in duration were predominantly used.  Eight weeks of HIIT 
cycling and running at > 80%   O2peak significantly enhanced brachial artery FMD and 
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maximal aerobic capacity in heart transplant patients, compared to inactive controls 9.  
Using four 4-min intervals at 90 – 95% HRpeak, Wisloff et al., 8 found significant 
improvements in aerobic capacity and endothelial function following 12 weeks of 
aerobic interval training compared to moderate-intensity exercise in individuals with 
CAD.  A similar 12 week randomised controlled trial also found significantly greater 
increases in brachial artery FMD and   O2peak following HIIT, involving 4 min intervals at 
85–95% HRmax, than 12 weeks of standard cardiac rehabilitation 140.  The longest study 
was 6 months in duration and found that supervised HIIT involving 4 min intervals at 80–
90% HRmax on a cycle ergometer or treadmill significantly increased   O2peak and FMD 
180.     
 Individuals assigned to CPCR in Study 3 had been attending a local community-
based Phase IV cardiac rehabilitation for at least 6 months, and continued attending 
class 2 times per week for the duration of the study.  Due to logistics, it was not possible 
to collect heart rate data on the participants during their participation in the CPCR 
group.  Participants in the HIIT group exercised at 77% HRmax during each exercise 
interval, falling below the target intensity of > 80% HRmax.  Considering the cohort, 
participant feedback and RPE values, it was difficult at times to further increase the 
intensity of the exercise intervals.  Although there was no change in   O2peak following 4 
weeks of HIIT or CPCR group, treadmill time to exhaustion increased significantly in the 
HIIT group only.   
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Differences in exercise prescription, study duration and participant 
characteristics may help to explain the inability to increase   O2peak.  Gibala et al, 
6,12 
recruited healthy young college-aged students, and the training was undertaken at a 
higher intensity (i.e. “all out” cycling against a fixed resistance) than the present 
investigation.  Previous HIIT studies involving CVD patients that have resulted in 
improvements in   O2peak have used training durations of > 8 weeks, have recruited 
patients with heart failure, a history of transplantation, that are mostly overweight, or 
individuals 2 – 12 weeks post MI, or immediately post PCI.  Participants in study 3 have 
been regularly participating in cardiac rehabilitations exercise classes for more than 6 
months and were excluded from study if they had heart failure. 
Endothelial-dependent dilation was significantly greater at week 4 (10.1%) than 
week 1 (5.4%) in the HIIT group only.  Brachial artery FMD was also significantly greater 
in the HIIT group (10.1%) than the CPCR group at week 4 (5.1%).  Despite no change in 
  O2peak, 4 weeks of HIIT significantly improved endothelial function.  These results 
support the potential role of HIIT in phase IV cardiac rehabilitation.   
The putative mechanisms responsible for the regulation of endothelial NO 
bioavailabilty and in turn the improved brachial artery FMD may include flow-mediated 
i) transcriptional upregulation of the endothelial NO synthase (eNOS), ii) post-
transcriptional activation of eNOS, and iii) reduction of reactive oxygen species-
mediated breakdown of NO by increaseing the antioxidative defence mechanisms 181. 
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Study Limitations  
 The most accurate method for normalizing FMD responses is believed to be the 
area under the curve shear response from post-occlusion to the time at which 
peak diameter occurs 71.  Presently, the Vascular Research Laboratory in DCU is 
not equipped to measure viscosity and the ultrasound system does not have the 
functionality for simultaneous acquisition of M mode diameter and pulsed-wave 
Doppler velocity signals, or the continuous measurement of blood flow velocity.  
Duplex ultrasound for simultaneous capture is recommended where available. 
For these reasons shear rate was calculated as an accepted estimate of shear 
stress, using peak blood flow velocity (equation: shear rate = 4*peak 
velocity/peak diameter) 69. 
 When assessing peak aerobic capacity in individuals with CVD, it may be difficult 
to attain true peak heart rate values due to medication affecting HR.  This can 
have a deleterious effect when using heart rate to establish training intensities.  
Use of effort perception may be useful to help ensure participants reach desired 
intensities during exercise training.  
Conclusions 
The developed ADM software system is a valid and reliable tool for brachial 
artery diameter assessment.  Self-regulated or high-intensity interval exercise does not 
provide the required stimulus to elicit acute improvements in endothelial function in 
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men and women with CVD.  In contrast, 8 sessions of high-intensity interval training 
significantly improve endothelial function and exercise capacity in patients with at least 
6 months participation in a community-based cardiac rehabilitation programme.  
Anecdotal evidence would indicate that upon completion of a 4-week HIIT programme, 
participants experienced increased self-efficacy and confidence in exercising alone and 
at higher intensities. 
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Appendix A 
School Of Health and Human Performance 
Dublin City University 
General Health Questionnaire 
 
Name:………………………………..  Occupation:…………………………… 
 
Address:………………………………………………………………………………. 
 
Telephone: (Home)………………….. (Wor ):……………………………….. 
_____________________________________________________________________ 
Do you have, or have you ever suffered from: -Diabetes?  Yes / No 
      -Asthma?   Yes / No 
      Epilepsy?   Yes / No 
Have you ever had pains in your chest or heart?    Yes / No 
Do you ever feel faint or have spells of dizziness?    Yes / No 
Do you have or have you ever had high blood pressure?   Yes / No 
Do you have a muscle, back or joint problem that could be aggravated by physical                                                                                                             
activity or made worse with exercise?     Yes / No 
Do you have any current injuries?      Yes / No 
In the past week, have you  suffered from any illness which required  
you to be in bed or off work for one day or more?    Yes / No 
Do you smoke?  If yes, how many per day?    Yes / No 
Do you drink?  If yes, how many units per week?   Yes / No 
Is there a good physical reason not mentioned here why you should not carry out 
laboratory testing?        Yes / No 
Please provide any further information concerning any condition/complaints that you 
suffer from and any medication which you may be taking by prescription or otherwise: 
Date:     Signature:______________ Authorising Signature:_______________ 
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Appendix C 
Submission to Ethics Committee 
 Dublin City University 
RESEARCH ETHICS COMMITTEE 
APPLICATION FOR APPROVAL OF A PROJECT INVOLVING HUMAN 
PARTICIPANTS 
Application No. (office use only)  DCUREC/2009/   
Period of Approval (office use only) ....../....../...... to
 ....../....../.... 
This application form is to be used by researchers seeking ethics approval for individual 
projects and studies. The signed original and an electronic copy of your completed 
application must be submitted to the DCU Research Ethics Committee.   
NB - The hard copy must be signed by the PI.  The electronic copy should consist of one 
file only, which incorporates all supplementary documentation.  The completed 
application must be proofread and spellchecked before submission to the REC.  All 
sections of the application form should be completed.  Applications which do not 
adhere to these requirements will not be accepted for review and will be returned 
directly to the applicant. 
Applications must be completed on the form; answers in the form of attachments will 
not be accepted, except where indicated.  No handwritten applications will be accepted.  
Research must not commence until written approval has been received from the 
Research Ethics Committee. 
PROJECT TITLE Effect of Exercise Duration on Vascular Health in Patients with CVD 
 
PRINCIPAL 
INVESTIGATOR 
Prof. Niall M. Moyna 
 
Please confirm that all supplementary information 
is included in your application (in both signed 
original and electronic copy). If questionnaire or 
INCLUDED NOT 
APPLICABLE 
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interview questions are submitted in draft form, a 
copy of the final documentation must be submitted 
for final approval when available. 
Bibliography    
Recruitment advertisement    
Plain language statement/Information Statement    
Informed Consent form    
Evidence of external approvals related to the 
research 
   
Questionnaire  
draft final 
 
Interview Schedule  
draft 
 
final 
 
Debriefing material     
Other    
Please note: 
1. Any amendments to the original approved proposal must receive prior REC 
approval. 
2. As a condition of approval investigators are required to document and report 
immediately to the Secretary of the Research Ethics Committee any adverse 
events, any issues which might negatively impact on the conduct of the research 
and/or any complaint from a participant relating to their participation in the 
study 
 
Please submit the signed original, plus the electronic copy of your completed application to:  
Ms. Fiona Brennan, Research Officer, Office of the Vice-President for Research  
(fiona.brennan@dcu.ie, Ph. 01-7007816) 
1. ADMINISTRATIVE DETAILS 
THIS PROJECT IS:  Research Project  Funded Consultancy 
(tick as many as 
apply) 
 Practical Class  Clinical Trial 
  Student Research Project  
Final Year Research Project 
 Other  - Please Describe:       
  Research Masters  Taught Masters 
  PhD  Undergraduate 
Project Start Start: 01/01/10  Project End End: 31/12/11 
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Date: Date:       
 
1.1 INVESTIGATOR CONTACT DETAILS 
PRINCIPAL INVESTIGATOR(S):  
TITLE SURNAME FIRST NAME PHONE FAX EMAIL 
Prof Moyna Niall 01 
7008802 
01 
7008888 
niall.moyna@dcu.ie 
OTHER INVESTIGATORS: 
TITLE SURNAME FIRST 
NAME 
PHONE FAX EMAIL 
Dr. 
Dr. 
Dr. 
Ms. 
Ms. 
Ms. 
Mc Caffrey 
Woods 
Susta 
Hughes 
Furlong 
Gray 
Noel 
Catherine 
Davide 
Sarah 
Bronagh 
Cleona 
087 2797597 
01 7008008 
085 7781748 
086 8673608 
086 3687961 
01 8034478 
01 7008888 
01 7008888 
01 7008888 
01 7008888 
01 7008888 
01 8034252 
noel.mccaffrey@dcu.ie 
Catherine.woods@dcu.ie 
davide.susta@dcu.ie 
sarah.hughes3@mail.dcu.ie 
brona.furlong2@mail.dcu.ie 
cgray@mater.ie 
 
FACULTY/DEPARTMENT/SCHOOL/ 
CENTRE: 
School of Health and Human Performance 
1.2 WILL THE RESEARCH BE UNDERTAKEN ON-SITE AT DUBLIN CITY UNIVERSITY? 
 YES  NO  
1.3 IS THIS PROTOCOL BEING SUBMITTED TO ANOTHER ETHICS COMMITTEE, OR 
HAS IT BEEN PREVIOUSLY SUBMITTED TO AN ETHICS COMMITTEE?) 
 YES  NO 
DECLARATION BY INVESTIGATORS 
The information contained herein is, to the best of my knowledge and belief, accurate.  I 
have read the University’s current research ethics guidelines, and accept responsibility 
for the conduct of the procedures set out in the attached application in accordance with 
the guidelines, the University’s policy on Conflict of Interest and any other condition laid 
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down by the Dublin City University Research Ethics Committee or its Sub-Committees.  I 
have attempted to identify all risks related to the research that may arise in conducting 
this research and acknowledge my obligations and the rights of the participants. 
If there any affiliation or financial interest for researcher(s) in this research or its 
outcomes or any other circumstances which might represent a perceived, potential or 
actual conflict of interest this should be declared in accordance with Dublin City 
University policy on Conflicts of Interest.  
I and my co-investigators or supporting staff have the appropriate qualifications, 
experience and facilities to conduct the research set out in the attached application and 
to deal with any emergencies and contingencies related to the research that may arise. 
Signature(s): 
Principal investigation:    
Print name(s) in block letters: Niall M. Moyna 
Date:  12 November 2009 
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2. PROJECT OUTLINE  
2.1 LAY DESCRIPTION  
The purpose of this study is to assess the effect of exercise duration on vascular 
health in patients with cardiovascular disease (CVD). 
Cardiovascular disease is the primary cause of death in Ireland.  Cardiovascular 
disease results in damage to blood vessels due to the build up of plaque. Plaque 
can begin to accumulate early in life, long before CVD has been diagnosed.  
Rupture of these plaques can lead to a blockage of the artery resulting in a heart 
attack or stroke.  The build up of plaque can be measured in the arteries of the 
neck using a simple ultrasound procedure.  This involves measuring the thickness 
of the wall of the carotid artery (carotid intima media thickness).  We will 
measure the carotid intima media thickness (CIMT) in patients who have known 
CVD.  Participants will lie on a table and have an ultrasound probe placed on their 
neck to get a clear image of their carotid arteries to allow the vessel wall to be 
assessed (Figure 1). 
The inner lining of blood vessels is called the endothelium.  Damage to the 
endothelium is an early indicator of CVD.  The ability of the brachial artery in the 
upper arm to increase in diameter following 5 min of blood flow restriction is 
called brachial artery reactivity (BAR) and is a measure of the health of blood 
vessels.  We will measure BAR in patients with CVD before and 1 hour and 24 
hours after 20 min and 40 min of exercise.  BAR will be measured using 
ultrasound while the subject is lying on a bed (Figure 2).   
The damaged endothelium also releases cells into the blood stream.  We will take 
blood samples before and 1 hour and 24 hours after the exercise to measure 
how many of these cells are in the blood.  
    
Figure 1: Carotid artery ultrasound   Figure 2: Brachial artery 
reactivity 
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AIMS OF AND JUSTIFICATION FOR THE RESEARCH  
Cardiovascular disease (CVD) collectively refers to diseases of the heart and 
circulatory system, and typically includes coronary heart disease (CHD), stroke, 
and peripheral vascular diseases (e.g. atherosclerosis, deep vein thrombosis, 
hypertension).  Ireland has the highest mortality rate from CVD in the EU (40%).  
The socio-economic impact of C D to Ireland and the EU is €169 billion/year.  
Physical activity plays a critical role in both the primary and secondary 
prevention of CVD.  In individuals with documented CVD, physical activity is an 
established, inexpensive, and generally safe secondary intervention that is 
associated with a 31% reduction in cardiovascular-related mortality.   
The beneficial effects of physical activity are multifactorial and are related to 
direct and indirect protective mechanisms that impact blood vessel health 
(endothelium function, inflammation, vessel remodeling), blood clotting 
processes (platelet activation and fibrinolysis), and cardiac performance.  This 
study will examine the effect of exercise duration on circulating endothelial cells 
(CECs), endothelial progenitor cells (EPCs) and microparticles (MPs) in individuals 
with CVD.  These cells are released by the damaged endothelium, and currently 
little is known about the effect of acute exercise on their number and function.  
Carotid intima media thickness (CIMT) will be used to estimate CVD.  Endothelial 
function will be assessed using endothelial dependent dilation (reactive 
hyperemia) and endothelial independent dilation (nitroglycerin). 
The aim of this study is to compare the effect of exercise duration on vascular 
health in patients with CVD. 
The purpose of this study is to 
1. Examine the relation between CIMT and the number of CECs, EPCs and 
MPs at rest in individuals with documented CVD. 
2. Examine the effect of exercise duration on blood levels of CECs, EPCs and 
MPs in individuals with documented CVD. 
3. Examine the relation between BAR and the number of CECs, EPCs and 
MPs at rest and 1 hour and 24 hours after 20 min and 40 min of acute 
exercise in individuals with documented CVD. 
2.3 PROPOSED METHOD 
Overview 
The study will take place in the Cardiovascular Research Unit in the School of 
Health and Human Performance.  Subjects will visit the laboratory on 3 separate 
occasions.  The first visit will be used to take a blood sample and measure CIMT.  
During the second and third visit the subjects will exercise on a treadmill for 20 
min or 40 min.  They will have a blood sample taken and endothelial dependent 
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and independent dilation assessed before, and 1 hour and 24 hours after the 
treadmill exercise.  
Carotid Intima Media Thickness:  Thickness of the carotid intima-media will be 
assessed using a 12.0 MHz linear-array transducer (SonoSite, MicroMaxx).  
Recordings will be obtained with the subject resting in a supine position, with the 
head turned slightly to the contralateral side.  The common carotid artery, 
including the carotid bulb, will be visualized, and 2 longitudinal B-mode images of 
the left and the right common carotid arteries at end diastole will be recorded 
and electronically stored.  Measurements of CIMT will be conducted in the 10-
mm linear segment proximal to the carotid bulb at 2 plaque-free sites twice in 
the near wall and twice in the far wall on both sides and combined as mean 
CIMT.  The combination of readings from the near and far walls yields the 
strongest association with cardiovascular disease.  The artery will be scanned 
longitudinally without colour flow to assess the grey scale image, and with colour 
flow to identify difficult anatomy and delineate irregularities in plaque.  
Brachial Artery Protocol:  Endothelial dependent dilation will be determined in 
response to reactive hyperemia following 5 min of lower arm occlusion.  A blood 
pressure cuff will be placed on the left arm for blood pressure monitoring and 
another on the right lower arm for occlusion.  ECG leads will be attached to 
monitor heart rate.  Subjects will rest for 10 min in a supine position.  Blood 
pressure will be determined during the final 2 minutes of the rest period.  
Baseline blood flow and brachial artery diameter (SonoSite, MicroMaxx) will be 
recorded.  The right arm blood pressure cuff will then be inflated to 
approximately 220-230 mmHg and maintained at that pressure for 5 minutes.  
The cuff will then be rapidly deflated after 5 min of occlusion.  Doppler blood 
flow measurement will be obtained during the first minute following cuff 
deflation.  Brachial artery diameter will be assessed at one and three minutes 
post occlusion.  Subjects will then rest for 15 minutes to eliminate endothelium 
dependent effects on brachial artery diameter.  After this period, endothelial 
independent dilation will be assessed.  Baseline blood flow and brachial artery 
diameter will be recorded and used as a baseline prior to sublingual 
nitroglycerine administration.  Nitroglycerin (0.4mg) will be placed under the 
subjects tongue.  Doppler blood flow measurement will be obtained three 
minutes following the sublingual nitroglycerin administration and brachial artery 
diameter measurements will be assessed 3 and 5 minutes post nitroglycerin 
administration.  Endothelial dependent and independent dilation assessment will 
be repeated at 1 hour and 24 hours after exercise.  If the subject is taking Viagra 
they will notify Sarah Hughes.  They will not be permitted to take Viagra for at 
least 24 hours before the administration of nitroglycerin. 
Acute Exercise:  Subjects will exercise for 20 min or 40 min at their preferred 
intensity (self regulated).  The exercise order will be randomized.  A 12 lead ECG 
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will be used to continuously monitor the electrical activity of the heart.  Rating of 
perceived exertion will be measured every 5 min.   
 
2.4 PARTICIPANT PROFILE  
Men and women aged 40-65 yr currently enrolled in HeartSmart Phase IV 
community based cardiac rehabilitation programme in DCU Sport’s complex will 
be recruited.  Phase IV cardiac rehabilitation aims to assist patients with the 
long-term maintenance of lifestyle changes.  In 2006, DCU, Beaumont Hospital, 
The Mater Hospital and Connolly Memorial Hospital established HeartSmart, a 
community-based phase IV physical activity programme.  This programme is 
located at DCU, and is specifically designed for patients who have successfully 
completed hospital based phase III cardiac rehabilitation programme.  Patients, 
who meet the inclusion criteria, are referred to the programme by the cardiac 
rehabilitation teams at the three partner hospitals.  To date, approximately 200 
individuals have enrolled in the DCU HeartSmart programme; with on average 80 
people exercising in the classes each week.  These individuals have diagnosed 
CVD and have passed a medical and physical examination that permits them to 
exercise.  Subjects recruited will be participating in HeartSmart for a minimum of 
4 wk. 
Inclusion Criteria: 
 Stable angina 
  Prior myocardial infarction 
 Undergone revascularisation procedure. 
 Participants must be able to achieve 30 min of continuous walking 
without symptoms (cardiac chest pain/discomfort, severe breathlessness, 
dizziness or palpitations) or be able to undertake activities of at least 5 
METS (manually washing a car, digging/turning over soil, walking/jogging 
a mile in less than 15 minutes) without symptoms.   
 Participants must be clinically stable and in good health for a minimum of 
two weeks prior to beginning the study 
 Participants must be attending HeartSmart for a minimum of 4 wk 
Exclusion Criteria:   
Potential subjects will be excluded if 
 They smoke,  
 Have unstable angina 
 Systolic  blood pressure >180 mmHg and/or diastolic blood pressure 
> 100 mmHg,   
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 Resting tachycardia   
 Unstable or acute heart failure. 
 
2.5 MEANS BY WHICH PARTICIPANTS ARE TO BE RECRUITED 
Men and women participating in the HeartSmart cardiac rehabilitation 
programme in DCU Sport for a minimum of 4 wk will be informed of the research 
study.  The study will be announced at the end of a HeartSmart class and a brief 
summary of the study will be provided to explain the study to the individuals and 
provide contact details.  Following an expression of interest, potential subjects 
will be asked to attend a screening session in the DCU Sports Centre.  They will 
be told by agreeing to attend the screening session they are not obligated to 
participate in the study.  A brief presentation will be given to each potential 
subject to explain the nature, benefits, risks and discomforts of the study.  The 
will be provided with a plain language statement, and the informed consent will 
be explained.  They will be encouraged to ask questions, and any individual with 
doubts about participating in the study will have an opportunity to ask questions.  
Individuals who wish to participate in the study will have to provide written 
informed consent.   Contact details will be provided to ensure all queries or 
concerns of the participant can be dealt with immediately. 
2.6 PLEASE EXPLAIN WHEN, HOW, WHERE, AND TO WHOM RESULTS WILL BE 
DISSEMINATED, INCLUDING WHETHER PARTICIPANTS WILL BE PROVIDED WITH 
ANY INFORMATION AS TO THE FINDINGS OR OUTCOMES OF THE PROJECT? 
The results will form the basis for a postgraduate thesis and will be presented at 
scientific meetings and published in scientific journals.  The identity of individual 
participants will not be divulged.  Group information will only be presented.  
Participants will be provided with a copy of their results, summarising 
information such as body mass index, blood pressure and cholesterol levels. 
2.7 OTHER APPROVALS REQUIRED Has permission to gain access to another 
location, organisation etc. been obtained?  Copies of letters of approval to be 
provided when available. 
 YES  NO  NOT APPLICABLE 
 (If YES, please specify from whom and attach a copy.  If NO, please explain when 
this will be obtained.) 
2.8 HAS A SIMILAR PROPOSAL BEEN PREVIOUSLY APPROVED BY THE REC? 
 YES  NO 
3. RISK AND RISK MANAGEMENT 
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3.1 ARE THE RISKS TO SUBJECTS AND/OR RESEARCHERS ASSOCIATED WITH YOUR 
PROJECT GREATER THAN THOSE ENCOUNTERED IN EVERYDAY LIFE? 
 YES  NO If YES, this proposal will be subject to full REC review 
If NO, this proposal may be processed by expedited 
administrative review 
3.2 DOES THE RESEARCH INVOLVE? 
 YES NO 
 use of a questionnaire? (attach copy)?   
 interviews (attach interview questions)?   
 observation of participants without their knowledge?   
 participant observation (provide details in section 2)?   
 audio- or video-taping interviewees or events?   
 access to personal and/or confidential data (including student, 
patient or client data) without the participant’s specific consent? 
  
 administration of any stimuli, tasks, investigations or procedures 
which may be experienced by participants as physically or 
mentally painful, stressful or unpleasant during or after the 
research process? 
  
 performance of any acts which might diminish the self-esteem 
of participants or cause them to experience embarrassment, 
regret or depression? 
  
 investigation of participants involved in illegal activities?   
 procedures that involve deception of participants?   
 administration of any substance or agent?   
 use of non-treatment of placebo control conditions?   
 collection of body tissues or fluid samples?   
 collection and/or testing of DNA samples?   
 participation in a clinical trial?   
 administration of ionising radiation to participants?   
3.3 POTENTIAL RISKS TO PARTICIPANTS AND RISK MANAGEMENT PROCEDURES  
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1. Exercise carries with it a very small risk of abnormal heart rhythms, heart 
attack, or death in less than one in 30,000 patients.  Subjects will exercise 
at a submaximal intensity and will be continuously monitored using a 12 
lead ECG.   
2. Drawing blood may cause a slight pain where the needle is inserted and 
can leave a bruise.  A person trained to take blood will be used to 
decrease these risks.   The amount of blood drawn is not harmful. 
3. Assessment of endothelial dependent and independent dilation will 
require restriction of blood flow for 5 minutes.  This may cause slight 
discomfort in the arm, which will go away after the blood pressure cuff in 
deflated.  The nitroglycerin used may induce a headache that may last 5 - 
10 minutes. 
Alternatives to the risks:  It is not possible to assess endothelial dependent and 
independent dilation without the use of brachial artery reactivity and the 
administration of nitroglycerin.  It is not possible to analyse cardiovascular 
biomarkers without taking a sample of blood.  The investigators are certified and 
experienced in these techniques. 
3.4 ARE THERE LIKELY TO BE ANY BENEFITS (DIRECT OR INDIRECT) TO 
PARTICIPANTS FROM THIS RESEARCH? 
 YES  NO Participants will be provided with a copy of their results, 
summarising information such as body mass index, blood 
pressure and their cholesterol levels 
3.5 ARE THERE ANY SPECIFIC RISKS TO RESEARCHERS? (e.g. risk of infection or 
where research is undertaken at an off-campus location) 
 YES  NO Working with blood and needles carries risks, however 
the exposure to blood and needles is minimal and the 
School of Health and Human Performance has standard 
operating procedures for the handling of biological 
products. 
3.6 ADVERSE/UNEXPECTED OUTCOMES 
The School of Health and Human Performance has the facilities to implement all 
aspects of this study and has an emergency plan for adverse events.  In the 
unlikely event of a major adverse outcome, an ambulance will be called and the 
participant will immediately be sent to Beaumont Hospital. In the unlikely event 
of a minor adverse outcome, the situation will be dealt with by the attending 
study physician with subsequent attention at the on-campus VHI SwiftCare clinic 
if required.   
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3.7 MONITORING 
The principal investigator will be involved in all aspects of the research, including 
participant recruitment and data collection.  The research team will have weekly 
meetings to update on all aspects of the study. The School of Health and Human 
Performance has a detailed list of Standard Operating Procedures for each of the 
protocols in this study.  All researchers, including students, must be familiar with 
the procedures and the Safety Statement before beginning data collection. 
3.8 SUPPORT FOR PARTICIPANTS 
This project does not require additional support for participants 
3.9 DO YOU PROPOSE TO OFFER PAYMENTS OR INCENTIVES TO PARTICIPANTS? 
 YES  NO (If YES, please provide further details.)      
4. IN ESTIGATORS’ QUALIFICATIONS, EXPERIENCE AND SKILLS (Approx. 200 words 
– see Guidelines) 
Prof. Moyna is an exercise physiologist and has extensive experience in 
cardiovascular research. Prior to joining the staff in DCU Niall was Director of the 
Applied Exercise physiology laboratory in the Division of Cardiology at the 
University of Pittsburgh Medical Centre, and Director of Clinical Research in the 
Division of Cardiology, Hartford Hospital, Connecticut, USA.  
Ms. Sarah Hughes is a graduate student in the School of Health and Human 
Performance, DCU.  She has extensive experience in studies involving human 
experimentation, and has undertaken extensive training in ultrasonography 
under the guidance of Cleona Gray, Chief Vascular Technologist in the 
Department of Vascular Surgery in the Mater Hospital, Dublin. She is a certified 
phlebotomist. 
Dr. Noel Mc Caffrey is a physician and member of staff in the School of Health 
and Human Performance.  He was instrumental in establishing the community 
based HeartSmart cardiac rehabilitation program in DCU.  Dr McCaffrey is 
actively involved in the supervision of the HeartSmart classes.  His role in the 
study is to screen potential subjects, supervise laboratory based exercise tests 
and assist with manuscript preparation.  
Dr. Davide Susta is a physician and member of staff in the School of Health and 
Human Performance.  Davide has extensive experience in clinical exercise 
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testing.  His role in the study is to supervise laboratory based exercise tests and 
assist with manuscript preparation.   
Dr. Catherine Woods is Head of the School of Health and Human Performance, 
Catherine and Dr. Noel McCaffrey established the community based HeartSmart 
cardiac rehabilitation program in DCU.  Dr Woods is actively involved in the 
supervision of the HeartSmart classes.  He role in the study is to assist with the 
recruitment of subjects and manuscript preparation. 
Cleona Gray is Senior Vascular Technologist in the Vascular Lab in the Mater 
Hospital.  Cleona has trained Sarah Hughes in ultrasonography and is currently 
training Brona Furlong (see below) in this technique.  Cleona’s involvement in the 
research project will continue in the form of a supervisory and troubleshooting 
role. 
Brona Furlong has recently graduated first in her class with a 1st class honours 
degree in Sports Science and Health.  She is currently enrolled as a PhD student 
in the School of Health and Human Performance.  She has extensive experience 
in blood sampling and research involving human subjects. 
 
5. CONFIDENTIALITY/ANONYMITY 
5.1 WILL THE IDENTITY OF THE PARTICIPANTS BE PROTECTED? 
 YES  NO  
IF YOU ANSWERED YES TO 5.1, PLEASE ANSWER THE FOLLOWING QUESTIONS: 
5.2 HOW WILL THE ANONYMITY OF THE PARTICIPANTS BE RESPECTED? 
Confidentiality is an important issue during data collection.  Participant’s identity 
and other personal information will not be revealed, published or used in further 
studies.  Subjects will be assigned an ID number under which all personal 
information will be stored in a secure locked cabinet and saved in a password-
protected file in a computer at DCU.  The principal investigator, and collaborators 
listed on this ethics application will have access to the data. 
5.3 LEGAL LIMITATIONS TO DATA CONFIDENTIALITY: (Have you included 
appropriate information in the plain language statement and consent form?  See 
Guidelines) 
 YES  NO (If NO, please advise how participants will be advised.) 
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6 DATA/SAMPLE STORAGE, SECURITY AND DISPOSAL (see Guidelines) 
6.1 HOW WILL THE DATA/SAMPLES BE STORED? (The REC recommends that all data 
be stored on campus) 
Stored at DCU      
Stored at another site     (Please explain where 
and for what purpose) 
6.2 WHO WILL HAVE ACCESS TO DATA/SAMPLES? 
Access by named researchers only    
Access by people other than named researcher(s)  (Please explain who and 
for what purpose) 
Other:        (Please explain) 
6.3 IF DATA/SAMPLES ARE TO BE DISPOSED OF, PLEASE EXPLAIN HOW, WHEN AND 
BY WHOM THIS WILL BE DONE? 
The principal investigator will be responsible for security of the data.  The data 
will be kept in locked cabinet in the Cardiovascular Research Unit in the School of 
Health and Human Performance in DCU. Access to the data will only be 
attainable by the named researchers.  Data will be kept for a minimum of five 
years from the date of publication of the research.  Aside from the named 
researchers, no others will have access to the raw data.  Data will be shredded 
by Prof. Moyna after 5 years. 
.7. FUNDING 
7.1 HOW IS THIS WORK BEING FUNDED? 
 School of Health and Human Performance/CLARITY 
7.2 PROJECT GRANT NUMBER (If relevant and/or known) 
 NA 
7.3 DOES THE PROJECT REQUIRE APPROVAL BEFORE CONSIDERATION FOR 
FUNDING BY A GRANTING BODY?  
 YES  NO  Not Applicable 
7.4 HOW WILL PARTICIPANTS BE INFORMED OF THE SOURCE OF THE FUNDING? 
 YES  NO  Not Applicable 
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Plain Language Statement 
Dublin City University 
Project Title:  Effect of Exercise Duration on Vascular Health in individuals with 
cardiovascular disease 
The Research Study will take place in the School of Health and Human 
Performance, DCU. 
The principle investigator is: Prof. Niall M. Moyna, (Tel: 7008802 Fax: 7008888) 
EMAIL niall.moyna@dcu.ie 
I. Disease of the heart and blood vessels is called cardiovascular disease 
(CVD), and is the main cause of death in Ireland.  CVD increases the 
thickness of blood vessels, and also reduces the ability of blood vessel to 
dilate (get bigger).  We can use a simple ultrasound procedure to 
measure the health of your blood vessel.  Tiny pieces of the damaged 
blood vessel wall break off into the blood and these can be measured by 
taking a blood sample.  People who exercise regularly have less chance of 
getting CVD.  The purpose of this study is to 1) measure the health of 
your blood vessels and 2) to evaluate the effect of 20 min or 40 min of 
exercise on your blood vessels.  You will be allowed to take part in the 
study if you meet the entry criteria and sign the informed consent.  
II. If you agree to take part in the study you will be asked to make 3 visits to 
the Cardiovascular Research Unit in the School of Health and Human 
Performance in DCU.  On your first visit you, that will last approximately 1 
hour, you will have a blood sample taken and an ultrasound picture will 
be taken of a blood vessel in your neck.  During the second and third visit 
you will walk on a treadmill for 20 min or 40 min.  You will be allowed to 
select the treadmill speed that you prefer.  About 2 tablespoons of blood 
will be taken before you exercise and 1 hour and 24 hours after you 
exercise.  The health of a blood vessel in your arm will be measured at 
the same times that blood samples are taken.  This will be done by using 
an ultrasound to take an image of your blood vessel and involves blocking 
the blood flow to your arm for 5 minutes using a blood pressure cuff and 
taking a nitroglycerin tablet under your tongue.  The second and third 
visit will last approximately 2 hours.  You will fast for at least 12 hours 
and will not be allowed to exercise for at least 24 hours before these 
visits.   
III.  1.  Exercise carries with it a very small risk of abnormal heart rhythms, 
heart attack, or death in less than one in 30,000 patients. 
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2.  Drawing blood may cause a slight pain where the needle is inserted 
and may leave a bruise.  A person trained to take blood will be used to 
decrease these risks.   
3.  Taking an ultrasound image of your arm requires blocking the blood 
flow to your arm for 5 minutes using a blood pressure cuff.  This may 
cause slight discomfort in your arm, which will go away after the blood 
pressure cuff in deflated.  The nitroglycerin used in this study may 
cause a headache that could last 5 to 10 min. 
IV. Your confidentiality will be guarded.  All information we gather will be 
stored in a secure filing cabinet.  The results of the study will be used for 
a postgraduate project and may be published in academic journals. You 
will not be identified, as your information will be presented as part of a 
group.  You will be assigned an ID number under which all personal 
information will be stored in the secure locked filing cabinet and saved in 
a password protected file in a computer at DCU.  You need to be aware 
that confidentiality of information provided can only be protected within 
the limitations of the law.  It is possible for data to be subject to 
subpoena, freedom of information claim or mandated reporting by some 
professions.  
VI. Involvement in this study is completely voluntary.  You may withdraw 
from the Research Study at any point. 
VIII. If you have concerns about this study and wish to contact an independent 
person, please contact: The Secretary, Dublin City University Research 
Ethics Committee, c/o Office of the Vice-President for Research, Dublin 
City University, Dublin 9.  Tel 01-7008000 
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Informed Consent 
Dublin City University 
Project Title Effect of Exercise Duration on Vascular Health in Patients 
with cardiovascular disease 
Principle Investigator Prof. Niall M. Moyna 
Introduction to this study 
Disease of the heart and blood vessels is called cardiovascular disease (CVD), and is 
the main cause of death in Ireland.  CVD can be indentified by measuring the 
thickness of the carotid artery in your neck using ultrasound.  CVD damages blood 
vessels and reduces their ability to dilate (get bigger).  We can also use a simple 
ultrasound procedure to measure how much the blood vessels can dilate.  Damaged 
blood vessels release cells into the blood which can be measured by taking a blood 
sample.  Regular physical activity improves the health of blood vessels, and also has 
a beneficial effect on many of the risk factors for CVD.  This study will measure the 
health of your blood vessels.  In addition we will evaluate how exercise of different 
durations affects your blood vessels. 
Participants Requirements 
1. I will visit the Cardiovascular Research Unit in the School of Health and Human 
Performance DCU on 3 separate days.  During my first visit (which lasts 
approximately I hour), I will have a blood sample taken and complete a medical 
history questionnaire that will include a list of all the medications I am currently 
taking.  An ultrasound measurement will be taken of my neck to measure my 
carotid artery (See Figure 1).  This test is painless and lasts about 15 min.   
2 During my second and third visit I will walk/jog on a treadmill for 20 min or 40 
min.  I will be allowed to select the treadmill speed.  A researcher will toss a coin 
to determine which test I do first.  A blood sample will be taken and the health of 
the arteries in my arm will be measured before and 1 hour and 24 hours after I 
finish the exercise.  The total amount of blood drawn will be 2 tablespoons (30 
cc).  I will have electrodes placed on my chest to allow the researchers observe 
the electrical activity of my heart during exercise.  The second and third visit will 
last approximately 2 hours.  I will fast for at least 12 hours and will not exercise 
for at least 24 hours before my second and third visit.  If I am taking Viagra I will 
notify Sarah Hughes.  I will not take Viagra for at least 24 hours before these two 
visits.   
3. The test the health of the arteries in my arms I will lie on my back, and an 
ultrasound will be placed on my upper arm to create an image of my artery.  
After the first image is recorded, a blood pressure cuff will be inflated on my 
forearm to block blood flow for five minutes.  This may be uncomfortable.  The 
 Neck ultrasound 
 Neck Ultrasound 
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cuff will be released and the images of my arteries repeated.  I will rest for 15 
minutes and then have a nitroglycerin pill placed under my tongue.  The 
nitroglycerin will cause my arm arteries to enlarge and how much they enlarge 
will again be documented by taking a third set of pictures.  
                                     
Potential risks to participants from involvement in the Research Study  
1.  Exercise carries with it a very small risk of abnormal heart rhythms, heart attack, 
or death in less than one in 30,000 patients. 
2.  Drawing blood may cause a slight pain where the needle is inserted and can leave 
a bruise.  A person trained to take blood will be used to decrease these risks. 
3.  The amount of blood drawn is not harmful, however, if I have a history of anemia, 
I should inform the investigator. 
4.  The pictures of my arm arteries require blocking the blood flow to my arm for 5 
minutes.  This may cause slight discomfort in the arm, which will go away after the 
blood pressure cuff in deflated.  The nitroglycerin used in this study may induce a 
headache that could last 5 to 10 min.   
Benefits (direct or indirect) to participants from involvement in the Research Study 
After completing the study I will be provided with a copy of my results, summarising 
information such as my body mass index, blood pressure and cholesterol levels.  
There are no other direct benefits to me. 
Participant – please complete the following (circle Yes or No for each question) 
Have you read or had read to you the Plain Language Statement? Yes  No  
Do you understand the information provided?    Yes  No  
Have you had an opportunity to ask questions and discuss this study? Yes  No  
Have you received satisfactory answers to all your questions?  Yes  No  
Arm ultrasound 
 Neck Ultrasound 
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Advice as to arrangements to be made to protect confidentiality of data, including 
that confidentiality of information provided is subject to legal limitations. 
Your identity and other personal information will not be revealed, published or used 
in further studies.  You will be assigned an ID number under which all personal 
information will be stored in a secure locked cabinet and saved in a password 
protected file in a computer at DCU.  The named investigators will have access to the 
data.  Data will be shredded after 5 years by Prof. Moyna. 
Confidentiality is insured, but you must be aware that confidentiality of information 
provided can only be protected within the limitations of the law.  It is possible for 
data to be subject to subpoena, freedom of information claim or mandated 
reporting by some professions. 
If you are in a dependent relationship with any of the researchers their involvement 
in the project will not affect ongoing assessment/grades/management or treatment 
of health at DCU. 
Signature: 
I have read and understood the information in this form.  The researchers have 
answered my questions and concerns, and I have a copy of this consent form.  
Therefore, I (print name) ______________________ consent to take part in this 
research project entitled Effect of Exercise Duration on Vascular Health in Patients 
with cardiovascular disease.  
Participants Signature:  ____________________________________ 
Name in Block Capitals       
Witness:          
Date:          
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Appendix D  
Submission to Ethics Committee 
 
 
Dublin City University 
RESEARCH ETHICS COMMITTEE 
APPLICATION FOR APPROVAL OF A PROJECT INVOLVING HUMAN 
PARTICIPANTS 
Application No. (office use only)  DCUREC/2010/   
Period of Approval (office use only) ....../....../......to....../....../.... 
This application form is to be used by researchers seeking ethics approval for individual 
projects and studies. The signed original and an electronic copy of your completed 
application must be submitted to the DCU Research Ethics Committee.   
NB - The hard copy must be signed by the PI.  The electronic copy should consist of one 
file only, which incorporates all supplementary documentation.  The completed 
application must be proofread and spellchecked before submission to the REC.  All 
sections of the application form should be completed.  Applications which do not 
adhere to these requirements will not be accepted for review and will be returned 
directly to the applicant. 
Applications must be completed on the form; answers in the form of attachments will 
not be accepted, except where indicated.  No handwritten applications will be accepted.  
Research must not commence until written approval has been received from the 
Research Ethics Committee. 
PROJECT TITLE Comparisons of two Exercise Training Programmes on Vascular Health 
in Patients with Cardiovascular Disease 
PRINCIPAL 
INVESTIGATOR(S) 
Prof. Niall M. Moyna 
 
Please confirm that all supplementary information is included in your application (in 
both signed original and electronic copy). If questionnaire or interview questions are 
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submitted in draft form, a copy of the final documentation must be submitted for final 
approval when available. 
 INCLUDED NOT 
APPLICABLE 
Bibliography    
Recruitment advertisement    
Plain language statement/Information Statement    
Informed Consent form    
Evidence of external approvals related to the 
research 
   
Questionnaire  
draft 
 
final 
 
Interview Schedule  
draft 
 
final 
 
Debriefing material     
Other    
 
Please note: 
 
3. Any amendments to the original approved proposal must receive prior REC 
approval. 
4. As a condition of approval investigators are required to document and report 
immediately to the Secretary of the Research Ethics Committee any adverse 
events, any issues which might negatively impact on the conduct of the research 
and/or any complaint from a participant relating to their participation in the 
study 
 
Please submit the signed original, plus the electronic copy of your completed application to:  
Ms. Fiona Brennan, Research Officer, Office of the Vice-President for Research  
(fiona.brennan@dcu.ie, Ph. 01-7007816) 
 
. ADMINISTRATIVE DETAILS 
THIS PROJECT IS:  Research Project  Funded Consultancy 
(tick as many as 
apply) 
 Practical Class  Clinical Trial 
  Student Research Project  
(please give details) 
 Other  - Please Describe:       
  Resear
chMast
ers 
 Taught Masters 
  PhD  Undergraduate 
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Project Start Date: 01/02/11 Project End Date 
01/06/11 
 
1.1 INVESTIGATOR CONTACT DETAILS (see Guidelines) 
PRINCIPAL INVESTIGATOR(S):  
TITLE SURNAME FIRST NAME PHONE FAX EMAIL 
Prof Moyna Niall 01 7008802 01 7008888 niall.moyna@dcu.ie 
 
OTHER INVESTIGATORS: 
TITLE SURNAME FIRST NAME PHONE FAX EMAIL 
Dr. Mc Caffrey Noel      087 2797597 01 7008888 noel.mccaffrey@dcu.ie 
Dr.      Woods Catherine      01 7008008 01 7008888 catherine.woods@dcu.ie 
Ms.      Hughes Sarah      086 8673608      01 7008888 sarah.hughes3@mail.dcu.ie 
Ms. Furlong Bróna 086 3687961 01 7008888 brona.furlong2@mail.dcu.ie 
Ms. Gray Cleona 01 8034478 01 8034252 cgray@mater.ie 
 
FACULTY/DEPARTMENT/SCHOOL/ 
CENTRE: 
(NB – if Nursing, please note all students 
including PhD’s must attach the letter from 
the Nursing Ethics Advisory Committee to 
this application) 
 
      
 
 
1.2 WILL THE RESEARCH BE UNDERTAKEN ON-SITE AT DUBLIN CITY UNIVERSITY? 
 
 YES  NO (If NO, give details of off-campus location.) 
      
 
1.3 IS THIS PROTOCOL BEING SUBMITTED TO ANOTHER ETHICS COMMITTEE, OR 
HAS IT BEEN PREVIOUSLY SUBMITTED TO AN ETHICS COMMITTEE?) 
 
 YES  NO (If YES, please provide details and copies of approval(s) 
received etc.)   
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DECLARATION BY INVESTIGATORS 
The information contained herein is, to the best of my knowledge and belief, accurate.  I 
have read the University’s current research ethics guidelines, and accept responsibility 
for the conduct of the procedures set out in the attached application in accordance with 
the guidelines, the University’s policy on Conflict of Interest and any other condition laid 
down by the Dublin City University Research Ethics Committee or its Sub-Committees.  I 
have attempted to identify all risks related to the research that may arise in conducting 
this research and acknowledge my obligations and the rights of the participants. 
If there any affiliation or financial interest for researcher(s) in this research or its 
outcomes or any other circumstances which might represent a perceived, potential or 
actual conflict of interest this should be declared in accordance with Dublin City 
University policy on Conflicts of Interest.  
I and my co-investigators or supporting staff have the appropriate qualifications, 
experience and facilities to conduct the research set out in the attached application and 
to deal with any emergencies and contingencies related to the research that may arise. 
Signature(s): 
Principal investigator(s):      
Print name(s) in block letters:   Niall M. Moyna 
Date:    2 December 2010 
2. PROJECT OUTLINE  
 
4.2 LAY DESCRIPTION 
 Cardiac Rehabilitation is a structured exercise and education programme 
designed to help patients recover from their heart event.  It is a multi-
disciplinary approach to improve short-term recovery and to promote long-term 
changes in lifestyle. Patients in Ireland currently enter an 8-10 week hospital-
based cardiac rehabilitation programme (Phase III) after discharge from hospital.  
This involves a gradual increase in physical activity, continuation of risk-factor 
modifications and development of maintenance programs.  This is followed by a 
community based Phase IV Cardiac Rehabilitation that aims to assist patients 
who have successfully completed a hospital based phase III programme.  
In 2006, DCU established a community-based phase IV Cardiac Rehabilitation 
programme (HeartSmart) in collaboration with Beaumont Hospital, The Mater 
Misericordiae University Hospital and Connolly Memorial Hospital.  The 
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HeartSmart programme is located in the DCU Sport Centre.  Patients, who meet 
the inclusion criteria, are referred to the programme by the cardiac 
rehabilitation teams at the three partner hospitals.  Individuals normally attend 2 
classes per week.  The classes are normally 60 minutes in duration and involve 
primarily aerobic exercise to stress the cardiovascular system and some form of 
resistance training.  Participants exercise in small groups and rotate between the 
various exercises during a class.  Substantial improvements in physical fitness, 
psychological well being and quality of life are evident after 3-6 months.  Further 
improvements in fitness levels and cardiovascular health may require 
participants to exercise at higher intensities under supervision.  
The purpose of this study is to compare the effect of a traditional 4 week 
community based cardiac rehabilitation exercise programme (HeartSmart) and 
an individualized 4 week high intensity intermittent exercise programme on 
vascular health in individuals who have participated in HeartSmart for at least 6 
months.   Aerobic fitness and the health of the arteries (Figure 1 and 2) will be 
assessed before and at the end of the 4 weeks.  In addition blood samples will be 
taken at the same time points.  The electrical activity of the heart will be 
continuously monitored during each class. 
                                                     
Figure 1: Carotid artery ultrasound   Figure 2: Brachial artery 
reactivity 
2.2 AIMS OF AND JUSTIFICATION FOR THE RESEARCH  
 Cardiovascular disease (CVD) collectively refers to diseases of the heart and 
circulatory system, and typically includes coronary heart disease (CHD), stroke, 
and peripheral vascular diseases (e.g. atherosclerosis, deep vein thrombosis, 
hypertension).  Ireland has the highest mortality rate from CVD in the EU (40%).  
The socio-economic impact of C D to Ireland and the EU is €169 billion/year.  
Physical activity plays a critical role in both the primary and secondary 
prevention of CVD.  In individuals with documented CVD, physical activity is an 
established, inexpensive, and generally safe secondary intervention that is 
associated with a 31% reduction in cardiovascular-related mortality.  The 
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beneficial effects of physical activity are multifactorial and are related to direct 
and indirect protective mechanisms that impact blood vessel health 
(endothelium function, inflammation, vessel remodeling), blood clotting 
processes (platelet activation and fibrinolysis), and cardiac performance.  
Substantial improvements in physical fitness, psychological well being and 
quality of life are evident after 3-6 months.  Further improvements in fitness 
levels and cardiovascular health may require participants to exercise at higher 
intensities under supervision. 
This study will compare the effect of a 4 week community-based exercise 
programme (HeartSmart) and an individualized 4 week high intensity 
intermittent exercise programme on aerobic fitness and circulating endothelial 
cells (CEC), endothelial progenitor cells (EPC) and microparticles (MP) in 
individuals with CVD.  CEC, EPC and MP are released by a damaged endothelium 
(innermost layer of blood vessel walls), and currently little is known about the 
effect of exercise on their number and function.  Carotid intima media thickness 
(CIMT) will be used to estimate CVD.  Endothelial function will be assessed using 
flow mediated dilation (endothelial dependent) and endothelial independent 
dilation (this involves the administration of vasodilator, glyceryl trinitrate). 
The aim of this study is to compare the effect of a traditional 4 week community 
based exercise programme (HeartSmart) and an individualized 4 week high 
intensity intermittent exercise programme on vascular health in patients with 
CVD who have participated in a community-based phase IV Cardiac 
Rehabilitation programme for at least 6 months. 
The purpose of this study is to 
1. Compare the effect of a traditional 4 week community-based cardiac 
rehabilitation exercise programme and an individualized 4 week high 
intensity intermittent exercise programme on vascular health in patients 
with CVD.   
2. Compare the effect of a traditional 4 week community based cardiac 
rehabilitation exercise programme and an individualized 4 week high 
intensity intermittent exercise programme on aerobic fitness in patients 
with CVD.   
3. Compare the effect of a traditional 4 week community based cardiac 
rehabilitation exercise programme and an individualized 4 week high 
intensity intermittent exercise programme on CECs, EPCs and MPs in 
patients with CVD.   
2.3  PROPOSED METHOD  
 Overview 
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Subjects participating in HeartSmart for more than 6 months will be recruited.  
The study will take place in the Vascular Research Unit in the School of Health 
and Human Performance.  Subjects will be randomly assigned to a traditional 
cardiac rehabilitation (TCR) group or to an individually tailored high intensity 
intermittent exercise (HIT) training group.  Subjects in the TCR will continue to 
attend HeartSmart twice a week for the duration of the 4 week study.  Subjects 
in training group will attend 2 supervised exercise sessions per week in the 
Vascular Research Unit.  Subjects in the training group will wear electrodes on 
their chest to monitor the electrical activity of their heart throughout the 
exercise sessions. 
Subjects will visit the laboratory for testing sessions on 2 occasions before and 2 
occasions after the 4 week exercise programme.  The first testing session will be 
used to further explain the requirements of the study, obtain informed consent, 
take a blood sample, measure CIMT and to assess endothelial function.  During 
the second testing session aerobic fitness (  O2peak) will be measured.  At the end 
of the 4 week programme the third testing session will be a repeat of the tests 
carried out during testing session 1, and similarly testing session 4 will consist of 
the same tests as carried out during testing session 2. . 
Traditional Cardiac Rehab Group: Subjects will attend HeartSmart twice per 
week.  They will wear a heart rate monitor during these classes each week.   
Training Group: Subjects will attend a high intensity intermittent exercise 
programme in the Vascular Research Unit twice a week.  They will wear an ECG 
during every class.  These exercise sessions will be supervised and include a 15 
min warm-up.  The sessions will involve individually prescribed programmes 
based on each subjects symptom-limited graded exercise test.  Subjects will 
perform bouts of high intensity exercise at 60-100% HRmax interspersed with 
periods of recovery.  The total duration of the high intensity intermittent 
exercise will increase from 5 min at week 1 up to 15 min at week 4.  Each session 
will take place on a treadmill.  Subjects will finish with a 10 min cool down and 
stretch.  Before and after the final interval exercise session (Session 8) a blood 
sample will be drawn and endothelial function will be assessed. 
Testing Session 1:  Approximately 1.5 hour in duration.  Subjects will read and 
sign the informed consent, have their CIMT measured and their endothelial 
function assessed.  Approximately 25 ml of blood will be taken from a vein in the 
arm.  
 Testing Session 2:  Approximately 1 hour in duration.  Aerobic fitness level 
(  O2peak) will be assessed and 10 L of blood will be taken using a lancing device 
to prick the earlobe. 
Testing Session 3:  Approximately 1.5 hour in duration.  The testing procedures 
that were carried out during testing session 1 will be repeated. 
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Testing Session 4:  Approximately 1 hour in duration. The testing procedures 
that were carried out during testing session 2 will be repeated. 
Carotid Intima Media Thickness (CIMT):  Thickness of the carotid intima-media 
will be assessed using a 12.0 MHz linear-array transducer (SonoSite, MicroMaxx).  
Recordings will be obtained with the subject resting in a supine position, with 
the head turned slightly to the contralateral side.  The common carotid artery, 
including the carotid bulb, will be visualized, and 2 longitudinal B-mode images 
of the left and the right common carotid arteries at end diastole will be recorded 
and electronically stored.  Measurements of CIMT will be conducted in the 10-
mm linear segment proximal to the carotid bulb at 2 plaque-free sites twice in 
the near wall and twice in the far wall on both sides and combined as mean 
CIMT.  The combination of readings from the near and far walls yields the 
strongest association with cardiovascular disease.  The artery will be scanned 
longitudinally without colour flow to assess the grey scale image, and with colour 
flow to identify difficult anatomy and delineate irregularities in plaque.  
Brachial Artery Reactivity (BAR): Endothelial dependent dilation will be 
determined in response to reactive hyperemia following 5 min of lower arm 
occlusion.  A blood pressure cuff will be placed on the left arm for blood pressure 
monitoring and another on the right lower arm for occlusion.  ECG leads will be 
attached to monitor heart rate.  Subjects will rest for 10 min in a supine position.  
Blood pressure will be determined during the final 2 minutes of the rest period.  
Baseline blood flow and brachial artery diameter (SonoSite, MicroMaxx) will be 
recorded.  The right arm blood pressure cuff will then be inflated to 
approximately 220-230 mmHg and maintained at that pressure for 5 minutes.  
The cuff will then be rapidly deflated after 5 min of occlusion.  Doppler blood 
flow measurement will be obtained during the first minute following cuff 
deflation.  Brachial artery diameter will be assessed at one and three minutes 
post occlusion.  Subjects will then rest for 15 minutes to eliminate endothelium 
dependent effects on brachial artery diameter.  After this period, endothelial 
independent dilation will be assessed.  Baseline blood flow and brachial artery 
diameter will be recorded and used as a baseline prior to sublingual glyceryl 
trinitrate administration.  Glyceryl trinitrate (0.4mg) will be placed under the 
subjects tongue.  Doppler blood flow measurement will be obtained three 
minutes following the sublingual glyceryl trinitrate administration and brachial 
artery diameter measurements will be assessed 3 and 5 minutes post glyceryl 
trinitrate administration.   
Peak Aerobic Capacity (  O2peak) Assessment:Peak aerobic capacity will be 
determined on a treadmill using open circuit spirometry.  During this assessment 
subjects will be fitted with a mouthpiece or facemask.  ECG will be continuously 
monitored using a 12 lead ECG, and a physician will be present. 
2.4 PARTICIPANT PROFILE  
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A total of 20 men aged 40-65 yr, enrolled in HeartSmart in DCU Sport’s complex 
for at least 6 months, will be recruited.  The subjects will be referred from 
Beaumont Hospital, The Mater Hospital and Connolly Memorial Hospital phase 
III cardiac rehabilitation programme.  Subjects will have documented CVD, will 
have passed a medical and physical examination that permits them to exercise.  
Each participant’s cardiologist will be informed of his/her participation in the 
study 
Inclusion Criteria: 
 Male 
 Involved in HeartSmart programme for more than 6 months 
 Referred from Beaumont Hospital, The Mater Hospital and Connolly 
Memorial Hospital phase III cardiac rehabilitation programme 
 Stable angina 
 Able to achieve 30 min of continuous walking without symptoms (cardiac 
chest pain/discomfort, severe breathlessness, dizziness or palpitations) or 
be able to undertake activities of at least 5 METS (manually washing a 
car, digging/turning over soil, walking/jogging a mile in less than 15 
minutes) without symptoms   
 Clinically stable and in good health for a minimum of 2 weeks prior to 
beginning the study 
Exclusion Criteria:   
Potential subjects will be excluded if 
 Current smoker  
 Unstable angina 
 Systolic blood pressure >180 mmHg and/or diastolic blood pressure > 
100 mmHg   
 Resting tachycardia   
 Unstable or acute heart failure 
 Ventricular arrhythmias during maximal exercise test 
 Prolonged ST-segment depression (> 2mm) during maximal exercise 
test 
 Severe angina during maximal exercise test 
2.5 MEANS BY WHICH PARTICIPANTS ARE TO BE RECRUITED  
 Men enrolled in the HeartSmart cardiac rehabilitation programme in DCU Sport 
for at least 6 months will be informed of the research study.  A brief summary of 
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the study and contact details will be provided to patients enrolling in 
HeartSmart.  Following an expression of interest, potential subjects will be asked 
to visit the Vascular Research Laboratory in the School of Health and Human 
Performance.  They will be told that by agreeing to visit the laboratory they are 
not obligated to participate in the study.  The nature, benefits, risks and 
discomforts of the study will be explained.  In addition, they will be provided 
with a plain language statement, and the informed consent will be explained.  
They will be encouraged to ask questions.  Individuals who wish to participate in 
the study will have to provide written informed consent.   
2.6 PLEASE EXPLAIN WHEN, HOW, WHERE, AND TO WHOM RESULTS WILL BE 
DISSEMINATED, INCLUDING WHETHER PARTICIPANTS WILL BE PROVIDED WITH 
ANY INFORMATION AS TO THE FINDINGS OR OUTCOMES OF THE PROJECT? 
 The results will form the basis for a postgraduate thesis and will be presented at 
scientific meetings and published in scientific journals.  The identity of individual 
participants will not be divulged.  Group information will only be presented.  
Participants will be provided with a copy of their results, summarising 
information such as body mass index, blood pressure and cholesterol levels. 
2.7 OTHER APPROVALS REQUIRED Has permission to gain access to another 
location, organisation etc. been obtained?  Copies of letters of approval to be 
provided when available. 
 
 
YES  NO  NOT APPLICABLE 
(If YES, please specify from whom and attach a copy.  If NO, please explain when 
this will be  obtained.) 
      
2.8 HAS A SIMILAR PROPOSAL BEEN PREVIOUSLY APPROVED BY THE REC? 
 
 YES  NO 
(If YES, please state both the REC Application Number and Project Title) 
 REC/2010/49 EFFECT OF AN 8 WEEK COMMUNITY BASED CARDIAC EXERCISE REHABILIATION 
PROGRAMME ON  VASCULAR HEALTH IN PATIENTS WITH CARDIOVASCULAR DISEASE 
3. RISK AND RISK MANAGEMENT 
3.1 ARE THE RISKS TO SUBJECTS AND/OR RESEARCHERS ASSOCIATED WITH YOUR 
PROJECT GREATER THAN THOSE ENCOUNTERED IN EVERYDAY LIFE? 
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 YES  NO If YES, this proposal will be subject to full REC review 
If NO, this proposal may be processed by expedited 
administrative review 
 
3.2 DOES THE RESEARCH INVOLVE: 
 YES N
O 
 use of a questionnaire? (attach copy)?   
 interviews (attach interview questions)?   
 observation of participants without their knowledge?   
 participant observation (provide details in section 2)?   
 audio- or video-taping interviewees or events?   
 access to personal and/or confidential data (including student, 
patient or client data) without the participant’s specific consent? 
  
 administration of any stimuli, tasks, investigations or procedures 
which may be experienced by participants as physically or 
mentally painful, stressful or unpleasant during or after the 
research process? 
  
 performance of any acts which might diminish the self-esteem 
of participants or cause them to experience embarrassment, 
regret or depression? 
  
 investigation of participants involved in illegal activities?   
 procedures that involve deception of participants?   
 administration of any substance or agent?   
 use of non-treatment of placebo control conditions?   
 collection of body tissues or fluid samples?   
 collection and/or testing of DNA samples?   
 participation in a clinical trial?   
 administration of ionising radiation to participants?   
3.3 POTENTIAL RISKS TO PARTICIPANTS AND RISK MANAGEMENT PROCEDURES  
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1. Exercise testing carries with it a very small risk of abnormal heart 
rhythms, heart attack, or death in less than one in 30,000 patients.  
Subjects will be continuously monitored using a 12 lead ECG and a 
physician will be present. 
2. Drawing blood may cause a slight pain where the needle is inserted and 
can leave a bruise.  A person trained to take blood will be used to 
decrease these risks.  The amount of blood drawn is not harmful. 
3. Assessment of endothelial dependent and independent dilation will 
require restriction of blood flow for 5 minutes.  This may cause slight 
discomfort in the arm, which will go away after the blood pressure cuff in 
deflated.  The glyceryl trinitrate used may induce a headache that may 
last 5 - 10 minutes. 
Alternatives to the risks  
It is not possible to assess endothelial dependent and independent dilation 
without the use of brachial artery reactivity and the administration of glyceryl 
trinitrate.  Subjects will be informed that they must refrain from Viagra, PDE5 
inhibitors and all other sexual enhancers (herbal or otherwise) 48 hours prior to 
participation in the study.   
Analysis of cardiovascular biomarkers cannot be undertaken without a sample of 
blood.  The investigators are certified and experienced in phlebotomy and 
ultrasonography. 
3.4 ARE THERE LIKELY TO BE ANY BENEFITS (DIRECT OR INDIRECT) TO 
PARTICIPANTS FROM THIS RESEARCH? 
 
 YES  NO Participants will be provided with a copy of their 
results, summarising information such as blood 
pressure and fitness levels       
3.5 ARE THERE ANY SPECIFIC RISKS TO RESEARCHERS? (e.g. risk of infection or 
where research is undertaken at an off-campus location) 
  
 YES  NO Working with blood and needles carries risks, however 
the exposure to blood and needles is minimal and the 
School of Health and Human Performance has standard 
operating procedures for the handling of biological 
products. 
3.6 ADVERSE/UNEXPECTED OUTCOMES  
 
 
198 
 
 
 The School of Health and Human Performance has the facilities to implement all 
aspects of this study and has an emergency plan for adverse events.  In the 
unlikely event of a major adverse outcome, an ambulance will be called and the 
participant will immediately be sent to Beaumont Hospital. In the unlikely event 
of a minor adverse outcome, the situation will be dealt with by the attending 
study physician with subsequent attention at the Mater Smithfield Rapid Injury 
Clinic if required.   
3.7 MONITORING 
 The principal investigator will be involved in all aspects of the research, including 
participant recruitment and data collection.  The research team will have weekly 
meetings to update on all aspects of the study. The School of Health and Human 
Performance has a detailed list of Standard Operating Procedures for each of the 
protocols in this study.  All researchers, including students, must be familiar with 
the procedures and the Safety Statement before beginning data collection. 
3.8 SUPPORT FOR PARTICIPANTS  
This project does not require additional support for participants 
3.9 DO YOU PROPOSE TO OFFER PAYMENTS OR INCENTIVES TO PARTICIPANTS? 
 
 YES  NO (If YES, please provide further details.)      
4. IN ESTIGATORS’ QUALIFICATIONS, EXPERIENCE AND SKILLS (Approx. 200 words 
– see Guidelines) 
Prof. Moyna is an exercise physiologist and has extensive experience in 
cardiovascular research. 
Dr. Noel McCaffrey is a physician with extensive experience in exercise related 
research 
Ms. Sarah Hughes is a graduate student in the School of Health and Human 
Performance, DCU.  She has extensive experience in studies involving human 
experimentation, and has undertaken extensive training in ultrasonography 
under the guidance of Cleona Gray, Chief Vascular Technologist in the 
Department of Vascular Surgery in the Mater Hospital, Dublin.  Sarah is also a 
certified phlebotomist. 
Dr. Catherine Woods is Head of the School of Health and Human Performance, 
Catherine and Dr. Noel McCaffrey established the community based HeartSmart 
cardiac rehabilitation program in DCU.  Dr Woods is actively involved in the co-
ordination of the HeartSmart classes. 
Brona Furlong has recently graduated first in her class with a 1st class honours 
degree in Sports Science and Health.  She is currently enrolled as a PhD student 
in the School of Health and Human Performance.  She has extensive experience 
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in blood sampling and research involving human subjects.  Brona will assist with 
data collection and supervising classes. 
Cleona Gray is Senior Vascular Technologist in the Vascular Lab in the Mater 
Hospital.  Cleona has trained Sarah Hughes and Brona Furlong in 
Ultrasonography.  Cleona’s involvement in the research project will continue in 
the form of a supervisory and troubleshooting role.  She will provide technical 
support in performing carotid and brachial ultrasound scanning 
5. CONFIDENTIALITY/ANONYMITY 
5.1 WILL THE IDENTITY OF THE PARTICIPANTS BE PROTECTED? 
 
 YES  NO (If NO, please explain) 
IF YOU ANSWERED YES TO 5.1, PLEASE ANSWER THE FOLLOWING QUESTIONS: 
5.2 HOW WILL THE ANONYMITY OF THE PARTICIPANTS BE RESPECTED?  
Confidentiality is an important issue during data collection.  Participant’s identity 
and other personal information will not be revealed, published or used in further 
studies.  Subjects will be assigned an ID number under which all personal 
information will be stored in a secure locked cabinet and saved in a password-
protected file in a computer at DCU.  The principal investigator, and 
collaborators listed on this ethics application will have access to the data. 
5.3 LEGAL LIMITATIONS TO DATA CONFIDENTIALITY: (Have you included 
appropriate information in the plain language statement and consent form?  See 
Guidelines) 
 
 YES  NO (If NO, please advise how participants will be 
advised.) 
6 DATA/SAMPLE STORAGE, SECURITY AND DISPOSAL (see Guidelines) 
6.1 HOW WILL THE DATA/SAMPLES BE STORED?  (The REC recommends that 
all data be stored on        campus) 
 
Stored at DCU      
Stored at another site    (Please explain where and for 
what purpose) 
 
6.2 WHO WILL HAVE ACCESS TO DATA/SAMPLES? 
Access by named researchers only         
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Access by people other than named researcher(s)  (Please explain who and 
for what purpose)  
Other  :     (Please explain) 
       
6.3 IF DATA/SAMPLES ARE TO BE DISPOSED OF, PLEASE EXPLAIN HOW, WHEN AND 
BY WHOM THIS WILL BE DONE? 
The principal investigator will be responsible for security of the data.  The data 
will be kept in locked cabinet in the Cardiovascular Research Unit in the School of 
Health and Human Performance in DCU. Access to the data will only be 
attainable by the named researchers.  Data will be kept for a minimum of five 
years from the date of publication of the research.  Aside from the named 
researchers, no others will have access to the raw data.  Data will be shredded 
by Prof. Moyna after 5 years. 
7. FUNDING 
7.1 HOW IS THIS WORK BEING FUNDED? 
 School of Health and Human Performance/CLARITY – SFI 
7.2 PROJECT GRANT NUMBER (If relevant and/or known) 
 P07625 - SFI  07/CE/I1147 
7.3 DOES THE PROJECT REQUIRE APPROVAL BEFORE CONSIDERATION FOR 
FUNDING BY A GRANTING BODY? 
 
 YES  NO  
7.5 HOW WILL PARTICIPANTS BE INFORMED OF THE SOURCE OF THE FUNDING? 
 Participants will be informed of the source of funding in the Plain Language 
Statement. 
7.5 DO ANY OF THE RESEARCHERS, SUPERVISORS OR FUNDERS OF THIS PROJECT 
HAVE A PERSONAL, FINANCIAL OR COMMERCIAL INTEREST IN ITS OUTCOME 
THAT MIGHT COMPROMISE THE INDEPENDENCE AND INTEGRITY OF THE 
RESEARCH, OR BIAS THE CONDUCT OR RESULTS OF THE RESEARCH, OR UNDULY 
DELAY OR OTHERWISE AFFECT THEIR PUBLICATION? 
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Plain Language Statement 
Dublin City University 
Project Title: Comparisons of two Exercise Training Programmes on Vascular 
Health in Patients with Cardiovascular Disease 
The Research Study will take place in the School of Health and Human 
Performance, DCU. 
The principal investigator is:  Prof. Niall M. Moyna, (Tel:  7008802, Fax: 7008888, 
Email: niall.moyna@dcu.ie) 
III. Disease of the heart and blood vessels is called cardiovascular disease 
(CVD), and is the main cause of death in Ireland.  CVD increases the 
thickness of blood vessels, and also reduces the ability of blood vessel to 
dilate (get bigger).  We can use a simple ultrasound procedure to 
measure the health of your blood vessel.  Tiny pieces of the damaged 
blood vessel wall break off into the blood and these can be measured by 
taking a blood sample.  People who exercise regularly have less chance of 
getting CVD.  People who have CVD also can reduce their risk of having a 
heart attack or stroke by exercising regularly).  The purpose of this study 
is to compare the effect of a traditional cardiac rehabilitation exercise 
programme and the effect of a high intensity exercise programme on 
your fitness level and the health of your blood vessels over the course of 
4 weeks.  You will be allowed to take part in the study if you meet the 
entry criteria and sign the informed consent.  
IV. If you agree to take part in the study you will attend exercise sessions in 
the Vascular Research Unit in the School of Health and Human 
Performance in DCU twice a week for 4 weeks.  In addition to this you will 
have 2 testing sessions carried out before you begin this training 
programme and 2 at the end (Testing Session 1, 2, 3 and 4).  You will not 
be allowed to exercise for at least 24 hours before each of these Testing 
Sessions.   
V. Before the study begins you will be assigned by chance to either a 
traditional cardiac rehabilitation exercise group, which is called the 
Control Group or an Interval Training Group. 
Control Group:  If you are assigned to the traditional cardiac 
rehabilitation group, you will be asked to visit the School of Health and 
Human Performance in DCU on 2 occasions before the 4 weeks begin and 
on 2 occasions at the end of the 4 weeks.  You will continue participating 
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in the HeartSmart classes two days per week.  During each class you will 
wear a strap around your chest to monitor your heart rate.  
Intermittent Exercise Group: If you are assigned to the interval training 
group, you will visit to the Vascular Research Unit in the School of Health 
and Human Performance in DCU for the first 2 Testing Sessions before 
the 4 week programme begins and for the second 2 Testing Sessions at 
the end of the 8 weeks.   You will attend exercise sessions in the Vascular 
Research Unit, DCU 2s days per week for 4 weeks.  During each exercise 
session you will wear small pads (ECG) and a  strap around your chest to 
monitor your heart rate.  
Testing Session 1:   
 The first Testing Session will take place in the Vascular Research 
Unit in the School of Health and Human Performance in DCU and 
will last approximately 1.5 hours 
 You will sign an informed consent and an ultrasound picture will 
be taken of a blood vessel in your neck   
 You will have a blood sample taken (about 2 tablespoons) 
 The health of a blood vessel in your arm will be measured using 
an ultrasound to take an image of your blood vessel. This will 
involve blocking the blood flow to your arm for 5 minutes using a 
blood pressure cuff and taking one spray of glyceryl trinitrate 
under your tongue.  You will be fasting before this test 
 If you are taking Viagra, other PDE5 inhibitors or any herbal sexual 
enhancers you will not take any of these for at least 48 hours 
before this testing visit 
Testing Session 2 
 This session will last about 1 hour 
 Your fitness level will be measured 
 During your fitness assessment you will wear a mouthpiece and 
exercise on a treadmill  
 You will wear small pads on your chest (ECG) to monitor your 
heart throughout exercise   
 A small droplet of blood will be taken from the earlobe before and 
after the exercise test  
Testing Session 3   
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 The third Testing Session will take place at the end of the 4 weeks 
again in the Vascular Research Unit in DCU and will last 
approximately 1.5 hour   
 You will undergo the same tests as you did during Testing Session 
1   
 If you are taking Viagra, other PDE5 inhibitors or any herbal sexual 
enhancers you will not take any of these for at least 48 hours 
before this testing visit 
Testing Session 4 
 The fourth testing session will also take place at the end of the 4 
weeks again in the Vascular Research Unit in DCU and will last 
approximately 1 hour 
 Your fitness will be assessed in the same way as Testing Session 2 
Interval Exercise sessions    
 The Interval Exercise Sessions will be monitored in the Vascular 
Research Unit   
 You will wear small pads (ECG) and a strap around on your chest 
to monitor your heart throughout exercise  
 During the second and eighth interval sessions you will wear a 
mouthpiece or a facemask during the exercise  
 You will have the health of your arteries assessed and blood 
samples drawn before and after the final (eighth) session 
 If you are taking Viagra, other PDE5 inhibitors or any herbal sexual 
enhancers you will not take any of these for at least 48 hours 
before interval session 8. 
 You will fast for at least 10 hours prior to interval session 8. 
III.  1.  Exercise testing carries with it a very small risk of abnormal heart 
rhythms, heart attack, or death in less than one in 30,000 patients.  Your 
heart will be continuously monitored using a 12 lead electrocardiogram 
(ECG) and a physician will be present.  A 12 lead ECG is a special machine 
that takes 12 different views of your heart (like photographs) while you 
are exercising.  You will have electrodes placed on your chest to allow the 
researchers observe the electrical activity of your heart during exercise. 
2.  Drawing blood may cause a slight pain where the needle is inserted 
and may leave a bruise.  A person trained to take blood will be used to 
decrease these risks.   
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3.  Taking an ultrasound image of your arm requires blocking the blood 
flow to your arm for 5 minutes using a blood pressure cuff.  This may 
cause slight discomfort in your arm, which will go away after the blood 
pressure cuff in deflated.  The glyceryl trinitrate spray used in this study 
may cause a headache that could last 5 to 10 min. 
IV. Your confidentiality will be guarded.  All information we gather will be 
stored in a secure filing cabinet.  The results of the study will be used for 
a postgraduate project and may be published in academic journals. You 
will not be identified, as your information will be presented as part of a 
group.  You will be assigned an ID number under which all personal 
information will be stored in the secure locked filing cabinet and saved in 
a password protected file in a computer at DCU.  You need to be aware 
that confidentiality of information provided can only be protected within 
the limitations of the law.  It is possible for data to be subject to 
subpoena, freedom of information claim or mandated reporting by some 
professions.  
VII. Involvement in this study is completely voluntary.  You may withdraw 
from the Research Study at any point.  Withdrawal from this study will 
not affect your participation in the HeartSmart programme or the medical 
treatment of your condition. 
VIII. This research is funded by Science Foundation Ireland. 
VIII. If you have concerns about this study and wish to contact an independent 
person, please contact: The Secretary, Dublin City University Research 
Ethics Committee, c/o Office of the Vice-President for Research, Dublin 
City University, Dublin 9.  Tel 01-7008000 
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Informed Consent 
Dublin City University 
Project Title Comparisons of two Exercise Training Programmes on Vascular 
Health in Patients with Cardiovascular Disease 
Principal Investigator Prof. Niall M. Moyna 
Introduction to this study 
Disease of the heart and blood vessels is called cardiovascular disease (CVD), and is 
the main cause of death in Ireland.  Measuring the thickness of the carotid artery in 
your neck using ultrasound can indentify CVD.  CVD damages blood vessels and 
reduces their ability to dilate (get bigger).  We can also use a simple ultrasound 
procedure to measure how much the blood vessels can dilate.  Damaged blood 
vessels release cells into the blood, which can be measured by taking a blood 
sample.  Regular physical activity improves the health of blood vessels, and also has 
a beneficial effect on many of the risk factors for CVD.  This study will measure the 
health of your blood vessels.  In addition, we will compare the effect of a traditional 
4 week cardiac rehabilitation programme and the effect of a high intensity 
intermittent exercise programme on your fitness level and the health of your blood 
vessels. 
Participants Requirements 
2. I will take part in a 4 week exercise programme in the Vascular Research Unit in 
the School of Health and Human Performance in DCU.  I will visit DCU for a 2 
Testing Sessions before and 2 at the end of the 4 weeks.  
Traditional Cardiac Rehab Group:  If I am assigned to this group, after Testing 
Sessions 1 and 2, I will continue participation in the HeartSmart classes twice 
per week.  During each class I will wear a strap around my chest to monitor my 
heart rate.  After 4 weeks of HeartSmart I will return to the Vascular Research 
Unit for my 3rd and 4th exercise testing visit. 
Intermittent Training Group: If I am assigned to the Intermittent training 
group I will attend 2 supervised exercise sessions per week in the Vascular 
Research Unit, DCU. During every session I will wear small pads on my chest and 
a strap around my chest to monitor my heart.  After 4 weeks of intermittent 
training I will return to the Vascular Research Unit for Testing Session 3 and 4. 
3. During my first Testing Session (which lasts approximately 1.5 hour), I will have a 
blood sample taken and an ultrasound measurement will be taken of my neck to 
measure my carotid artery (See Figure 1).  This test is painless and lasts about 15 
min.  I will also have a blood sample taken from a vein in my arm.  The total 
amount of blood drawn will be 2 tablespoons.  The health of an artery in my 
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arm will also be measured. If I am taking Viagra, other PDE5 inhibitors or any 
herbal sexual enhancers I will not take any of these for at least 48 hours before 
this testing visit. 
4. My second Testing Session will last about 1 hour and I will have my fitness 
assessed.  During this test the electrical activity of my heart will be assessed by a 
12 lead electrocardiogram (ECG).  This is a special machine that takes 12 
different views of my heart (like photographs).  I will have electrodes (small 
pads) placed on my chest and a heart rate monitor to allow the researchers 
observe the electrical activity of my heart during exercise. I will be fitted with a 
mouthpiece and will undergo a treadmill exercise test to assess my fitness level.   
5. At the end of the 4 week programme, I will return to the Vascular Research Unit 
in the School of Health and Human Performance DCU for my third Testing 
Session.  This will be a repeat of the tests carried out during Testing Session 1.  If 
I am taking Viagra, other PDE5 inhibitors or any herbal sexual enhancers I will 
not take any of these for at least 48 hours before this testing visit. 
6. Testing Session 4 will be a repeat of the test carried out during during Testing 
Session 2. 
7. During the 4 week exercise programme, all training sessions will take place in 
the Vascular Research Unit in DCU.   
- During these sessions I will wear a mouthpiece and walk on a treadmill 
-  I will have a small droplet of blood taken from my earlobe at the end of 
each session  
- I will wear electrodes and a strap on my chest to monitor my heart 
throughout the exercise 
- Before and after the last exercise session I will have a blood sample taken 
and the  health of a blood vessel in my arm will be measured.  I will fast 
for 10 hour before this session.  If I am taking Viagra, other PDE5 
inhibitors or any herbal sexual enhancers I will not take any of these for 
at least 48 hours before the last exercies sessions (Session 8). 
8. I will not exercise for at least 24 hours before each visit to the Vascular Research 
Unit. 
6. To test the health of the arteries in my neck (testing session 1) I will lie on my 
back and an ultrasound will be placed on my neck and a number of photographs 
of the artery will be taken. 
7. To test the health of the arteries in my arm (exercise session 2 and 3, and testing 
session 2) I will lie on my back, and an ultrasound will be placed on my upper arm 
to create an image of my artery.  After the first image is recorded, a blood 
pressure cuff will be inflated on my forearm to block blood flow for five minutes.  
This may be uncomfortable.  The cuff will be released and the images of my 
arteries repeated.  I will rest for 15 minutes and then have one spray of glyceryl 
 
 
207 
 
 
trinitrate under my tongue.  The glyceryl trinitrate will cause my arm arteries to 
enlarge and how much they enlarge will again be documented by taking a third 
set of pictures.  
                                     
Potential risks to participants from involvement in the Research Study  
1.  Exercise testing carries with it a very small risk of abnormal heart rhythms, heart 
attack, or death in less than one in 30,000 patients. Your heart will be continuously 
monitored using a 12 lead ECG and a physician will be present. 
2.  Drawing blood may cause a slight pain where the needle is inserted and can leave 
a bruise.  A person trained to take blood will be used to decrease these risks. 
3.  The amount of blood drawn is not harmful, however, if I have a history of 
anaemia, I should inform the investigator. 
4.  The pictures of my arm arteries require blocking the blood flow to my arm for 5 
minutes.  This may cause slight discomfort in the arm, which will go away after the 
blood pressure cuff in deflated.  The glyceryl trinitrate used in this study may induce 
a headache that could last 5 to 10 min.   
Benefits (direct or indirect) to participants from involvement in the Research Study 
After completing the study I will be provided with a copy of my results, summarising 
information such as my body mass index, blood pressure and cholesterol levels.  
There are no other direct benefits to me. 
Participant – please complete the following (circle Yes or No for each question) 
Have you read or had read to you the Plain Language Statement? Yes  No  
Do you understand the information provided?    Yes  No  
Have you had an opportunity to ask questions and discuss this study? Yes  No  
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Have you received satisfactory answers to all your questions?  Yes  No  
Advice as to arrangements to be made to protect confidentiality of data, including 
that confidentiality of information provided is subject to legal limitations. 
Your identity and other personal information will not be revealed, published or used 
in further studies.  You will be assigned an ID number under which all personal 
information will be stored in a secure locked cabinet and saved in a password 
protected file in a computer at DCU.  The named investigators will have access to the 
data.  Data will be shredded after 5 years by Prof. Moyna. 
Confidentiality is insured, but you must be aware that confidentiality of information 
provided can only be protected within the limitations of the law.  It is possible for 
data to be subject to subpoena, freedom of information claim or mandated 
reporting by some professions. 
If you are in a dependent relationship with any of the researchers their involvement 
in the project will not affect ongoing assessment/grades/management or treatment 
of health at DCU. Withdrawal from this study will not affect your participation in the 
HeartSmart programme or the medical treatment of your condition. 
Signature: 
I have read and understood the information in this form.  The researchers have 
answered my questions and concerns, and I have a copy of this consent form.  
Therefore, I (print name) ______________________ consent to take part in this 
research project entitled Comparisons of two Exercise Training Programmes on 
Vascular Health in Patients with Cardiovascular Disease.  
Participants Signature:  ____________________________________ 
Name in Block Capitals       
Witness:          
Date:          
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Appendix E 
  O2peak Protocol 1 
Stage Time Speed Slope 
Warm Up 2:00 3.4 0.0 
1 2:00 4.0 2.5 
2 2:00 4.0 5.0 
3 2:00 4.0 7.5 
4 2:00 4.0 10.0 
5 2:00 4.0 12.5 
6 2:00 4.0 15.0 
7 2:00 4.0 17.5 
8 2:00 4.0 20.0 
9 2:00 4.0 22.5 
10 2:00 4.0 22.5 
11 99:00 4.0 22.5 
Recovery 5:00 3.2 0.0 
 
  O2peak Protocol 2 
Stage Time Speed Slope 
Warm Up 2:00 4.0 0.0 
1 2:00 4.8 2.5 
2 2:00 4.8 5.0 
3 2:00 4.8 7.5 
4 2:00 4.8 10.0 
5 2:00 4.8 12.5 
6 2:00 4.8 15.0 
7 2:00 4.8 17.5 
8 2:00 4.8 20.0 
9 2:00 4.8 22.5 
10 2:00 4.8 22.5 
11 99:00 4.8 22.5 
Recovery 5:00 3.2 0.0 
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  O2peak Protocol 3 
Stage Time Speed Slope 
Warm Up 2:00 3.4 0.0 
1 2:00 5.5 2.5 
2 2:00 5.5 5.0 
3 2:00 5.5 7.5 
4 2:00 5.5 10.0 
5 2:00 5.5 12.5 
6 2:00 5.5 15.0 
7 2:00 5.5 17.5 
8 2:00 5.5 20.0 
9 2:00 5.5 22.5 
10 2:00 5.5 22.5 
11 99:00 5.5 22.5 
Recovery 5:00 3.2 0.0 
 
  O2peak Protocol 4 
Stage Time Speed Slope 
Warm Up 2:00 6.0 0.0 
1 2:00 6.0 2.5 
2 2:00 6.0 5.0 
3 2:00 6.0 7.5 
4 2:00 6.0 10.0 
5 2:00 6.0 12.5 
6 2:00 6.0 15.0 
7 2:00 6.0 17.5 
8 2:00 6.0 20.0 
9 2:00 6.0 22.5 
10 2:00 6.0 22.5 
11 99:00 6.0 22.5 
Recovery 5:00 3.2 0.0 
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  O2peak Protocol 5 
Stage Time Speed Slope 
Warm Up 2:00 7.0 0.0 
1 2:00 9.0 2.5 
2 2:00 9.0 5.0 
3 2:00 9.0 7.5 
4 2:00 9.0 10.0 
5 2:00 9.0 12.5 
6 2:00 9.0 15.0 
7 2:00 9.0 17.5 
8 2:00 9.0 20.0 
9 2:00 9.0 22.5 
10 2:00 9.0 22.5 
11 99:00 9.0 22.5 
Recovery 5:00 3.2 0.0 
 
